<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Higher versus lower protein intake in formula‐fed term infants - Gonzalez-Garay, AG - 2023 | Cochrane Library</title> <meta content="Higher versus lower protein intake in formula‐fed term infants - Gonzalez-Garay, AG - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013758.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Higher versus lower protein intake in formula‐fed term infants - Gonzalez-Garay, AG - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013758.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013758.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Higher versus lower protein intake in formula‐fed term infants" name="citation_title"/> <meta content="Alejandro G Gonzalez-Garay" name="citation_author"/> <meta content="Instituto Nacional de Pediatría" name="citation_author_institution"/> <meta content="pegasso.100@hotmail.com" name="citation_author_email"/> <meta content="Aurora E Serralde-Zúñiga" name="citation_author"/> <meta content="Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán" name="citation_author_institution"/> <meta content="Isabel Medina Vera" name="citation_author"/> <meta content="Instituto Nacional de Pediatría" name="citation_author_institution"/> <meta content="Liliana Velasco Hidalgo" name="citation_author"/> <meta content="Instituto Nacional de Pediatría" name="citation_author_institution"/> <meta content="Mathy Victoria Alonso Ocaña" name="citation_author"/> <meta content="Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD013758.pub2" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/11/06" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013758.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013758.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013758.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Diarrhea; Growth Disorders; *Malnutrition; *Milk Hypersensitivity; Obesity; Overweight; Thinness; Vomiting" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013758.pub2&amp;doi=10.1002/14651858.CD013758.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="na56WA6j";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013758\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013758\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013758\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013758\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ko","ms","hr","fa","pl","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013758.pub2",title:"Higher versus lower protein intake in formula\\u2010fed term infants",firstPublishedDate:"Nov 6, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neonatal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=na56WA6j&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013758.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013758.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013758.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013758.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013758.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013758.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013758.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013758.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013758.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013758.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1119 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013758.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/full#CD013758-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/full#CD013758-sec-0109"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/full#CD013758-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/full#CD013758-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/full#CD013758-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/full#CD013758-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/full#CD013758-sec-0041"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/full#CD013758-sec-0103"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/appendices#CD013758-sec-0116"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/supinfo/CD013758-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/supinfo/CD013758-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Higher versus lower protein intake in formula‐fed term infants</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/information#CD013758-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Alejandro G Gonzalez-Garay</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/information#CD013758-cr-0005">Aurora E Serralde-Zúñiga</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/information#CD013758-cr-0006">Isabel Medina Vera</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/information#CD013758-cr-0007">Liliana Velasco Hidalgo</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013758.pub2/information#CD013758-cr-0008">Mathy Victoria Alonso Ocaña</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/information/en#CD013758-sec-0135">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 06 November 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013758.pub2">https://doi.org/10.1002/14651858.CD013758.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013758-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013758-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013758-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013758-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013758-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013758-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013758-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013758-abs-0001" lang="en"> <section id="CD013758-sec-0001"> <h3 class="title" id="CD013758-sec-0001">Background</h3> <p>Many infants are fed infant formulas to promote growth. Some formulas have a high protein content (≥ 2.5 g per 100 kcal) to accelerate weight gain during the first year of life. The risk‐benefit balance of these formulas is unclear. </p> </section> <section id="CD013758-sec-0002"> <h3 class="title" id="CD013758-sec-0002">Objectives</h3> <p>To evaluate the benefits and harms of higher protein intake versus lower protein intake in healthy, formula‐fed term infants. </p> </section> <section id="CD013758-sec-0003"> <h3 class="title" id="CD013758-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE, Embase, CINAHL, LILACS, OpenGrey, clinical trial registries, and conference proceedings in October 2022. </p> </section> <section id="CD013758-sec-0004"> <h3 class="title" id="CD013758-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs) of healthy formula‐fed infants (those fed only formula and those given formula as a complementary food). We included infants of any sex or ethnicity who were fed infant formula for at least three consecutive months at any time from birth. We excluded quasi‐randomized trials, observational studies, and infants with congenital malformations or serious underlying diseases. We defined high protein content as 2.5 g or more per 100 kcal, and low protein content as less than 1.8 g per 100 kcal (for exclusive formula feeding) or less than 1.7 g per 100 kcal (for complementary formula feeding). </p> </section> <section id="CD013758-sec-0005"> <h3 class="title" id="CD013758-sec-0005">Data collection and analysis</h3> <p>Four review authors independently assessed the risk of bias and extracted data from trials, and a fifth review author resolved discrepancies. We performed random‐effects meta‐analyses, calculating risk ratios (RRs) or Peto odds ratios (Peto ORs) with 95% confidence intervals (CIs) for dichotomous outcomes, and mean differences (MDs) with 95% CIs for continuous outcomes. We used the GRADE approach to evaluate the certainty of the evidence. </p> </section> <section id="CD013758-sec-0006"> <h3 class="title" id="CD013758-sec-0006">Main results</h3> <p>We included 11 RCTs (1185 infants) conducted in high‐income countries. Seven trials (1629 infants) compared high‐protein formula against standard‐protein formula, and four trials (256 infants) compared standard‐protein formula against low‐protein formula. The longest follow‐up was 11 years. </p> <p><b>High‐protein formula versus standard‐protein formula</b> </p> <p>We found very low‐certainty evidence that feeding healthy term infants high‐protein formula compared to standard‐protein formula has little or no effect on underweight (MD in weight‐for‐age z‐score 0.05 SDs, 95% CI −0.09 to 0.19; P = 0.51, I<sup>2</sup> = 61%; 7 studies, 1629 participants), stunting (MD in height‐for‐age z‐score 0.15 SDs, 95% CI −0.05 to 0.35; P = 0.14, I<sup>2</sup> = 73%; 7 studies, 1629 participants), and wasting (MD in weight‐for‐height z‐score −0.12 SDs, 95% CI −0.31 to 0.07; P = 0.20, I<sup>2</sup> = 94%; 7 studies, 1629 participants) in the first year of life. </p> <p>We found very low‐certainty evidence that feeding healthy infants high‐protein formula compared to standard‐protein formula has little or no effect on the occurrence of overweight (RR 1.26, 95% CI 0.63 to 2.51; P = 0.51; 1 study, 1090 participants) or obesity (RR 1.96, 95% CI 0.59 to 6.48; P = 0.27; 1 study, 1090 participants) at five years of follow‐up. </p> <p>No studies reported all‐cause mortality.</p> <p>Feeding healthy infants high‐protein formula compared to standard‐protein formula may have little or no effect on the occurrence of adverse events such as diarrhea, vomiting, or milk hypersensitivity (RR 0.93, 95% CI 0.76 to 1.13; P = 0.44, I<sup>2</sup> = 0%; 4 studies, 445 participants; low‐certainty evidence) in the first year of life. </p> <p><b>Standard‐protein formula versus low‐protein formula</b> </p> <p>We found very low‐certainty evidence that feeding healthy infants standard‐protein formula compared to low‐protein formula has little or no effect on underweight (MD in weight‐for‐age z‐score 0.0, 95% CI −0.43 to 0.43; P = 0.99, I<sup>2</sup> = 81%; 4 studies, 256 participants), stunting (MD in height‐for‐age z‐score −0.01, 95% CI −0.36 to 0.35; P = 0.96, I<sup>2</sup> = 73%; 4 studies, 256 participants), and wasting (MD in weight‐for‐height z‐score 0.13, 95% CI −0.29 to 0.56; P = 0.54, I<sup>2</sup> = 95%; 4 studies, 256 participants) in the first year of life. </p> <p>No studies reported overweight, obesity, or all‐cause mortality.</p> <p>Feeding healthy infants standard‐protein formula compared to low‐protein formula may have little or no effect on the occurrence of adverse events such as diarrhea, vomiting, or milk hypersensitivity (Peto OR 1.55, 95% CI 0.70 to 3.40; P = 0.28, I<sup>2</sup> = 0%; 2 studies, 206 participants; low‐certainty evidence) in the first four months of life. </p> </section> <section id="CD013758-sec-0007"> <h3 class="title" id="CD013758-sec-0007">Authors' conclusions</h3> <p>We are unsure if feeding healthy infants high‐protein formula compared to standard‐protein formula has an effect on undernutrition, overweight, or obesity. There may be little or no difference in the risk of adverse effects between infants fed with high‐protein formula versus those fed with standard‐protein formula. </p> <p>We are unsure if feeding healthy infants standard‐protein formula compared to low‐protein formula has any effect on undernutrition. There may be little or no difference in the risk of adverse effects between infants fed with standard‐protein formula versus those fed with low‐protein formula. </p> <p>The findings of six ongoing studies and two studies awaiting classification studies may change the conclusions of this review. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013758-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013758-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013758-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013758-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013758-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD013758-abs-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ko#CD013758-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD013758-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD013758-abs-0012">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD013758-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013758-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013758-abs-0002" lang="en"> <h3>Higher‐protein formula versus lower‐protein formula: which works better to prevent malnutrition and obesity in infants? </h3> <p><b>Key messages</b> </p> <p>1. We are unsure if high‐protein formula affects malnutrition or obesity in infants.<br/>2. Larger studies are needed to further evaluate the benefits and potential harms of the different types of formula.<br/>3. Future research should focus on long‐term growth and brain development. </p> <p><b>What are high‐ and low‐protein infant formulas?</b> </p> <p>Infant formulas have a similar nutritional content to breast milk, and contain ingredients such as cow's milk, fats, vitamins, proteins (such as whey or soy protein), and carbohydrates. Depending on the amount of protein they contain, formulas are categorized as low‐protein (less than 1.8 g per 100 kcal), standard‐protein, or high‐protein (2.5 g or more per 100 kcal). </p> <p><b>Why is it important to study infant formula?</b> </p> <p>Despite World Health Organization (WHO) recommendations, many full‐term infants around the world are fed formula instead of breast milk. Some infant formulas contain more that the recommended amount of protein; they are designed to increase weight gain in infants during the first year of life. However, we do not know the effect of high‐protein formula on malnutrition, overweight, or obesity during infancy. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to find out whether high protein formula is better than standard or low protein formula for preventing:<br/>1. malnutrition (low weight for age, low height for age, or low weight or height);<br/>2. overweight or obesity (high weight for height); and<br/>3. other unwanted events. </p> <p><b>What did we do?</b> </p> <p>We searched for studies examining higher‐protein formula compared with lower‐protein formula in healthy infants of either sex, born at nine months of pregnancy and with normal birth weight and height. </p> <p>We compared and summarized the results of the studies, and rated our confidence in the evidence based on factors such as study methods and sizes. </p> <p><b>What did we find?</b> </p> <p>We found 11 eligible studies involving 1885 healthy, full‐term, formula‐fed infants. Seven studies (1629 infants) compared high‐protein formula with standard‐protein formula, and four studies (256 infants) compared standard‐protein formula with low‐protein formula. The biggest study included 1090 infants, and the smallest study included 20 infants. Ten studies were conducted in Europe and one in the USA. Most studies lasted approximately four months; only two studies lasted five years or more. Pharmaceutical companies funded all the studies. </p> <p>Overall, we are unsure if feeding healthy infants high‐protein formula compared to standard‐protein formula has any effect on undernutrition, overweight, or obesity in the first year of life. We are unsure if feeding healthy infants standard‐protein formula compared to low‐protein formula has any effect on undernutrition in childhood. The occurrence of unwanted events in formula‐fed infants may be unrelated to the protein content of the formula. </p> <p><b>What are the limitations of the evidence</b> </p> <p>We are not confident about the evidence because the studies provided information in different ways, and the results varied considerably across studies. Moreover, some studies had many dropouts, which could have affected the results. Further research is likely to modify the results of this review. </p> <p><b>How up to date is this evidence?</b> </p> <p>The evidence is current to October 2022.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013758-sec-0109" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013758-sec-0109"></div> <h3 class="title" id="CD013758-sec-0110">Implications for practice</h3> <section id="CD013758-sec-0110"> <section id="CD013758-sec-0111"> <h5 class="title">High‐protein formula versus standard‐protein formula</h5> <p>We are unsure if feeding healthy term infants high‐protein formula (&gt; 2.5 g per 100 kcal) compared with standard‐protein formula (1.8 g to &lt; 2.5 g per 100 kcal) has an effect on undernutrition (underweight, stunting, or wasting) in the first year of life, regardless of whether the infants are exclusively formula‐fed or are given formula in addition complementary foods. </p> <p>We are unsure if feeding healthy term infants high‐protein formula compared with standard‐protein formula has an effect on the risk of overweight or obesity in the first five years of life. </p> <p>Only one study reported neurodevelopmental outcomes, and no studies reported all‐cause mortality. </p> <p>The evidence suggests that there is little or no difference in the risk of adverse events between infants fed high‐protein formula and those fed standard‐protein formula, either exclusively or with complementary foods, in the first year of life. </p> <p>We are unsure if feeding healthy term infants high‐protein formula compared with standard‐protein formula, either exclusively or with complementary foods, has an effect on anthropometric measurements, such as weight, height, body mass index (BMI), and head circumference in the first year of life. No studies reported arm circumference. </p> </section> <section id="CD013758-sec-0112"> <h5 class="title">Standard‐protein formula versus low‐protein formula</h5> <p>We are unsure if feeding healthy term infants standard‐protein formula, compared with low‐protein formula (&lt; 1.8 g per 100 kcal) has an effect on undernutrition (underweight, stunting, or wasting) in the first year of life, regardless of whether the infants are exclusively formula‐fed or are given formula with complementary foods. </p> <p>No studies reported overweight, obesity, neurodevelopment, or all‐cause mortality.</p> <p>The evidence suggests that there is little or no difference in the risk of experiencing adverse events between infants who are exclusively fed standard protein formula and those who are exclusively fed low‐protein formula in the first four months of life. No studies reported adverse events in children who were given formula in addition to complementary foods. </p> <p>We are unsure if feeding healthy term infants standard‐protein formula compared with low‐protein formula, either exclusively or with complementary foods, has an effect on anthropometric measurements, such as weight, height, BMI, and head circumference in the first year of life. No studies reported arm circumference. </p> </section> </section> <h3 class="title" id="CD013758-sec-0113">Implications for research</h3> <section id="CD013758-sec-0113"> <p>The conclusion of our review may change if and when we incorporate the findings of the six ongoing trials and the two trials pending classification in future updates. </p> <p>There is a need for standardized research with lower attrition rates to determine whether the protein content of infant formula has any effect on infant morbidity and neurodevelopment in the short and long term. This information is necessary to establish adequate feeding programs for ensuring the optimal growth and development of infants. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013758-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013758-sec-0008"></div> <div class="table" id="CD013758-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">High‐protein formula versus standard‐protein formula in healthy term infants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>High‐protein formula versus standard‐protein formula in healthy term infants</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Population:</b> healthy, full‐term, formula‐fed infants<br/><b>Setting:</b> outpatient<br/><b>Intervention:</b> high‐protein formula (≥ 2.5 g per 100 kcal)<br/><b>Comparison:</b> standard‐protein formula (1.8 g to &lt; 2.5 g per 100 kcal) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with standard‐protein formula</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with high‐protein formula</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Underweight (weight‐for‐age z‐score)</b> </p> <p>Follow‐up: median 4 months, maximum 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean weight‐for‐age z‐score was 0.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD0.05 higher</b> (0.09 lower to 0.19 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1629<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are unsure if feeding healthy term infants high‐protein formula compared to standard‐protein formula has an effect on weight‐for‐age z‐score in the first year of life. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Stunting (height‐for‐age z‐score)</b> </p> <p>Follow‐up: median 4 months, maximum 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean height‐for‐age z‐score was 0.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD0.15 higher</b> (0.05 lower to 0.35 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1629<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are unsure if feeding healthy term infants high‐protein formula compared to standard‐protein formula has an effect on height‐for‐age z‐score in the first year of life. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Wasting (weight‐for‐height z‐score)</b> </p> <p>Follow‐up: median 4 months, maximum 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean weight‐for‐height z‐score was 0.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.12 lower</b> (0.31 lower to 0.07 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1629<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are unsure if feeding healthy term infants high‐protein formula compared to standard‐protein formula has an effect on weight‐for‐height z‐score in the first year of life. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Overweight</b> </p> <p>Follow up: 5 years</p> </td> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.26</b> (0.63 to 2.51) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1090</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We are unsure if feeding healthy term infants high‐protein formula compared to standard‐protein formula has an effect on risk of overweight in the first five years of life. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b> </p> <p>(16 to 65)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Obesity</b> </p> <p>Follow up: 5 years</p> </td> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.96</b><br/>(0.59 to 6.48) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1090<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We are unsure if feeding healthy term infants high‐protein formula compared to standard‐protein formula has an effect on risk of obesity in the first five years of life. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b><br/>(4 to 48) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No studies reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> </p> <p>Follow‐up: median 4 months, maximum 1 year</p> </td> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.93</b><br/>(0.76 to 1.13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>445<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There may be little or no difference between the risk of adverse events with high‐protein formula versus standard‐protein formula in healthy term infants in the first year of life. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>342 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>318 per 1000</b><br/>(260 to 387) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RR:</b> risk ratio; <b>RCT:</b> randomized controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level for attrition bias (data available in up to 55% of the random sample), one level for inconsistency (I<sup>2</sup> &gt; 30%), and one level for imprecision (wide 95% CI encompassing both potential benefit and potential harm).<br/><sup>b</sup> Downgraded one level for attrition bias (data available in up to 55% of the random sample), two levels for inconsistency (I<sup>2</sup> &gt; 80%), and one level for imprecision (wide 95% CI encompassing both potential benefit and potential harm).<br/><sup>c</sup> Downgraded one level for attrition bias (data available in up to 55% of the random sample) and two levels for imprecision (wide 95% CI encompassing both potential benefit and potential harm).<br/><sup>d</sup> Downgraded one level for attrition bias (data available in up to 55% of the random sample) and one level for imprecision (wide 95% CI encompasses both potential benefit and potential harm). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013758-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Standard‐protein formula versus low‐protein formula in healthy term infants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Standard‐protein formula versus low‐protein formula in healthy term infants</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> healthy, full‐term (37 to 42 weeks), formula‐fed infants<br/><b>Setting:</b> outpatient<br/><b>Intervention:</b> standard‐protein formula (1.8 g to &lt; 2.5 g per 100 kcal)<br/><b>Comparison:</b> low‐protein formula (&lt; 1.8 g per 100 kcal) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with low‐protein formula</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with standard‐protein formula</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Underweight (weight‐for‐age z‐score)</b> </p> <p>Follow‐up: median 4 months, maximum 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean weight‐for‐age z‐score was 0</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0</b> (0.43 lower to 0.43 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>256</p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are unsure if feeding healthy term infants standard‐protein formula compared to low‐protein formula has an effect on weight‐for‐age z‐score in the first year of life. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Stunting (height‐for‐age z‐score)</b> </p> <p>Follow‐up: median 4 months, maximum 1 yea</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean height‐for‐age z‐score was 0.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.01 lower</b> (0.36 lower to 0.35 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>256</p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are unsure if feeding healthy term infants standard‐protein formula compared to low‐protein formula has an effect on height‐for‐age z‐score in the first year of life. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Wasting (weight‐for‐height z‐score)</b> </p> <p>Follow‐up: median 4 months, maximum 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean weight‐for‐height z‐score was 0.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.13 higher</b> (0.29 lower to 0.56 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>256</p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are unsure if feeding healthy term infants standard‐protein formula compared to low‐protein formula has an effect on weight‐for‐height z‐score in the first year of life. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overweight</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No studies reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Obesity</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No studies reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No studies reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> </p> <p>Follow‐up: maximum 4 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Peto OR 1.55</b> (0.70 to 3.40) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>206</p> <p>(2 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There may be little or no difference between the risk of adverse events with standard‐protein formula versus low‐protein formula in healthy term infants in the first year of life. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>114 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>167 per 1000</b><br/>(83 to 305) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>OR:</b> odds ratio; <b>RCT:</b> randomized controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level for selection bias, two levels for inconsistency (I<sup>2</sup> &gt; 80%), and one level for imprecision (wide 95% CI encompassing both potential benefit and potential harm).<br/><sup>b</sup> Downgraded one level for selection bias, one level for inconsistency (I<sup>2</sup> &gt; 30%), and one level for imprecision (wide 95% CI encompassing both potential benefit and potential harm).<br/><sup>c</sup> Downgraded one level for selection bias and one level for imprecision (wide 95% CI encompassing both potential benefit and potential harm). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013758-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013758-sec-0009"></div> <section id="CD013758-sec-0010"> <h3 class="title" id="CD013758-sec-0010">Description of the condition</h3> <p>The United Nations Children's Fund (UNICEF) and the World Health Organization (WHO) clearly support breastfeeding as the ideal form of nutrition for the newborn. This is because breast milk provides the energy and nutrients necessary for safe and proper growth and development. Breastfeeding further offers protection against the development of food allergies, malnutrition, and respiratory and gastrointestinal infections, which are some of the leading causes of death in children aged under five years worldwide (<a href="./references#CD013758-bbs2-0054" title="American Academy of Pediatrics. Breastfeeding and the use of human milk. Pediatrics2012;129(3):e827-41. [DOI: 10.1542/peds.2011-3552] [PMID: 22371471]">AAP 2012</a>; <a href="./references#CD013758-bbs2-0141" title="Food &amp; Nutrition Action in Health Systems, Guidelines Review Committee, Nutrition and Food Safety World Health Organization and the United Nations International Children's Fund (UNICEF) (editors). Protecting, promoting and supporting breastfeeding in facilities providing maternity and newborn services: implementing the revised baby-friendly hospital Initiative. Switzerland: World Health Organization &amp; United Nations Children's Fund (‎UNICEF)‎, 2018. [ISBN: 978-92-4-151380-7]">WHO 2018</a>). Despite these benefits, the prevalence of breastfeeding at 12 months is low: from 1% to 35% in high‐ and upper middle‐income countries, and from 76% to 85% in low‐ and lower middle‐income countries (<a href="./references#CD013758-bbs2-0054" title="American Academy of Pediatrics. Breastfeeding and the use of human milk. Pediatrics2012;129(3):e827-41. [DOI: 10.1542/peds.2011-3552] [PMID: 22371471]">AAP 2012</a>; <a href="./references#CD013758-bbs2-0093" title="IpS , ChungM , RamanG , ChewP , MagulaN , DeVineD , et al. Breastfeeding and maternal and infant health outcomes in developed countries. Evidence Report Technology Assessment2007;153:1-186. [PMID: 17764214]">Ip 2007</a>; <a href="./references#CD013758-bbs2-0128" title="SzucsKA . American Academy of Pediatrics section on breastfeeding. Journal of Human Lactation2011;27(4):378-9. [DOI: 10.1177/0890334411422704] [PMID: 22048758]">Szucs 2011</a>; <a href="./references#CD013758-bbs2-0135" title="VictoriaCG , BahlR , BarrosAJ , FrançaG , HortonS , KrasevecJ , et al, Lancet Breastfeeding Series Group. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet2016;387(10017):475-90. [DOI: 10.1016/S0140-6736(15)01024-7] [PMID: 26869575]">Victoria 2016</a>; <a href="./references#CD013758-bbs2-0141" title="Food &amp; Nutrition Action in Health Systems, Guidelines Review Committee, Nutrition and Food Safety World Health Organization and the United Nations International Children's Fund (UNICEF) (editors). Protecting, promoting and supporting breastfeeding in facilities providing maternity and newborn services: implementing the revised baby-friendly hospital Initiative. Switzerland: World Health Organization &amp; United Nations Children's Fund (‎UNICEF)‎, 2018. [ISBN: 978-92-4-151380-7]">WHO 2018</a>). </p> <p>According to WHO, malnutrition is an imbalance between the intake of energy or nutrients (or both) in a person. It is classified into the following three types. </p> <p> <ol id="CD013758-list-0001"> <li> <p>Undernutrition: a nutritional deficiency resulting from insufficient food intake, or the inability to convert or absorb food, which is often accompanied by repeated infections (<a href="./references#CD013758-bbs2-0132" title="UNICEF. Child malnutrition. data.unicef.org/topic/nutrition/malnutrition/ (accessed 18 April 2023).">UNICEF 2020</a>; <a href="./references#CD013758-bbs2-0142" title="World Health Organization. Malnutrition. who.int/en/news-room/fact-sheets/detail/malnutrition (accessed 20 August 2020).">WHO 2020</a>). Undernutrition manifests in the following three ways. </p> <ol id="CD013758-list-0002"> <li> <p>Underweight: when the weight of a person is much lower than average for their age (weight for age more than 2 standard deviations (SDs) below the median of the WHO Child Growth Standards; <a href="./references#CD013758-bbs2-0139" title="World Health Organization. WHO Global Database on Child Growth and Malnutrition. In: World Health Organization , editors(s). Departament of Nutrition for Health and Development (NHD). Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data, 2010. [ISBN 9789241599955]">WHO 2010</a>; <a href="./references#CD013758-bbs2-0144" title="World Health Organization. Child growth standards. who.int/tools/child-growth-standards/standards (accessed 13 April 2023).">WHO standards 2023</a>). </p> </li> <li> <p>Stunting or growth retardation: the result of long‐term nutritional deprivation (height for age more than 2 SDs below the median of the WHO Child Growth Standards; <a href="./references#CD013758-bbs2-0139" title="World Health Organization. WHO Global Database on Child Growth and Malnutrition. In: World Health Organization , editors(s). Departament of Nutrition for Health and Development (NHD). Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data, 2010. [ISBN 9789241599955]">WHO 2010</a>; <a href="./references#CD013758-bbs2-0144" title="World Health Organization. Child growth standards. who.int/tools/child-growth-standards/standards (accessed 13 April 2023).">WHO standards 2023</a>). </p> </li> <li> <p>Wasting: a consequence of insufficient food intake that increases the risk of infectious diseases and death (weight for height more than 2 SDs below the median of the WHO Child Growth Standards; <a href="./references#CD013758-bbs2-0139" title="World Health Organization. WHO Global Database on Child Growth and Malnutrition. In: World Health Organization , editors(s). Departament of Nutrition for Health and Development (NHD). Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data, 2010. [ISBN 9789241599955]">WHO 2010</a>; <a href="./references#CD013758-bbs2-0144" title="World Health Organization. Child growth standards. who.int/tools/child-growth-standards/standards (accessed 13 April 2023).">WHO standards 2023</a>). </p> </li> </ol> </li> <li> <p>Micronutrient‐related malnutrition: a deficiency of important vitamins and minerals or micronutrient excess (<a href="./references#CD013758-bbs2-0139" title="World Health Organization. WHO Global Database on Child Growth and Malnutrition. In: World Health Organization , editors(s). Departament of Nutrition for Health and Development (NHD). Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data, 2010. [ISBN 9789241599955]">WHO 2010</a>). </p> </li> <li> <p>Overweight or obesity: excessive fat accumulation that may impair health, classified as follows. </p> <ol id="CD013758-list-0003"> <li> <p>Overweight: weight for height more than 2 SDs above the median of the WHO Child Growth Standards (<a href="./references#CD013758-bbs2-0139" title="World Health Organization. WHO Global Database on Child Growth and Malnutrition. In: World Health Organization , editors(s). Departament of Nutrition for Health and Development (NHD). Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data, 2010. [ISBN 9789241599955]">WHO 2010</a>; <a href="./references#CD013758-bbs2-0144" title="World Health Organization. Child growth standards. who.int/tools/child-growth-standards/standards (accessed 13 April 2023).">WHO standards 2023</a>). </p> </li> <li> <p>Obesity: weight for height more than 3 SDs above the median of the WHO Child Growth Standards (<a href="./references#CD013758-bbs2-0139" title="World Health Organization. WHO Global Database on Child Growth and Malnutrition. In: World Health Organization , editors(s). Departament of Nutrition for Health and Development (NHD). Geneva, Switzerland: WHO Library Cataloguing-in-Publication Data, 2010. [ISBN 9789241599955]">WHO 2010</a>; <a href="./references#CD013758-bbs2-0144" title="World Health Organization. Child growth standards. who.int/tools/child-growth-standards/standards (accessed 13 April 2023).">WHO standards 2023</a>). </p> </li> </ol> </li> </ol> </p> </section> <section id="CD013758-sec-0011"> <h3 class="title" id="CD013758-sec-0011">Description of the intervention</h3> <p>Infants who are not exclusively breastfed can receive breast milk substitutes (<a href="./references#CD013758-bbs2-0135" title="VictoriaCG , BahlR , BarrosAJ , FrançaG , HortonS , KrasevecJ , et al, Lancet Breastfeeding Series Group. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet2016;387(10017):475-90. [DOI: 10.1016/S0140-6736(15)01024-7] [PMID: 26869575]">Victoria 2016</a>). These substitutes are formulas made from cow's milk, serum proteins, vegetable oils, and carbohydrates; their physical characteristics and nutritional and energy composition resemble those of human milk. The aim of formula feeding is to promote the normal growth and development of infants (<a href="./references#CD013758-bbs2-0095" title="KoletzkoB , BakerS , CleghornG , NetoUF , GopalanS , HernellO , et al. Global standard for composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. Journal of Pediatric Gastroenterology and Nutrition2005;41(5):584-99. [DOI: 10.1097/01.mpg.0000187817.38836.42] [PMID: 16254515]">Koletzko 2005</a>; <a href="./references#CD013758-bbs2-0134" title="VermilyeaS , LierVL . Enteral feeding in children: sorting out tubes, buttons and formulas. Nutrition in Clinical Practice2016;31(1):59-67. [DOI: 10.1177/0884533615604806] [PMID: 26341918]">Vermilyea 2015</a>). </p> <p>Different types of infant formulas are available to address to the varying nutritional needs of newborns. For example, formulas for preterm infants can have additional thickeners and modified carbohydrates, fats, or proteins. Infant formulas for healthy infants (i.e. infants with a weight and height at birth between the 10th and 90th percentiles for age) are constituted according to the recommendations of the Food and Agriculture Organization of the United Nations (FAO) Codex Alimentarius Commission (<a href="./references#CD013758-bbs2-0064" title="ButteNF . Energy requirements of infants. Public Health Nutrition2005;8(7A):953-67. [DOI: 10.1079/PHN2005790] [PMID: 16277814]">Butte 2005</a>; <a href="./references#CD013758-bbs2-0068" title="Food and Agriculture Organization of the United Nations. Codex Alimentarius. Standard for follow-up formula. fao.org/fao-who-codexalimentarius (accessed 20 August 2020).">Codex 2017</a>), and the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN; <a href="./references#CD013758-bbs2-0070" title="Dalmau SerraJ , Ferrer LorenteB , Vitoria MiñanaI . Artificial lactation [Lactancia artificial]. pediatriaintegral.es/wp-content/uploads/2015/xix04/03/n4-251-259_Jaime%20Dalmau.pdf (accessed 20 August 2020).">Dalmau Serra 2015</a>; <a href="./references#CD013758-bbs2-0095" title="KoletzkoB , BakerS , CleghornG , NetoUF , GopalanS , HernellO , et al. Global standard for composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. Journal of Pediatric Gastroenterology and Nutrition2005;41(5):584-99. [DOI: 10.1097/01.mpg.0000187817.38836.42] [PMID: 16254515]">Koletzko 2005</a>; <a href="./references#CD013758-bbs2-0097" title="KoletzkoB , BhuttaZA , CaiW , CruchetS , El GuindiM , FuchsGJ , et al. Compositional requirements of follow-up formula for use in infancy: recommendations of an International Expert Group Coordinated by the Early Nutrition Academy. Annals of Nutrition &amp; Metabolism2012;6:1-11. [DOI: 10.1159/000345906] [PMID: 23258234]">Koletzko 2012</a>). </p> <p>Infant formula, when used as the sole source of food in infants during the first six months of life, should provide 60 kilocalories (kcal) to 70 kcal of energy per 100 mL, and have the following composition. </p> <p> <ol id="CD013758-list-0004"> <li> <p>Carbohydrates (9 g to 14 g per 100 kcal)</p> </li> <li> <p>Fats (4.4 g to 6 g per 100 kcal)</p> </li> <li> <p>Proteins (1.8 g to 2.5 g per 100 kcal of cow's milk whey protein, or 2.25 g to 3 g per 100 kcal of soy protein isolate) </p> </li> <li> <p>Vitamins, minerals, trace elements, and other micronutrients</p> </li> </ol> </p> <p>From six months of age, infants can receive follow‐up formula in addition to complementary foods. It should have broadly the same nutrient content as formula given to younger infants, but provide slightly less protein (1.7 g to 2.5 g per 100 kcal of cow's milk whey proteins, or 2.1 g to 2.5 g per 100 kcal of soy protein isolate). </p> <p>The rationale for including a minimum of 1.7 g of protein per 100 kcal of infant formula is to provide essential amino acids to promote brain maturation and mineral absorption in the kidneys, without increasing the development of fatty tissue or decreasing glomerular filtration (<a href="./references#CD013758-bbs2-0055" title="AbramsSA , Hawthorne KM PammiM . A systematic review of controlled trials of lower-protein or energy-containing infant formulas for use by healthy full-term infants. Advances in Nutrition2015;6(2):178-88. [DOI: 10.3945/an.114.006379] [PMID: 25770256]">Abrams 2015</a>; <a href="./references#CD013758-bbs2-0075" title="EFSA NDA Panel (EFSA panel on dietetic products, nutrition and allergies), TurckD , BressonJL , BurlingameB , DeanT , Fairweather-TaitS , HeinonenM , et al. Scientific opinion on the safety and suitability for use by infants of follow-on formulae with a protein content of at least 1.6 g/100 kcal. EFSA Journal2017;15(5):4781. [DOI: 10.2903/j.efsa.2017.4781] [PMID: 32625487]">EFSA 2017</a>; <a href="./references#CD013758-bbs2-0109" title="MichaelsenKF , LarnkjærA , MølgaardC . Amount and quality of dietary proteins during the first two years of life in relation to NCD risk in adulthood. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD2012;22(10):781-6. [DOI: 10.1016/j.numecd.2012.03.014] [PMID: 22770749]">Michaelsen 2012</a>; <a href="./references#CD013758-bbs2-0114" title="OropezaLG , RosadoJL , RonquilloD , GarcíaOP , CaamañoMD , et al. Lower protein intake supports normal growth of full-term infants fed formula: a randomized controlled trial. Nutrients2018;10(7):886. [DOI: 10.3390/nu10070886] [PMID: 29996492]">Oropeza 2018</a>). Despite the FAO and ESPGHAN recommended ranges of 1.8 g to 3 g of protein per 100 kcal, some manufacturers have modified the composition of infant formula to include up to 4.5 g of protein per 100 kcal. This amount of protein is the equivalent of more than 15% additional energy from protein and is intended to accelerate growth during the first year of life for newborns with low birth weight (i.e. below 2500 g). However, this increase in protein may contribute to the development of adverse events such as gastrointestinal intolerance, obesity, metabolic syndrome, and non‐communicable diseases during childhood (<a href="./references#CD013758-bbs2-0071" title="DeweyKG , HeinigMJ , NommsenLA , PeersonJM , LönnerdalB . Breast-fed infants are leaner than formula-fed infants at 1 y of age: the DARLING study. American Journal of Clinical Nutrition1993;57(2):140-5. [DOI: 10.1093/ajcn/57.2.140] [PMID: 8424381]">Dewey 1993</a>; <a href="./references#CD013758-bbs2-0087" title="HaschkeF , GrathwohlD , DetzelP , SteenhourP , WagemansN , ErdmannP . Postnatal high protein intake can contribute to accelerated weight gain of infants and increased obesity risk. Nestle Nutrition Institute Workshop Series2016;85:101-9. [DOI: 10.1159/000439492] [PMID: 27088337]">Haschke 2016</a>; <a href="./references#CD013758-bbs2-0102" title="LindMV , LarnkjærA , MølgaardC , MichaelsenKF . Dietary protein intake and quality in early life: impact on growth and obesity. Current Opinion in Clinical Nutrition and Metabolic Care2017;20(1):71-6. [DOI: 10.1097/MCO.0000000000000338] [PMID: 27749711]">Lind 2017</a>; <a href="./references#CD013758-bbs2-0105" title="MadsenAL , LarnkjærA , MølgaardC , MichaelsenKF . IGF-1 and IGFBP-3 in healthy 9 month old infants from the SKOT cohort. Breastfeeding, diet, and later obesity. Growth Hormone &amp; IGF Research2011;21(4):199-204. [DOI: 10.1016/j.ghir.2011.05.003] [PMID: 21624842]">Madsen 2011</a>; <a href="./references#CD013758-bbs2-0140" title="World Health Organization. WHA57.17 Global strategy on diet, physical activity and health. apps.who.int/gb/ebwha/pdf_files/WHA57/A57_R17-en.pdf (accessed 18 April 2023).">WHO 2016</a>). </p> </section> <section id="CD013758-sec-0012"> <h3 class="title" id="CD013758-sec-0012">How the intervention might work</h3> <p>Lower intake of protein decreases the efficiency of its use for tissue accretion and other metabolic functions, leading to deterioration in growth, immune response, nutrition, and neurodevelopment (<a href="./references#CD013758-bbs2-0096" title="KoletzkoB , vonKriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]">Koletzko 2009a</a>; <a href="./references#CD013758-bbs2-0138" title="ButteN , Lopez-AlarconM , GarzaC . Nutrient adequacy of exclusive breastfeeding for the term infant during the first six months of life. In: Department of Nutrition for Health and Development, World Health Organization. Beneva, Switzerland: World Health Organization, 2002:1-57. [WS 125]">WHO 2002</a>). However, consumption of high amounts of protein can have adverse effects. A rapid increase in weight during the first two years of life might be associated with increased risk of obesity in later years (<a href="./references#CD013758-bbs2-0111" title="MonteiroPO , VictoriaCG . Rapid growth in infancy and child-hood and obesity in later life – a systematic review. Obesity Reviews2005;6(2):143-54. [DOI: 10.1111/j.1467-789X.2005.00183.x] [PMID: 15836465]">Monteiro 2005</a>; <a href="./references#CD013758-bbs2-0113" title="OngKK , LoosRJ . Rapid infancy weight gain and subsequent obesity: systematic reviews and hopeful suggestions. Acta Paediatrica2006;95(8):904-8. [DOI: 10.1080/08035250600719754] [PMID: 16882560]">Ong 2006</a>). The hypothesis underpinning high‐protein formulas is that a high energy intake increases plasma concentrations of branched‐chain amino acids such as leucine, which favors insulin secretion and insulin‐like growth factor 1 (IGF‐1). This concentration promotes the activity of a highly conserved protein kinase known as TOR (target of rapamycin), which is a central controller of nutrient‐sensitive cell growth. When activated, it promotes muscle and adipose tissue growth, leading to weight gain and increasing the risk of obesity during childhood (<a href="./references#CD013758-bbs2-0055" title="AbramsSA , Hawthorne KM PammiM . A systematic review of controlled trials of lower-protein or energy-containing infant formulas for use by healthy full-term infants. Advances in Nutrition2015;6(2):178-88. [DOI: 10.3945/an.114.006379] [PMID: 25770256]">Abrams 2015</a>; <a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0063" title="BrandsB , DemmelmairH , KoletzkoB , EarlyNutrition Project. How growth due to infant nutrition influences obesity and later disease risk. Acta Paediatrica2014;103(6):578-85. [DOI: 10.1111/apa.12593] [PMID: 24521522]">Brands 2014</a>; <a href="./references#CD013758-bbs2-0072" title="DruetC , StettlerN , SharpS , SimmonsRK , CooperC , SmithGD , et al. Prediction of childhood obesity by infancy weight gain: an individual-level meta-analysis. Paediatric and Perinatal Epidemiology2012;26(1):19-26. [DOI: 10.1111/j.1365-3016.2011.01213.x] [PMID: 22150704]">Druet 2012</a>; <a href="./references#CD013758-bbs2-0079" title="FentonTR , Al-WassiaH , PremjiSS , Sauve Rs. Higher versus lower protein intake in formula-fed low birth weight infants. Cochrane Database of Systematic Reviews2020, Issue 6. Art. No: CD003959. [DOI: 10.1002/14651858.CD003959.pub4]">Fenton 2020</a>; <a href="./references#CD013758-bbs2-0098" title="KoletzkoB , DemmelmairH , GroteV , PrellC , WeberM . High protein intake in young children and increased weight gain and obesity risk. American Journal of Clinical Nutrition2016;103(2):303-4. [DOI: 10.3945/ajcn.115.128009] [PMID: 26791192]">Koletzko 2016</a>; <a href="./references#CD013758-bbs2-0102" title="LindMV , LarnkjærA , MølgaardC , MichaelsenKF . Dietary protein intake and quality in early life: impact on growth and obesity. Current Opinion in Clinical Nutrition and Metabolic Care2017;20(1):71-6. [DOI: 10.1097/MCO.0000000000000338] [PMID: 27749711]">Lind 2017</a>; <a href="./references#CD013758-bbs2-0104" title="LovellAL , MilneT , MatsuyamaM , HillRJ , DaviesPS , GrantCC , et al. Protein intake, IGF-1 concentrations, and growth in the second year of life in children receiving growing up milk – lite (GUMLi) or cow's milk (CM) intervention. Frontiers in Nutrition2021;8:666228. [DOI: 10.3389/fnut.2021.666228] [PMID: 34179057]">Lovell 2021</a>; <a href="./references#CD013758-bbs2-0105" title="MadsenAL , LarnkjærA , MølgaardC , MichaelsenKF . IGF-1 and IGFBP-3 in healthy 9 month old infants from the SKOT cohort. Breastfeeding, diet, and later obesity. Growth Hormone &amp; IGF Research2011;21(4):199-204. [DOI: 10.1016/j.ghir.2011.05.003] [PMID: 21624842]">Madsen 2011</a>; <a href="./references#CD013758-bbs2-0108" title="MelnikBC . Milk – a nutrient system of mammalian evolution promoting mTORC1-dependent translation. International Journal of Molecular Sciences2015;16(8):17048-87. [DOI: 10.3390/ijms160817048] [PMID: 26225961]">Melnik 2015</a>; <a href="./references#CD013758-bbs2-0109" title="MichaelsenKF , LarnkjærA , MølgaardC . Amount and quality of dietary proteins during the first two years of life in relation to NCD risk in adulthood. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD2012;22(10):781-6. [DOI: 10.1016/j.numecd.2012.03.014] [PMID: 22770749]">Michaelsen 2012</a>; <a href="./references#CD013758-bbs2-0110" title="MonastaL , BattyGD , CattaneoA , LutjeV , RonfaniL , Van LentheFJ , et al. Early-life determinants of overweight and obesity: a review of systematic reviews. Obesity Reviews2010;11(10):695-708. [DOI: 10.1111/j.1467-789X.2010.00735.x] [PMID: 20331509]">Monasta 2010</a>; <a href="./references#CD013758-bbs2-0111" title="MonteiroPO , VictoriaCG . Rapid growth in infancy and child-hood and obesity in later life – a systematic review. Obesity Reviews2005;6(2):143-54. [DOI: 10.1111/j.1467-789X.2005.00183.x] [PMID: 15836465]">Monteiro 2005</a>; <a href="./references#CD013758-bbs2-0121" title="ScaglioniS , AgostoniC , NotarisRD , RadaelliG , RadiceN , ValentiM , et al. Early macronutrient intake and overweight at five years of age. International Journal of Obesity and Related Metabolic Disorders2000;24(6):777-81. [DOI: 10.1038/sj.ijo.0801225] [PMID: 10878686]">Scaglioni 2000</a>; <a href="./references#CD013758-bbs2-0129" title="TangM . Protein intake during the first two years of life and its association with growth and risk of overweight. International Journal of Environmental Research and Public Health2018;15(8):1742-50. [DOI: 10.3390/ijerph15081742] [PMID: 30110887]">Tang 2018</a>; <a href="./references#CD013758-bbs2-0146" title="YangZ , HuffmanSL . Nutrition in pregnancy and early childhood and associations with obesity in developing countries. Maternal &amp; Child Nutrition2013;9(Suppl 1):105-19. [DOI: 10.1111/mcn.12010] [PMID: 23167588]">Yang 2013</a>; <a href="./references#CD013758-bbs2-0147" title="ZhengM , LambKE , GrimesC , LawsR , BoltonK , OngKK , et al. Rapid weight gain during infancy and subsequent adiposity: a systematic review and meta-analysis of evidence. Obesity Reviews2017;19(3):321-32. [DOI: 10.1111/obr.12632] [PMID: 29052309]">Zheng 2017</a>). </p> </section> <section id="CD013758-sec-0013"> <h3 class="title" id="CD013758-sec-0013">Why it is important to do this review</h3> <p>A large proportion of term infants are fed formula (<a href="./references#CD013758-bbs2-0057" title="Australian Institute of Health and Welfare. 2010 Australian national infant feeding survey: indicator results. aihw.gov.au/reports/mothers-babies/2010-australian-national-infant-feeding-survey/summary (accessed prior to 13 April 2023).">AIHW 2011</a>; <a href="./references#CD013758-bbs2-0058" title="AppletonJ , RussellCG , LawsR , FowlerC , CampbellK , Denney-WilsonE . Infant formula feeding practices associated with rapid weight gain: a systematic review. Maternal &amp; Child Nutrition2018;14(3):e.12602. [DOI: 10.1111/mcn.12602] [PMID: 29655200]">Appleton 2018</a>; <a href="./references#CD013758-bbs2-0066" title="Center for Disease Control and Prevention. Breastfeeding report card. cdc.gov/breastfeeding/pdf/2014breastfeedingreportcard.pdf (accessed 15 March 2019).">CDC 2014</a>; <a href="./references#CD013758-bbs2-0084" title="GutiérrezJP , Rivera-DommarcoJ , Shamah-LevyT , Villalpando-HernándezS , FrancoA , et al. National survey of health and nutrition 2018 [Encuesta Nacional de Salud y Nutricion]. ensanut.insp.mx (accessed 20 August 2020).">Gutiérrez 2012</a>; <a href="./references#CD013758-bbs2-0093" title="IpS , ChungM , RamanG , ChewP , MagulaN , DeVineD , et al. Breastfeeding and maternal and infant health outcomes in developed countries. Evidence Report Technology Assessment2007;153:1-186. [PMID: 17764214]">Ip 2007</a>; <a href="./references#CD013758-bbs2-0141" title="Food &amp; Nutrition Action in Health Systems, Guidelines Review Committee, Nutrition and Food Safety World Health Organization and the United Nations International Children's Fund (UNICEF) (editors). Protecting, promoting and supporting breastfeeding in facilities providing maternity and newborn services: implementing the revised baby-friendly hospital Initiative. Switzerland: World Health Organization &amp; United Nations Children's Fund (‎UNICEF)‎, 2018. [ISBN: 978-92-4-151380-7]">WHO 2018</a>). The protein content of some formulas is higher than recommended by the FAO Codex Alimentarius Commission and the ESPGHAN. According to the manufacturers, the aim of increasing the protein content is to accelerate the growth rate of infants by up to 2.36 g/kg/day. However, some studies have reported that an accelerated growth rate promotes increased adipose tissue as well as increased muscle mass. Increased adipose tissue is associated with overweight or obesity during childhood. </p> <p>Given the wide range of available protein contents for formula, it is unclear which is most effective for promoting an appropriate growth rate in term infants without increasing the risk of obesity, overweight, or adverse events. We aimed to address this question in our review. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013758-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013758-sec-0014"></div> <p>To evaluate the benefits and harms of higher protein intake versus lower protein intake in healthy, formula‐fed term infants. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013758-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013758-sec-0015"></div> <section id="CD013758-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013758-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included randomized controlled trials (RCTs) and cluster‐RCTs of infants who were fed infant formula for at least three consecutive months at any time from birth to two years of age, either exclusively or in addition to complementary foods (<a href="./references#CD013758-bbs2-0138" title="ButteN , Lopez-AlarconM , GarzaC . Nutrient adequacy of exclusive breastfeeding for the term infant during the first six months of life. In: Department of Nutrition for Health and Development, World Health Organization. Beneva, Switzerland: World Health Organization, 2002:1-57. [WS 125]">WHO 2002</a>). </p> <p>We excluded quasi‐randomized trials and observational studies*.</p> <p>*See <a href="#CD013758-sec-0044">Included studies</a> (Study design) and <a href="#CD013758-sec-0139">Differences between protocol and review</a>. </p> </section> <section id="CD013758-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included infants of any sex and ethnicity, born at full term (37 to 42 weeks of gestation), whose weight and length were within 2 SDs of the age‐specific median of the WHO Child Growth Standards (<a href="./references#CD013758-bbs2-0144" title="World Health Organization. Child growth standards. who.int/tools/child-growth-standards/standards (accessed 13 April 2023).">WHO standards 2023</a>). We excluded studies with the following populations. </p> <p> <ol id="CD013758-list-0005"> <li> <p>Infants with congenital malformations (central nervous system, cardiovascular, respiratory, digestive, or musculoskeletal abnormalities) </p> </li> <li> <p>Infants with other serious underlying illness, including sepsis, cystic fibrosis, untreated congenital hypothyroidism, bronchopulmonary dysplasia, hepatic or renal insufficiency, renal tubular acidosis, and any inborn metabolic errors </p> </li> <li> <p>Infants with milk hypersensitivity, lactose intolerance, malabsorption syndromes, chronic diarrhea, parenteral nutrition, or fasting periods </p> </li> <li> <p>Infants fed with soy formula, rice formula, or modified formulas (e.g. anti‐reflux formula, lactose‐free formula, partially or fully hydrolyzed formula) </p> </li> </ol> </p> </section> <section id="CD013758-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We evaluated high‐protein formula (≥ 2.5 g per 100 kcal) versus standard‐protein or low‐protein formula. When infant formula was the sole method of feeding, we defined standard protein content as 1.8 g to less than 2.5 g per 100 kcal and low protein content as less than 1.8 g per 100 kcal (<a href="./references#CD013758-bbs2-0095" title="KoletzkoB , BakerS , CleghornG , NetoUF , GopalanS , HernellO , et al. Global standard for composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. Journal of Pediatric Gastroenterology and Nutrition2005;41(5):584-99. [DOI: 10.1097/01.mpg.0000187817.38836.42] [PMID: 16254515]">Koletzko 2005</a>). When infant formula was given with complementary foods, we defined standard protein intake as 1.7 g to less than 2.5 g per 100 kcal and low protein intake as less than 1.7 g per 100 kcal (<a href="./references#CD013758-bbs2-0070" title="Dalmau SerraJ , Ferrer LorenteB , Vitoria MiñanaI . Artificial lactation [Lactancia artificial]. pediatriaintegral.es/wp-content/uploads/2015/xix04/03/n4-251-259_Jaime%20Dalmau.pdf (accessed 20 August 2020).">Dalmau Serra 2015</a>; <a href="./references#CD013758-bbs2-0097" title="KoletzkoB , BhuttaZA , CaiW , CruchetS , El GuindiM , FuchsGJ , et al. Compositional requirements of follow-up formula for use in infancy: recommendations of an International Expert Group Coordinated by the Early Nutrition Academy. Annals of Nutrition &amp; Metabolism2012;6:1-11. [DOI: 10.1159/000345906] [PMID: 23258234]">Koletzko 2012</a>; <a href="./references#CD013758-bbs2-0127" title="SuthutvoravutU , AbiodunPO , ChomthoS , ChongviriyaphanN , CruchetS , DaviesPS , et al. Composition of follow-up formula for young children aged 12-36 months: recommendations of an international expert group coordinated by the Nutrition Association of Thailand and the Early Nutrition Academy. Annals of Nutrition &amp; Metabolism2015;67(2):119-32. [DOI: 10.1159/000438495] [PMID: 26360877]">Suthutvoravut 2015</a>). </p> </section> <section id="CD013758-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD013758-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD013758-list-0006"> <li> <p>Undernutrition</p> <ol id="CD013758-list-0007"> <li> <p>Underweight: weight‐for‐age z‐score more than 2 SDs below the median of the WHO Child Growth Standards (<a href="./references#CD013758-bbs2-0144" title="World Health Organization. Child growth standards. who.int/tools/child-growth-standards/standards (accessed 13 April 2023).">WHO standards 2023</a>) </p> </li> <li> <p>Stunting: height‐for‐age z‐score more than 2 SDs below the median of the WHO Child Growth Standards (<a href="./references#CD013758-bbs2-0144" title="World Health Organization. Child growth standards. who.int/tools/child-growth-standards/standards (accessed 13 April 2023).">WHO standards 2023</a>) </p> </li> <li> <p>Wasting: weight‐for‐height z‐score more than 2 SDs below the median of the WHO Child Growth Standards (<a href="./references#CD013758-bbs2-0144" title="World Health Organization. Child growth standards. who.int/tools/child-growth-standards/standards (accessed 13 April 2023).">WHO standards 2023</a>) </p> </li> </ol> </li> <li> <p>Overweight or obesity</p> <ol id="CD013758-list-0008"> <li> <p>Overweight: weight‐for‐height z‐score more than 2 SDs above the median of the WHO Child Growth Standards (<a href="./references#CD013758-bbs2-0144" title="World Health Organization. Child growth standards. who.int/tools/child-growth-standards/standards (accessed 13 April 2023).">WHO standards 2023</a>) </p> </li> <li> <p>Obesity: weight‐for‐height z‐score more than 3 SDs above the median of the WHO Child Growth Standards (<a href="./references#CD013758-bbs2-0144" title="World Health Organization. Child growth standards. who.int/tools/child-growth-standards/standards (accessed 13 April 2023).">WHO standards 2023</a>) </p> </li> </ol> </li> </ol> </p> <section id="CD013758-sec-0022"> <h6 class="title">Timing of outcome measurement (primary outcomes)</h6> <p> <ol id="CD013758-list-0009"> <li> <p>In infants who were exclusively formula‐fed: from birth to four months</p> </li> <li> <p>In infants who were given formula in addition to complementary foods: from six months to five years </p> </li> </ol> </p> </section> </section> <section id="CD013758-sec-0023"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD013758-list-0010"> <li> <p>Neurodevelopmental outcomes (e.g. cerebral palsy, mental developmental delays, blindness, deafness, lacking verbal fluency) evaluated by a validated instrument, such as the Bayley scale (<a href="./references#CD013758-bbs2-0061" title="BayleyN . Bayley Scales of Infant Development–II. San Antonio, Texas: Psychological Corporation, 1993.">Bayley 1993</a>; <a href="./references#CD013758-bbs2-0062" title="BayleyN . Bayley Scales of Infant and Toddler Development. 3 edition. San Antonio, TX: Harcourt Assessment, 2005.">Bayley 2005</a>) </p> </li> <li> <p>All‐cause mortality</p> </li> <li> <p>Adverse events, based on inquiries to the parents and daily records. Possible adverse events include the following. </p> <ol id="CD013758-list-0011"> <li> <p>Diarrhea (three or more loose or liquid stools per day, or more frequently for the individual; <a href="./references#CD013758-bbs2-0143" title="World Health Organization. Health topics. Diarrhoea. who.int/health-topics/diarrhoea#tab=tab_1 (accessed 18 April 2023).">WHO diarrhoea 2020</a>) </p> </li> <li> <p>Vomiting</p> </li> <li> <p>Abdominal pain (<a href="./references#CD013758-bbs2-0115" title="Ortega PáezaE , Barroso EspaderoD . Infant colic [Cólico del lactante]. Pediatria Atencion Primaria2013;15(13):81-7. [DOI: 10.4321/S1139-76322013000300009]">Ortega Páeza 2013</a>) </p> </li> <li> <p>Constipation (difficulty in defecation for two or more weeks; <a href="./references#CD013758-bbs2-0060" title="BakerSS , LiptakGS , ColletiRB , CroffieJM , Di LorenzoC , EctorW , et al. Constipation in infants and children; evaluation and treatment. A medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. Journal of Pediatric Gastroenterology and Nutrition1999;29(5):612-26. [DOI: 10.1097/00005176-199911000-00029] [PMID: 10554136]">Baker 1999</a>) </p> </li> <li> <p>Milk hypersensitivity (atopic dermatitis, skin rash, respiratory symptoms, or diarrhea after 12 to 24 hours of milk ingestion; <a href="./references#CD013758-bbs2-0081" title="GoldmanAS , Anderson DW Jr, SellersWA , SapersteinS , KnikerWT , HalpernSR . Milk allergy. I. Oral challenge with milk and isolated milk proteins in allergic children. Pediatrics1963;32(3):425-43. [PMID: 14063522]">Goldman 1963</a>; <a href="./references#CD013758-bbs2-0133" title="VandenplasY , KoletzkoS , IsolauriE , HillD , OranjeAP , BruetonM , et al. Guidelines for the diagnosis and management of cow's milk protein allergy in infants. Archives of Disease in Childhood2007;92(10):902-8. [DOI: 10.1136/adc.2006.110999] [PMID: 17895338]">Vandenplas 2007</a>) </p> </li> <li> <p>Renal insufficiency (glomerular filtration rate &lt; 40 mL/minute/1.73 m<sup>2</sup>;<a href="./references#CD013758-bbs2-0067" title="ChanJC , WilliamsDM , RothKS . Kidney failure in infants and children. Pediatrics in Review2002;23(2):47-60. [DOI: 10.1542/pir.23-2-47] [PMID: 11826257]">Chan 2002</a>) </p> </li> <li> <p>Hyperglycemia (plasma glucose &gt; 150 mg/dL; <a href="./references#CD013758-bbs2-0088" title="HemachandraAH , CowettRM . Neonatal hyperglycemia. Pediatrics in Review1999;20(7):e16-24. [DOI: 10.1542/pir.20-7-e16]">Hemachandra 1999</a>; <a href="./references#CD013758-bbs2-0148" title="ŞimşekD , EcevitA , HatipoğluN , ÇobanA , ArısoyA , BaşF , et al. Neonatal hyperglycemia, which threshold value, diagnostic approach and treatment?: Turkish Neonatal and Pediatric Endocrinoloy and Diabetes Societies consensus report. Türk Pediatri Arşivi2018;53(Suppl 1):S234-8. [DOI: 10.5152/TurkPediatriArs.2018.01821] [PMID: 31236036]">Şimşek 2018</a>) </p> </li> </ol> </li> <li> <p>Anthropometric measurements</p> <ol id="CD013758-list-0012"> <li> <p>Weight (kg)</p> </li> <li> <p>Height (cm)</p> </li> <li> <p>Body mass index (BMI; kg/m<sup>2</sup>) </p> </li> <li> <p>Head circumference (cm)</p> </li> <li> <p>Arm circumference (cm)</p> </li> </ol> </li> </ol> </p> <section id="CD013758-sec-0024"> <h6 class="title">Timing of outcome measurement (secondary outcomes)</h6> <p> <ol id="CD013758-list-0013"> <li> <p>For neurodevelopmental outcomes, all‐cause mortality, and adverse events: at any time after randomization </p> </li> <li> <p>For anthropometric measurements: from birth to five years</p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD013758-sec-0025"> <h3 class="title">Search methods for identification of studies</h3> <p>Cochrane Neonatal's Information Specialist, Michelle Fiander, developed the search strategies in consultation with the review authors. </p> <section id="CD013758-sec-0026"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases in October 2022 without restrictions on language or publication type. We did not restrict trial searches by publication date, but we did restrict the search for systematic reviews to those published from 2020. We used methodological filters to limit retrieval to trials and systematic reviews. <a href="./appendices#CD013758-sec-0117">Appendix 1</a> shows the search strategies and methodological filters. </p> <p>We searched the following electronic databases.</p> <p> <ol id="CD013758-list-0014"> <li> <p>Cochrane via CRS (Issue 10, 2022; searched 27 October 2022)</p> </li> <li> <p>Ovid MEDLINE(R) and Epub Ahead of Print, In‐Process, In‐Data‐Review &amp; Other Non‐Indexed Citations, Daily and Versions (1946 to 26 October 2022) </p> </li> <li> <p>Ovid Embase (1974 to 26 October 2022)</p> </li> <li> <p>CINAHL Complete (EBSCOhost; 1981 to 27 October 2022)</p> </li> <li> <p>LILACS (via Virtual Health Library, 27 October 2022)</p> </li> </ol> </p> <p>We searched the following clinical trial registries for ongoing or recently completed trials. </p> <p> <ol id="CD013758-list-0015"> <li> <p>WHO International Clinical Trials Registry Platform (ICTRP; <a href="https://trialsearch.who.int" target="_blank">trialsearch.who.int</a>; searched 27 October 2022) </p> </li> <li> <p>US National Institutes of Health Ongoing Trials Registry ClinicalTrials.gov (<a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>; searched 27 October 2022) </p> </li> <li> <p>ISRCTN Registry (<a href="https://www.isrctn.com/" target="_blank">www.isrctn.com</a>; searched 28 October 2022) </p> </li> </ol> </p> </section> <section id="CD013758-sec-0027"> <h4 class="title">Searching other resources</h4> <p>We attempted to identify other potentially eligible trials or ancillary publications by searching the reference lists of included trials and relevant systematic reviews, meta‐analyses, and clinical practice guidelines. </p> <p>We also searched the following sources for conference proceedings and symposiums of the annual meetings up to 27 October 2022. </p> <p> <ol id="CD013758-list-0016"> <li> <p>American Academy of Pediatrics</p> </li> <li> <p>European Society for Paediatric Research</p> </li> <li> <p>Royal College of Paediatrics and Child Health</p> </li> <li> <p>Pediatric Academic Societies</p> </li> </ol> </p> <p>For gray literature, we searched OpenGrey (<a href="http://www.opengrey.eu" target="_blank">www.opengrey.eu</a>). </p> </section> </section> <section id="CD013758-sec-0028"> <h3 class="title" id="CD013758-sec-0028">Data collection and analysis</h3> <p>We performed the review following the recommendations in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> and the standard methods of Cochrane Neonatal (<a href="./references#CD013758-bbs2-0090" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Higgins 2022</a>). </p> <section id="CD013758-sec-0029"> <h4 class="title">Selection of studies</h4> <p>We used Cochrane's Screen4Me workflow to help assess the search results. Screen4Me comprises the following three components. </p> <p> <ol id="CD013758-list-0017"> <li> <p>Known assessments: a service that matches records in the search results to records that have already been screened in Cochrane Crowd and been labeled 'RCT' or 'Not an RCT' </p> </li> <li> <p>RCT classifier: a machine learning model that distinguishes RCTs from non‐RCTs</p> </li> <li> <p>Cochrane Crowd: Cochrane's citizen science platform where the Crowd help to identify and describe health evidence. </p> </li> </ol> </p> <p>For more information, see <a href="https://community.cochrane.org/organizational-info/resources/resources-groups/information-specialists-portal/crs-videos-and-quick-reference-guides#Screen4Me" target="_blank">Screen4Me</a>. Previous publications provide detailed information regarding evaluations of the Screen4Me components (<a href="./references#CD013758-bbs2-0107" title="MarshallIJ , Noel-StorrA , KuiperJ , ThomasJ , WallaceBC . Machine learning for identifying randomized controlled trials: an evaluation and practitioner’s guide. Research Synthesis Methods2018;9(4):602-14. [DOI: 10.1002/jrsm.1287] [PMID: 29314757]">Marshall 2018</a>; <a href="./references#CD013758-bbs2-0112" title="Noel-StorrAH , DooleyG , ElliottJ , SteeleE , ShemiltI , MavergamesC , et al. An evaluation of Cochrane Crowd found that crowd sourcing produced accurate results in identifying randomised trials. Journal of Clinical Epidemiology2021;133:130-9. [DOI: 10.1016/j.jclinepi.2021.01.006] [PMID: 33476769]">Noel‐Storr 2021</a>; <a href="./references#CD013758-bbs2-0130" title="ThomasJ , McDonaldS , Noel-StorrAH , ShemiltI , ElliottJ , MavergamesC , et al. Machine learning reduces workload with minimal risk of missing studies: development and evaluation of an RCT classifier for Cochrane Reviews. Journal of Clinical Epidemiology2021;133:140-51. [DOI: 10.1016/j.jclinepi.2020.11.003] [PMID: 33171275]">Thomas 2020</a>). </p> <p>Two of four review authors (IM, AS, LV, MA) independently assessed the abstract or title, or both, of each record and eliminated those that were clearly irrelevant. We then retrieved and investigated the full‐text reports of all potentially relevant records. We resolved any discrepancies through discussion or by involving a fifth review author (AG). We included full‐text reports or abstracts of published and unpublished RCTs. We also included observational studies that reported follow‐up of participants included in the original RCTs. We presented an adapted PRISMA flow diagram showing the process of study selection (<a href="./references#CD013758-bbs2-0101" title="LiberatiA , AltmanDG , TetzlaffJ , MulrowC , GøtzschePC , IoannidisJP , et al. The PRISMA statement for reporting systematic and meta-analyses of studies that evaluate interventions: explanation and elaboration. PLoS Medicine2009;62(10):e1-34. [DOI: 10.1371/journal.pmed.1000100] [PMID: 19631507]">Liberati 2009</a>). </p> </section> <section id="CD013758-sec-0030"> <h4 class="title">Data extraction and management</h4> <p>Two of four review authors (IM, AS, LV, MA) independently extracted data from the included studies using a standardized data extraction form. For each included trial, we collected information regarding design, methods, participants, interventions, outcomes, and treatment effects. We discussed any disagreement between the review authors with a fifth review author (AG) to achieve a final consensus. </p> <p>One review author (AG) entered the data into Cochrane's statistical software Review Manager Web (<a href="./references#CD013758-bbs2-0118" title="Review Manager Web (RevMan Web). Version 4.12.0. The Cochrane Collaboration, 2022. Available at revman.cochrane.org.">RevMan Web 2022</a>), and a second review author (MA) checked the entries for accuracy. We attempted to contact the authors of the original reports for further information whenever necessary. </p> </section> <section id="CD013758-sec-0031"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two of four review authors (IM, AS, LV, MA) independently assessed all included trials using the original Cochrane risk of bias tool (RoB 1), assigning a judgment of low, high, or unclear risk of bias for each of the following domains (<a href="./references#CD013758-bbs2-0089" title="HigginsJP , AltmanDG , SterneJA , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from training.cochrane.org/handbook/archive/v5.2.">Higgins 2017</a>). </p> <p> <ol id="CD013758-list-0018"> <li> <p>Sequence generation (selection bias)</p> </li> <li> <p>Allocation concealment (selection bias)</p> </li> <li> <p>Blinding of participants and personnel (performance bias)</p> </li> <li> <p>Blinding of outcome assessment (detection bias)</p> </li> <li> <p>Incomplete outcome data (attrition bias)</p> </li> <li> <p>Selective reporting (reporting bias)</p> </li> <li> <p>Any other bias</p> </li> </ol> </p> <p>We resolved any disagreements by discussion or by consulting a fifth review author (AG). See <a href="./appendices#CD013758-sec-0125">Appendix 2</a> for a more detailed description of the RoB 1 domains. </p> </section> <section id="CD013758-sec-0032"> <h4 class="title">Measures of treatment effect</h4> <p>When at least two studies reported the same outcome within the same comparison, we pooled their results in a meta‐analysis. We expressed dichotomous data as risk ratios (RRs) or Peto odd ratios (Peto ORs) with 95% confidence intervals (CIs). We planned to report the number needed to treat for an additional beneficial outcome (NNTB) or the number needed to treat for an additional harmful outcome (NNTH), with 95% CIs, when the 95% CI of the RR did not include the null value. We expressed continuous data as mean differences (MDs) with 95% CIs. </p> </section> <section id="CD013758-sec-0033"> <h4 class="title">Unit of analysis issues</h4> <p>If we had identified cluster‐RCTs, we would have included them in the analyses along with individually randomized trials, using the generic inverse variance method. We planned to adjust for the cluster effect using the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>, using an estimate of the intracluster correlation coefficient (ICC) derived from the study, or from a similar report, or from a study of a similar population (<a href="./references#CD013758-bbs2-0090" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Higgins 2022</a>). We planned to report this and perform sensitivity analyses to investigate the effect of variation in the ICC (<a href="./references#CD013758-bbs2-0080" title="GluudLL , ThorlundK , GluudC , WoodsL , HarrisR , SterneJA . Correction: reported methodologic quality and discrepancies between large and small randomised trials in meta-analyses. Annals of Internal Medicine2008;149(3):219. [DOI: 10.7326/0003-4819-149-3-200808050-00023] [PMID: 18942172]">Gluud 2008</a>). </p> </section> <section id="CD013758-sec-0034"> <h4 class="title">Dealing with missing data</h4> <p>We attempted to obtain missing data from study authors. We carried out analyses, as far as possible, on an intention‐to‐treat (ITT) basis (i.e. we attempted to include all participants in the analyses, and analyze all participants in the group to which they were randomized, regardless of whether they received the allocated intervention). The denominator for each outcome in each trial was the number of randomized participants. </p> <p>Where the trials did not report means and SDs, and we were unable to obtain these data from the trial authors, we imputed the mean and variance from the median, range, and the size of the sample (<a href="./references#CD013758-bbs2-0092" title="HozoSP , DjulbegovicB , HozoI . Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology2005;5:13. [DOI: 10.1186/1471-2288-5-13] [PMID: 15840177]">Hozo 2005</a>), or we assumed the SD of the outcome was the average of the SDs from all studies that had provided these values. When studies did not report z‐scores, we calculated them using the WHO Child Growth Standards software, adjusting for age and sex (<a href="https://www.who.int/tools/child-growth-standards/software" target="_blank">WHO Anthro v3.2.2</a>). We obtained the weighted mean and SD adjusted for the number of participants in each study, based on the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013758-bbs2-0090" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Higgins 2022</a>). </p> <p>We attempted to investigate the impact of imputation on meta‐analyses by way of sensitivity analysis, using the methods suggested in previous publications (<a href="./references#CD013758-bbs2-0073" title="EbrahimS , AklEA , MustafaRA , SunX , WalterSD , Heels-AnsdellD , et al. Addressing continuous data for participants excluded from trial analysis: a guide for systematic reviewers. Journal of Clinical Epidemiology2013;66(9):1014-21.e1. [DOI: 10.1016/j.jclinepi.2013.03.014] [PMID: 23774111]">Ebrahim 2013</a>; <a href="./references#CD013758-bbs2-0074" title="EbrahimS , JohnstonBC , AklEA , MustafaRA , SunX , WalterSD , et al. Addressing continuous data measured with different instrument for participants excluded from trial analysis. A guide for systematic reviewers. Journal of Clinical Epidemiology2014;67(5):560-70. [DOI: 10.1016/j.jclinepi.2013.11.014] [PMID: 24613497]">Ebrahim 2014</a>). </p> </section> <section id="CD013758-sec-0035"> <h4 class="title">Assessment of heterogeneity</h4> <p>We evaluated statistical heterogeneity by visually inspecting the forest plots and performing a standard Chi<sup>2</sup> test, with a significance level of 0.1. Considering the low power of this test, we also calculated the I<sup>2</sup> statistic, which quantifies inconsistency across studies to assess the impact of heterogeneity on meta‐analysis. An I<sup>2</sup> statistic of 30% or less indicates a low level of heterogeneity. If we identified moderate heterogeneity (an I<sup>2</sup> value of 31% to 49%) or high heterogeneity (an I<sup>2</sup> value greater than 75%), we attempted to determine the possible reasons for it by examining individual study characteristics (e.g. participants, interventions, or outcome assessments) and performing subgroup analyses (<a href="./references#CD013758-bbs2-0090" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Higgins 2022</a>). </p> </section> <section id="CD013758-sec-0036"> <h4 class="title">Assessment of reporting biases</h4> <p>If we had included 10 or more studies in a meta‐analysis, we would have explored publication bias by creating funnel plots. We would have tested funnel plot asymmetry with the Egger test for continuous outcomes and the Harbord test for dichotomous outcomes (<a href="./references#CD013758-bbs2-0076" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. BMJ1997;315(7109):629-34. [DOI: 10.1136/bmj.315.7109.629] [PMID: 9310563]">Egger 1997</a>; <a href="./references#CD013758-bbs2-0086" title="HarbordRM , EggerM , SterneJA . A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statistics in Medicine2006;25(20):3443-57. [DOI: 10.1002/sim.2380] [PMID: 16345038]">Harbord 2006</a>). </p> </section> <section id="CD013758-sec-0037"> <h4 class="title">Data synthesis</h4> <p>We performed meta‐analysis using Review Manager Web (<a href="./references#CD013758-bbs2-0118" title="Review Manager Web (RevMan Web). Version 4.12.0. The Cochrane Collaboration, 2022. Available at revman.cochrane.org.">RevMan Web 2022</a>). For dichotomous outcomes (overweight or obesity, all‐cause mortality, adverse events), we calculated the typical estimates of RR and OR, each with its 95% CI. For continuous outcomes (undernutrition, neurodevelopmental outcomes, anthropometric measurements), we calculated the MD with its 95% CI. We used a fixed‐effect model to combine data where it was reasonable to assume that studies were estimating the same underlying treatment effect. If we considered meta‐analysis was inappropriate, we analyzed and interpreted individual trials separately. If there was evidence of clinical heterogeneity, we used a random‐effects model and attempted to explain the heterogeneity based on the different study characteristics and subgroup analyzes (<a href="./references#CD013758-bbs2-0090" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.">Higgins 2022</a>). </p> </section> <section id="CD013758-sec-0038"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We conducted subgroup analyses of the primary outcomes for the following factors.</p> <p> <ol id="CD013758-list-0019"> <li> <p>Type of fomula feeding (exclusive or with complementary foods)</p> </li> <li> <p>Length of treatment (feeding of formula): two months, four months, six months, one year, two years, five years, more than five years </p> </li> </ol> </p> </section> <section id="CD013758-sec-0039"> <h4 class="title">Sensitivity analysis</h4> <p>We attempted to perform sensitivity analyses to determine the effect of excluding studies at high or unclear risk of selection bias, performance bias, detection bias, and attrition bias, on the findings for primary outcomes. </p> </section> <section id="CD013758-sec-0040"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We used the GRADE approach, as outlined in the <i>GRADE Handbook</i>, to assess the certainty of evidence for the following outcomes (<a href="./references#CD013758-bbs2-0122" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.">Schünemann 2013</a>). </p> <p> <ol id="CD013758-list-0020"> <li> <p>Underweight</p> </li> <li> <p>Stunting</p> </li> <li> <p>Wasting</p> </li> <li> <p>Overweight</p> </li> <li> <p>Obesity</p> </li> <li> <p>All‐cause mortality</p> </li> <li> <p>Adverse events</p> </li> </ol> </p> <p>Two review authors (AS and AG) independently assessed the certainty of the evidence for each outcome. We considered evidence from RCTs as high certainty to begin with, downgrading by one level for serious (or two levels for very serious) risk of bias concerns, inconsistency across studies, indirectness of the evidence, imprecision of estimates, or presence of publication bias. We used <a href="./references#CD013758-bbs2-0082" title="GRADEpro GDT. McMaster University. Hamilton (ON): McMaster University (developed by Evidence Prime), (accessed 15 March 2019). Available at gradepro.org.">GRADEpro GDT</a> to create two summary of findings tables to report the certainty of the evidence for the following comparisons. </p> <p> <ol id="CD013758-list-0021"> <li> <p>High‐protein formula versus standard‐protein formula (<a href="./full#CD013758-tbl-0001">summary of findings Table 1</a>) </p> </li> <li> <p>Standard‐protein formula versus low‐protein formula (<a href="./full#CD013758-tbl-0002">summary of findings Table 2</a>) </p> </li> </ol> </p> <p>The GRADE approach assigns one of the following four ratings to a body of evidence.</p> <p> <ol id="CD013758-list-0022"> <li> <p>High certainty: we are very confident that the true effect lies close to that of the estimate of the effect. </p> </li> <li> <p>Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> </li> <li> <p>Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect. </p> </li> <li> <p>Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </li> </ol> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013758-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013758-sec-0041"></div> <section id="CD013758-sec-0042"> <h3 class="title">Description of studies</h3> <p>For detailed information on the trials, see the <a href="./references#CD013758-sec-0141" title="">Characteristics of included studies</a>, <a href="./references#CD013758-sec-0142" title="">Characteristics of excluded studies</a>, <a href="./references#CD013758-sec-0143" title="">Characteristics of studies awaiting classification</a>, and <a href="./references#CD013758-sec-0144" title="">Characteristics of ongoing studies</a> tables. </p> <section id="CD013758-sec-0043"> <h4 class="title">Results of the search</h4> <p>We identified 4459 references from database and trial registry searching and other sources. After removing 1526 duplicates, we screened the titles/abstracts of the remaining 2933 references, excluding 2875 (353 via Screen4Me; see <a href="#CD013758-fig-0001">Figure 1</a>). We then retrieved 58 full‐text reports or trial registry records. During full‐text review, we selected 11 studies (14 references) for inclusion, excluded 34 studies (36 references), identified six ongoing studies, and listed two studies as awaiting classification. See <a href="#CD013758-fig-0002">Figure 2</a> for the selection process. </p> <div class="figure" id="CD013758-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Screen4Me summary diagram." data-id="CD013758-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Screen4Me summary diagram.</p> </div> </div> </div> <div class="figure" id="CD013758-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="PRISMA diagram illustrating the study selection process." data-id="CD013758-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA diagram illustrating the study selection process.</p> </div> </div> </div> </section> <section id="CD013758-sec-0044"> <h4 class="title">Included studies</h4> <p>We included 11 RCTs, which enrolled a total of 1885 infants (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). </p> <p>Seven studies (1629 infants) compared high‐protein formula with standard‐protein formula; four of these studies evaluated exclusive formula feeding only (<a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>); two studies evaluated exclusive formula feeding or formula feeding with complementary foods (<a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>); and one study only evaluated formula feeding with complementary foods (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>). </p> <p>Four studies (256 infants) compared standard‐protein with low‐protein formula; three of these studies evaluated exclusive formula feeding only (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>); and one evaluated formula as the sole feeding method or in addition to complementary foods (<a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>). </p> <p>For details, see the <a href="./references#CD013758-sec-0141" title="">Characteristics of included studies</a> table. </p> <section id="CD013758-sec-0045"> <h5 class="title">Study design</h5> <p>We obtained data from the published reports of all 11 included RCTs. We also obtained follow‐up data from secondary, observational studies of the participants of six of our included RCTs (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>: <a href="./references#CD013758-bbs2-0094" title="Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. 22665843 [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865]">Karlsland 1998</a>; <a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>: <a href="./references#CD013758-bbs2-0059" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. 22665845 [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]">Axelsson 1989</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>: <a href="./references#CD013758-bbs2-0077" title="EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]">Escribano 2011</a>; <a href="./references#CD013758-bbs2-0083" title="GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]">Gruszfeld 2016</a>; <a href="./references#CD013758-bbs2-0131" title="TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;17(12):e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]">Totzauer 2022</a>; <a href="./references#CD013758-bbs2-0137" title="WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]">Weber 2014</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>: <a href="./references#CD013758-bbs2-0099" title="KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]">Kouwenhoven 2021a</a>; <a href="./references#CD013758-bbs2-0100" title="KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]">Kouwenhoven 2021b</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>: <a href="./references#CD013758-bbs2-0085" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. 21653176 [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]">Hahn‐Zoric 1990</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>: <a href="./references#CD013758-bbs2-0120" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. 22665860 [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]">Räihä 1986b</a>). </p> <p>The unit of analysis was the individual participant in all studies. Ten studies included at least one intervention group, a parallel control group, and an observational arm of exclusively breastfed infants. Three of these studies had four arms (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>), and seven studies had three arms (<a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). Only <a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a> (a two‐arm trial) did not include an exclusive breastfeeding group. </p> </section> <section id="CD013758-sec-0046"> <h5 class="title">Settings</h5> <p>All studies were conducted in an outpatient setting in high‐income countries (<a href="./references#CD013758-bbs2-0145" title="The World Bank. High income data. data.worldbank.org/country/XD (accessed prior to 16 May 2023).">World Bank 2022</a>). Four studies took place in Italy (<a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>); two in Sweden (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>); three in France (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>); and one in the USA (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>). Studies were conducted from 1980 to 2020. Seven studies were conducted in a single healthcare center (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>); two studies were conducted in multiple centers in the same country (<a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>); one study was carried out in multiple centers in five countries (Belgium, Germany, Italy, Poland, and Spain; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>); and one study was conducted in the Netherlands and Germany (<a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>). </p> </section> <section id="CD013758-sec-0047"> <h5 class="title">Participants</h5> <p>Baseline characteristics were similar between intervention groups in all included studies; however, we noted the following. </p> <p> <ol id="CD013758-list-0023"> <li> <p>Although all RCTs included term infants, only five specified the participants' gestational age at birth, which ranged from 38.3 weeks to 40.3 weeks (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>); nine studies reported birth weight, which ranged from 3.13 kg to 3.74 kg, and birth height, which ranged from 48.6 cm to 54.6 cm (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>); and three studies reported BMI at baseline, which ranged from 12.7 kg/m<sup>2</sup> to 13.9 kg/m<sup>2</sup> (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). </p> </li> <li> <p>No studies reported the ethnicity of their participants.</p> </li> <li> <p>In eight studies, male participants constituted 40% to 58% of the sample studied (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>); one study included only males (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>); and two studies did not report the sex of participants (<a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>). </p> </li> <li> <p>Six studies reported their calculation of the study sizes, which ranged from 156 participants to 1679 participants (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). </p> </li> <li> <p>The main inclusion criteria were singleton pregnancy, gestational age of 37 to 42 weeks, normal weight and height for age at birth, no pregnancy or delivery complications or medical conditions that could limit growth, no physical malformations, and no maternal history of diabetes, chronic diseases, or perinatal infections. </p> </li> </ol> </p> </section> <section id="CD013758-sec-0048"> <h5 class="title">Interventions and comparisons</h5> <p>We identified a wide variety of interventions and comparisons, as follows.</p> <p> <ol id="CD013758-list-0024"> <li> <p>In 10 studies, formula feeding was the sole feeding method until the infants were at least four months of age (<a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>); in three studies, formula was initially the sole feeding method, and was then given with complementary foods until the infants were at least two years of age (<a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>); and one study only examined formula feeding with complementary foods (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>). </p> </li> <li> <p>Eight studies reported the proportion of whey and casein in the formulas: they contained from 18% to 70% whey and from 30% to 82% casein (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). </p> </li> <li> <p>Regarding the frequency and amount of infant formula feeding, five studies reported that infants consumed at least 125 mL/kg formula per day (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>), and three studies only reported that the participants received formula 'ad libitum' (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>). </p> </li> <li> <p>Six of the 11 studies reported the timing of initiation of infant formula feeding. Two studies started formula feeding on the second day after birth (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>); three studies started in the first month of life (<a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>), and one study started in the third month (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>). The remaining studies only reported the duration and follow‐up of the intervention. </p> </li> </ol> </p> </section> <section id="CD013758-sec-0049"> <h5 class="title">Outcomes</h5> <p>The most common outcome was the measurement of growth by weight, height, head circumference, and BMI over a wide range of time points, from one month to 11 years. <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a> and <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a> also reported their results in z‐scores according to WHO Child Growth Standards (<a href="./references#CD013758-bbs2-0144" title="World Health Organization. Child growth standards. who.int/tools/child-growth-standards/standards (accessed 13 April 2023).">WHO standards 2023</a>). </p> <p>Five studies reported adverse events (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>); two studies reported serum glucose levels and insulin secretion (<a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>); one study reported serum albumin and urea levels (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>); one study reported gut microbiota (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>), and one study reported protein metabolism (<a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>). </p> </section> <section id="CD013758-sec-0050"> <h5 class="title">Funding sources</h5> <p>All studies received funding from at least one commercial company: Nestlé funded five studies (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>); Danone S.A. funded two studies (<a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>); Ross Laboratories funded two studies (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>); Findus funded one study (<a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>), and Humana Italia SpA funded one study (<a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>). </p> <p>Two studies received partial funding from the Bristol‐Myers Squibb Company (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>). Five studies received funding from multiple sources such as governments, foundations, or commercial companies (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>). </p> </section> <section id="CD013758-sec-0051"> <h5 class="title">Conflicts of interest</h5> <p>Three studies clearly detailed the activities of their sponsors (<a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>); sponsor involvement was unclear in five studies (<a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>); and sponsors appeared to be involved in critical procedures in three studies (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>). For more details, see the <a href="./references#CD013758-sec-0141" title="">Characteristics of included studies</a> table. </p> </section> </section> <section id="CD013758-sec-0052"> <h4 class="title">Excluded studies</h4> <p>We excluded 34 studies for the following reasons.</p> <p> <ol id="CD013758-list-0025"> <li> <p>Ineligible intervention (12 studies: <a href="./references#CD013758-bbs2-0012" title="ACTRN12614000918628. A randomised control trial in children aged 12-23 months consuming growing up milk - lite or cow's milk. [A multi-centre, double blind, randomised, placebo controlled trial to evaluate the effect of consuming growing up milk ‘lite’ on body composition in children aged 12 – 23 months]. anzctr.org.au/ACTRN12614000918628.aspx (first received 27 August 2014). [CENTRAL: CN-01801401] ">ACTRN12614000918628</a>; <a href="./references#CD013758-bbs2-0013" title="ACTRN12620000552987. The infant feeding study [Infant nutrition with milk fat globule membrane for infant cognition in early life]. anzctr.org.au/ACTRN12620000552987.aspx (first received 11 May 2020). [CENTRAL: CN-02165323] ">ACTRN12620000552987</a>; <a href="./references#CD013758-bbs2-0020" title="InostrozaJ , HaschkeF , SteenhoutP , GrathwohlD , NelsonSE , ZieglerEE . Low-protein formula slows weight gain in infants of overweight mothers. Journal of Pediatric Gastroenterology and Nutrition2014;59(1):70-7. [DOI: 10.1097/MPG.0000000000000349] [PMID: 24637965]InostrozaJ , SteenhoutP , PrietoR , GrathwohlD , ZieglerE , HaschkeF . In: Pediatric Academic Societies Annual Meeting. Lower weight gain in infants of obese mothers who receive a low protein formula; 2012 April 28 - May 1; Boston Ma, United States. www.medscape.com/viewcollection/32429: Pediatric Academic Societies, 2012. NCT00820833. Effect of formula on growth of infants from overweight or obese mothers. clinicaltrials.gov/ct2/show/NCT00820833 (first posted 12 January 2009). [CENTRAL: CN-02027763] ">Inostroza 2014</a>; <a href="./references#CD013758-bbs2-0023" title="KuehnD , ZeiselSH , OrensteinDF , GermanJB , FieldCJ , TeerdhalaS , et al. Effects of a novel high-quality protein infant formula on energetic efficiency and tolerance: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2022;75(4):521-8. [DOI: 10.1097/MPG.0000000000003490] [PMID: 35666855]NCT04218929. Evaluation of growth, safety, and efficacy of an infant formula for healthy term infants. clinicaltrials.gov/ct2/show/NCT04218929 (first received 6 January 2020). [CENTRAL: CN-02048363] NCT04389606. Follow-up study of growth, safety, and efficacy of an infant formula for healthy term infants. clinicaltrials.gov/ct2/show/NCT04389606 (first posted 15 May 2020). [CENTRAL: CN-02180584] ">Kuehn 2022</a>; <a href="./references#CD013758-bbs2-0026" title="LönnerdalB , HernellO . Effects of feeding ultrahigh-temperature (UHT)-treated infant formula with different protein concentrations or powdered formula, as compared with breast-feeding, on plasma amino acids, hematology, and trace element status. American Journal of Clinical Nutrition1998;68(2):350-6. [DOI: 10.1093/ajcn/68.2.350] [PMID: 9701193]">Lönnerdal 1998</a>; <a href="./references#CD013758-bbs2-0027" title="LoweCU , MosovichLL , PessinV . Effects of protein level and type of heat treatment of milk formulas on growth and maturation of infants. Journal of Pediatrics1964;64:666-82. [DOI: 10.1016/s0022-3476(64)80613-2] [PMID: 14148999]">Lowe 1964</a>; <a href="./references#CD013758-bbs2-0028" title="MartinF , MontoliuI , CollinoS , SilvaL , MocoS , InostrozaJ , et al. In: Pediatric Academic Societies Annual Meeting. Metabolomic characterization of the effect of breast-feeding, high and low protein formula on host-gut microbial metabolism during growth of infants from overweight or obese mothers 2013 May 4 - 7; Washington, DC. United States. www.medscape.com/viewcollection/32827: Pediatric Academic Societies, 2013. MartinFP , MocoS , MontoliuI , CollinoS , Da SilvaL , RezziS , et al. Impact of breast-feeding and high- and low-protein formula on the metabolism and growth of infants from overweight and obese mothers. Pediatric Research2014;75(4):535-43. [DOI: 10.1038/pr.2013.250] [PMID: 24375085]">Martin 2014</a>; <a href="./references#CD013758-bbs2-0035" title="NCT02469402. Nutritive efficacy and safety of a modified infant formula with a reduced protein content and improved protein quality [Nutritive efficacy and safety of a modified infant formula with a reduced protein: content and improved protein quality: lactPro‐Minus]. clinicaltrials.gov/ct2/show/NCT02469402 (first posted 11 June 2015). [CENTRAL: CN-01552812] ">NCT02469402</a>; <a href="./references#CD013758-bbs2-0041" title="TaitzLS , ScholeyE . Are babies more satisfied by casein based formulas?Archives of Disease in Childhood1989;64(4):619-21. [DOI: 10.1136/adc.64.4.619] [PMID: 2665662]">Taitz 1989</a>; <a href="./references#CD013758-bbs2-0042" title="NCT00624689. Effects of milk fat globule membrane (MFGM) - enriched formula with reduced energy and protein content on growth and development (TUMME) [Double‐blinded interventional study on the effects of MFGM‐enriched formula with reduced energy and protein content on growth and development]. clinicaltrials.gov/ct2/show/NCT00624689 (first posted 27 February 2008). [CN-02042825]TimbyN , HernellO , LönnerdalB , DomellöfM . Parenteral feeding control in relation to feeding mode on growth pattern during early infancy. Acta Paediatrica2014;103(10):1072-7. [DOI: 10.1111/apa.12721] [PMID: 24948384]">Timby 2014</a>; <a href="./references#CD013758-bbs2-0043" title="TrabulsiJ , CapedingM , RamanujamK , FengP , McsweeneyS , HarrisB , et al. The effect of 2 different protein concentrations in term infant formula on growth. Journal of Pediatric Gastroenterology and Nutrition2009;48(Suppl 3):E78. [DOI: 10.1097/MPG.0b013e3181aa06ea]TrabulsiJ , CapedingR , LebumfacilJ , RamanujamK , FengP , McSweeneyS , et al. Effect of an alpha-lactalbumin-enriched infant formula with lower protein on growth. European Journal of Clinical Nutrition2011;65(2):167-74. [CENTRAL: CN-00792926] [DOI: 10.1038/ejcn.2010.236] [PMID: 21063429]">Trabulsi 2011</a>; <a href="./references#CD013758-bbs2-0045" title="NCT00716105. Effect of the level of dietary protein on infant growth [Effect of the level of dietary protein on infant growth and body composition in the first year of life]. clinicaltrials.gov/ct2/show/NCT00716105 (first posted 16 July 2008). [CENTRAL: CN-02028397] ZieglerEE , FieldsDA , ChernausekSD , SteenhoutP , GrathwohlD , JeterJ , et al. Adequacy of infants formula with protein content of 1.6 g/100 kcal for infants between 3 and 12 months. Journal of Pediatric Gastroenterology and Nutrition2015;61(5):596-603. [DOI: 10.1097/MPG.0000000000000881] [PMID: 26154030]">Ziegler 2015</a>) </p> </li> <li> <p>Ineligible comparator (10 studies: <a href="./references#CD013758-bbs2-0014" title="AxelssonI , BorulfS , AbildskovK , HeirdW , RähiäN . Protein and anergy intake during weaning. III. Effects on plasma amino acids. Acta Paediatrica Scandinavica1988;77(1):42-8. [DOI: 10.1111/j.1651-2227.1988.tb10595.x] [PMID: 3369304]AxelssonI , BorulfS , RaihaN . Protein intake during weaning. II. Metabolic responses. Acta Paediatrica Scandinavica1987;76(3):457-62. [DOI: 10.1111/j.1651-2227.1987.tb10499.x] [PMID: 3604663]AxelssonI , BorulfS , RighardL , RäihäN . Protein and energy intake during weaning: I. Effects on growth. Acta Paediatrica Scandinavica1987;76(2):321-27. [DOI: 10.1111/j.1651-2227.1987.tb10468.x] [PMID: 3591298]">Axelsson 1987</a>; <a href="./references#CD013758-bbs2-0015" title="Chen C-M, Wang Y-Y, Chang S-Y. Effect of in-home fortification of complementary feeding on intellectual development of Chinese children. Biomedical and Environmental Sciences2010;23(2):83-91. [DOI: 10.1016/S0895-3988(10)60036-0] [PMID: 20514982]">Chen 2010</a>; <a href="./references#CD013758-bbs2-0017" title="HarrisonGG , GraverEJ , VargasM , ChurellaHR , PauleCL . Growth and adiposity of term infants fed whey-predominant or casein-predominant formulas or human milk. Journal of Pediatric Gastroenterology and Nutrition1987;6(5):739-47. [DOI: 10.1097/00005176-198709000-00014] [PMID: 3501007]">Harrison 1987</a>; <a href="./references#CD013758-bbs2-0019" title="HeinigMJ , NommsenLA , PeersonJM , LonnerdalB , DeweyKG . Energy and protein intakes of breast-fed and formula-fed infants during the first year of life and their association with growth velocity: the DARLING Study. American Journal of Clinical Nutrition1993;58(2):152-61. [DOI: 10.1093/ajcn/58.2.152] [PMID: 8338041]">Heinig 1993</a>; <a href="./references#CD013758-bbs2-0021" title="JinnoS , YamazakiK , NakamuraY , KinouchiT . Daily protein and energy intakes of infants fed a commercial infant formula with a reduced protein concentration of 2.2 g/100 kcal: an impact of feeding interval on energy intake. Bioscience, Biotechnology, and Biochemistry2020;84(6):1259-64. [DOI: 10.1080/09168451.2020.1722609] [PMID: 31996104]">Jinno 2020</a>; <a href="./references#CD013758-bbs2-0022" title="JuryG , CastilloC , AtalahE , PuentesR , RiumalloJ . Growth, acceptance, and tolerance with a new milk formula [Crecimiento, aceptación y tolerancia con una nueva formula láctea]. Revista Chilena de Pediatria1991;62(2):87-93. [PMID: 1844168]">Jury 1991</a>; <a href="./references#CD013758-bbs2-0025" title="LönnerdalB , ChenC . Effects of formula protein level and ratio on infant growth, plasma amino acids and serum trace elements. I. Cow's milk formula. Acta Paediatrica Scandinavica1990;79(3):257-65. [DOI: 10.1111/j.1651-2227.1990.tb11454.x] [PMID: 2333739]">Lönnerdal 1990</a>; <a href="./references#CD013758-bbs2-0033" title="NCT02010749. Protein concentration in infant formula: a follow-up study of growth at 2 years of age. clinicaltrials.gov/ct2/show/NCT02010749 (first posted 13 December 2013). ">NCT02010749</a>; <a href="./references#CD013758-bbs2-0039" title="NTR1199. Effects of a nutrient dense infant formula on the growth and tolerance of infants compared to current practice in Spain [A randomized, controlled, open-label, parallel-arm, multi-centre intervention trial on the effect of a nutrient dense infant formula compared to current practice, on the growth and tolerance of infants in Spain]. trialsearch.who.int/Trial2.aspx?TrialID=NTR1199 (first received 30 January 2008). [CENTRAL: CN-01825595] ">NTR1199</a>; <a href="./references#CD013758-bbs2-0040" title="RähiäNC , Fazzolari-NesciA , Cajozzo, C, PuccioG , MonestierA , MoroG , et al. Whey predominant, whey modified infant formula with protein/energy ratio of 1.8 g/100 kcal: adequate and safe for term infants from birth to four months. Journal of Pediatric Gastroenterology and Nutrition2002;35(3):275-81. [DOI: 10.1097/00005176-200209000-00008] [PMID: 12352513]RähiäNC , Fazzolari-NesciA , CayozzoC , PuccioG , MonestierA , MoroG , et al. Whey modified infant formula with protein-energy ratio of 1.8 g/100 kcal is adequate and a safe from birth to 4 months. Journal of Pediatric Gastroenterology and Nutrition2000;31(Suppl 2):S94. [PMID: 12352513]">Rähiä 2002</a>) </p> </li> <li> <p>Formula feeding lacking details of protein content (six studies: <a href="./references#CD013758-bbs2-0029" title="NCT00465764. Tolerance and development of healthy, term infants [Pilot tolerance and bone status of healthy, term infants fed infant formulas]. clinicaltrials.gov/ct2/show/NCT00465764 (first posted 25 April 2007). [CENTRAL: CN-01515062] ">NCT00465764</a>; <a href="./references#CD013758-bbs2-0030" title="NCT00916565. Evaluation of cow milk-based formulas - functional proteins. clinicaltrials.gov/ct2/show/NCT00916565 (first posted 9 June 2009). ">NCT00916565</a>; <a href="./references#CD013758-bbs2-0031" title="NCT00977964. Tolerance of healthy term infants fed infant formulas #3 [Tolerance of healthy term infants fed infant formulas]. clinicaltrials.gov/ct2/show/NCT00977964 (first posted 16 September 2009). [CENTRAL: CN-01525847] ">NCT00977964</a>; <a href="./references#CD013758-bbs2-0032" title="NCT01489098. Effect of the level of dietary protein on body composition [Effect of the level of dietary protein on infant growth and body composition in the first year of life - three and five year growth and body composition follow-up]. clinicaltrials.gov/ct2/show/NCT01489098 (first posted 9 December 2011). ">NCT01489098</a>; <a href="./references#CD013758-bbs2-0036" title="NCT02481531. Growth and tolerance of cow's milk-based infant formulas. clinicaltrials.gov/ct2/show/NCT02481531 (first posted 25 June 2015). [CENTRAL: CN-01553167] ">NCT02481531</a>; <a href="./references#CD013758-bbs2-0037" title="NCT02658500. Short and long term effect of early infant feeding and nutritional status on the children's health. clinicaltrials.gov/ct2/show/NCT02658500 (first posted 20 January 2016). [PMID: CN-01555179]">NCT02658500</a>) </p> </li> <li> <p>Protocol discontinued due to insufficient participant recruitment (two studies: <a href="./references#CD013758-bbs2-0034" title="NCT02433600. The effect of feeding infant formula with enriched protein fractions in the US [The effect of feeding infant formula with enriched protein fractions]. clinicaltrials.gov/ct2/show/NCT02433600 (first posted 5 May 2015). [CENTRAL: CN-01506193] [NCT02433600]">NCT02433600</a>; <a href="./references#CD013758-bbs2-0038" title="NCT04859231. Nutritive effects of cow's milk-based formulas through 18 months of age. clinicaltrials.gov/ct2/show/NCT04859231 (first posted 26 April 2021). [CENTRAL: CN-02254892] ">NCT04859231</a>) </p> </li> <li> <p>Study design inappropriate for this review (two studies: <a href="./references#CD013758-bbs2-0018" title="Haschke-BecherE , FazzolariA , MinoliI , RähiäNC , CarrieAL , HaschkeF , et al. Plasma amino acids of infants fed modified whey formulas with protein-energy ratio of 1.8 g/100kcalg. Journal of Pediatric Gastroenterology and Nutrition2000;31(Suppl 2):S92. Haschke-BecherE , KainzA , BachmannC . Reference values of amino acids and of common clinical chemistry in plasma of healthy infants aged 1 and 4 months. Journal of Inherited Metabolic Disease2016;39(1):25-37. [DOI: 10.1007/s10545-015-9870-4] [PMID: 26227325]">Haschke‐Becher 2016</a>; <a href="./references#CD013758-bbs2-0024" title="LifschitzC . Can we do something in early life to reduce the risk of obesity?Iranian Journal of Neonatology2016;7(2):16-9. [DOI: 10.22038/ijn.2016.7108]">Lifschitz 2016</a>) </p> </li> <li> <p>Study retraction by the author (<a href="./references#CD013758-bbs2-0044" title="TsengE , PotterSM , PiccianoMF . Dietary protein source and plasma lipid profiles of infants. Pediatrics1990;85(4):548-52 (Retraction in Pediatrics. 1990 Oct;86(4):534.PMID: 2216617). [PMID: 2242108]">Tseng 1990</a>) </p> </li> <li> <p>Formula feeding period less than three months (<a href="./references#CD013758-bbs2-0016" title="GunnTR , StunznerD . A comparative trial of casein or whey-predominant formulae in healthy infants. New Zealand Medical Journal1986;99(813):843-6. [PMID: 3537872]">Gunn 1986</a>) </p> </li> </ol> </p> <p>For more details, see the <a href="./references#CD013758-sec-0142" title="">Characteristics of excluded studies</a> table. </p> </section> <section id="CD013758-sec-0053"> <h4 class="title">Ongoing studies</h4> <p>We identified the following six ongoing studies.</p> <p> <ol id="CD013758-list-0026"> <li> <p><a href="./references#CD013758-bbs2-0048" title="NCT01300000. Effects of early nutrient intake on growth and body composition [Effects of early nutrition on growth]. clinicaltrials.gov/ct2/show/NCT01300000 (first posted 21 February 2011). [CENTRAL: CN-01532058] ">NCT01300000</a>: an RCT that began in 2011, to evaluate the effect on weight gain and gastrointestinal tolerability of a calorie‐ and protein‐reduced formula versus a standard formula, administered for one year </p> </li> <li> <p><a href="./references#CD013758-bbs2-0049" title="NCT02282488. Effect of the level of dietary protein on the infant hormonal profile and body composition. clinicaltrials.gov/ct2/show/NCT02282488 (first posted 4 November 2014). [CENTRAL: CN-01549951] ">NCT02282488</a>: an RCT that began in 2006, to evaluate the effect on body composition of a high‐protein formula versus a low‐protein formula, administered for one year </p> </li> <li> <p><a href="./references#CD013758-bbs2-0050" title="NCT02646969. Growth and metabolic biomarkers of healthy term infants fed formulas with staged protein concentrations over the first year of life. clinicaltrials.gov/ct2/show/NCT02646969 (first posted 6 January 2016). [CENTRAL: CN-01584608] ">NCT02646969</a>: an RCT that began in 2016, to analyze the effect on weight gain of regimen 1 versus regimen 2 formula, administered for one year </p> </li> <li> <p><a href="./references#CD013758-bbs2-0051" title="GroteV , JaegerV , EscribanoJ , ZaragozaM , GispertM , GrathwohlD , et al. Effect of milk protein content in Toddler formula on later BMI and obesity risk: protocol of the multicentre randomised controlled Toddler Milk Intervention (ToMI) trial. BMJ Open2021;11(12):e048290. [DOI: 10.1136/bmjopen-2020-048290] [PMID: 34876419]NCT02907502. Toddler milk intervention Trial (TOMI) [Effects of milk protein intake in young children on early growth and later obesity risk: a multicentre randomized clinical trial]. clinicaltrials.gov/ct2/show/NCT02907502 (first posted 20 September 2016). [CENTRAL: CN-01520941] VylliotiA , KoletzkoB , Zaragoza-JordanaM , EscribanoJ , HoldtL , DemmelmairH , et al. The association of total milk intake, the IGF-I axis, and growth at 1 year of age: baseline results from the toddler milk Intervention (TOMI) Trial. Journal of Pediatric Gastroenterology and Nutrition2022;74(Suppl 2):S1134. [DOI: 10.1097/MPG.0000000000003446]">NCT02907502</a>: an RCT that began in 2016 to analyze the effect on development of overweight and obesity of a high‐protein formula versus a low‐protein formula, administered for one year </p> </li> <li> <p><a href="./references#CD013758-bbs2-0052" title="NCT03456934. Lower protein intake and long-term risk of obesity and cardiovascular disease (BabyGrowth) [Lower protein intake and long‐term risk of obesity and cardiovascular disease: a multi‐centred, randomised, controlled trial]. clinicaltrials.gov/ct2/show/NCT03456934 (first posted 7 March 2018). [CENTRAL: CN-01483741] ">NCT03456934</a>: an RCT that began in 2017 to evaluate the effect on weight gain and adverse events of a standard‐protein versus a low‐protein formula, administered for one year </p> </li> <li> <p><a href="./references#CD013758-bbs2-0053" title="NCT03513991. Evaluation of different protein content of formulas on nutrition status of infants [Evaluation of the impact of infant formulas with different protein content on growth, gastrointestinal tolerance, and B‐casomorphin concentration of infants]. clinicaltrials.gov/ct2/show/NCT03513991 (first posted 2 May 2018). [CENTRAL: CN-01599423] ">NCT03513991</a>: an RCT that began in 2016 to analyze the effect on weight and adverse events at one year of two standard protein formulas versus a low protein formula </p> </li> </ol> </p> <p>For further information, see the <a href="./references#CD013758-sec-0144" title="">Characteristics of ongoing studies</a> table. </p> </section> <section id="CD013758-sec-0054"> <h4 class="title">Studies awaiting classification</h4> <p>The following two studies, available only as conference abstracts, are awaiting classification.</p> <p> <ol id="CD013758-list-0027"> <li> <p><a href="./references#CD013758-bbs2-0046" title="BeckL , LachambreL , KempfC , GirardetJ . How to assess the impact of protein content in follow-on formula during the second half-year of life? In: 50th Annual Meeting of the European Society for Paediatric Research; 2009 October 9-12; Hamburg, Germany. 2009. ">Beck 2009</a>: an oral presentation at the 50th Annual Meeting of the European Society for Pediatric Research </p> </li> <li> <p><a href="./references#CD013758-bbs2-0047" title="SinghalA , LaniganJ , MackeyA , MerritR , MarriageB , IbhanesebhorS , et al. Early nutrition and later risk of obesity. Obesity2010;18(Suppl 2):S51. [DOI: 10.1038/oby.2010.156]">Shingal 2010</a>: an abstract presented in 2010 </p> </li> </ol> </p> <p>For details, see the <a href="./references#CD013758-sec-0143" title="">Characteristics of studies awaiting classification</a> table. </p> </section> </section> <section id="CD013758-sec-0055"> <h3 class="title">Risk of bias in included studies</h3> <p>For details on the risk of bias of the included trials, see the <a href="./references#CD013758-sec-0141" title="">Characteristics of included studies</a> table. Additionally, for an overview of the reviewers' judgments of each risk of bias across all studies and in each study, see <a href="#CD013758-fig-0003">Figure 3</a> and <a href="#CD013758-fig-0004">Figure 4</a>. </p> <div class="figure" id="CD013758-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013758-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD013758-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013758-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD013758-sec-0056"> <h4 class="title">Allocation</h4> <section id="CD013758-sec-0057"> <h5 class="title">Random sequence generation</h5> <p><a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a> reported having allocated participants alternatively; we judged the study at high risk of bias as this is an inadequate randomization method that does not avoid selection bias. Two studies provided insufficient information on how the infants were randomly assigned to permit a judgment, so we considered them at unclear risk of bias (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>). </p> </section> <section id="CD013758-sec-0058"> <h5 class="title">Allocation concealment</h5> <p>We considered three trials at low risk of bias because the reported allocation concealment techniques involved sequentially numbered and sealed envelopes, internet‐based randomization platform, or code‐numbered labels without identification of protein content (<a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>). The remaining eight trials did not report allocation concealment in detail (unclear risk of bias). </p> </section> </section> <section id="CD013758-sec-0059"> <h4 class="title">Blinding</h4> <section id="CD013758-sec-0060"> <h5 class="title">Blinding of participants and personnel</h5> <p>Only <a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a> did not report how the blinding was performed (unclear risk of bias). The remaining 10 studies adequately reported how blinding was performed or mentioned that their formulas were almost identical in composition, making them indistinguishable from each other. We judged these 10 studies at low risk of performance bias. </p> </section> <section id="CD013758-sec-0061"> <h5 class="title">Blinding of outcome assessment</h5> <p>Six studies provided sufficient information on the blinding of outcome assessment so were at low risk of detection bias (<a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>). The remaining five studies provided insufficient detail to determine whether blinding of outcome assessment was suitable (unclear risk of bias). </p> </section> </section> <section id="CD013758-sec-0062"> <h4 class="title">Incomplete outcome data</h4> <p>We judged eight of the 11 studies at low risk of attrition bias because their attrition rates were below 20%. Attrition rates in the remaining three studies ranged from 25% to 44% due to the difficulty of conducting long‐term follow‐up; we considered them at high risk of bias (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). </p> </section> <section id="CD013758-sec-0063"> <h4 class="title">Selective reporting</h4> <p>We judged all 11 studies at low risk of reporting bias because, despite the lack of published protocols or trial registries, they reported all specified outcomes. Given that eight of 11 studies (73%) were published before 2010, we did not expect them to have a preregistered protocol (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). </p> </section> <section id="CD013758-sec-0064"> <h4 class="title">Other potential sources of bias</h4> <p>We judged three studies at high risk of other bias, mainly because the sponsor was involved in the analysis of the results or because at least one study author was employed by the sponsor (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>). We judged five studies at unclear risk of other bias because the information provided was insufficient to determine the involvement of the sponsor (<a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). </p> </section> </section> <section id="CD013758-sec-0065"> <h3 class="title" id="CD013758-sec-0065">Effects of interventions</h3> <p>See: <a href="./full#CD013758-tbl-0001"><b>Summary of findings 1</b> High‐protein formula versus standard‐protein formula in healthy term infants</a>; <a href="./full#CD013758-tbl-0002"><b>Summary of findings 2</b> Standard‐protein formula versus low‐protein formula in healthy term infants</a> </p> <p>Because nine studies did not report z‐scores for the weight, height, head circumference, or BMI of their participants, we used the reported anthropometric measures to calculate weighted mean z‐score values using the WHO Child Growth Standards software, adjusting for age, sex, and the number of participants in each study (<a href="https://www.who.int/tools/child-growth-standards/software" target="_blank">WHO Anthro v3.2.2</a>). </p> <section id="CD013758-sec-0066"> <h4 class="title">High‐protein formula versus standard‐protein formula</h4> <p>See <a href="./full#CD013758-tbl-0001">summary of findings Table 1</a>. </p> <p>Seven studies (including 1629 participants) compared infants who were fed high‐protein formula with those fed standard‐protein formula (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). In six studies, the infants were fed only formula for four months (<a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>), and then in two of those studies, the infants were kept on formula (with the same protein content) after moving on to complementary foods, for at least one year of follow‐up (<a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>). In <a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>, the infants received formula in addition to complementary foods throughout the study. </p> <section id="CD013758-sec-0067"> <h5 class="title">Primary outcomes</h5> <section id="CD013758-sec-0068"> <h6 class="title">1. Undernutrition</h6> <p>We were unable to calculate the RR or Peto OR for the different types of undernutrition because no studies provided dichotomous data for these outcomes (number of participants with the outcome); however, since all the studies provided continuous data, we calculated the z‐scores for each study and used the MD as the pooled effect measure. </p> <section id="CD013758-sec-0069"> <p><b>a) Underweight (weight‐for‐age z‐score)</b></p> <p>Two studies provided weight‐for‐age z‐scores (<a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>), and five studies provided data that we could use to calculate weight‐for‐age z‐scores (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). We are unsure if feeding healthy term infants high‐protein formula compared to standard‐protein formula has any effect on weight‐for‐age z‐score in the first year of life (MD 0.05 SDs, 95% CI −0.09 to 0.19; P = 0.51, I<sup>2</sup> = 61%; 7 studies, 1629 participants; very low‐certainty evidence; <a href="./references#CD013758-fig-0005" title="">Analysis 1.1</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in weight‐for‐age z‐score between those fed high‐protein formula and those fed standard‐protein formula at four months of follow‐up (MD −0.10 SDs, 95% CI −0.24 to 0.04; P = 0.16, I<sup>2</sup> = 3%; 4 studies, 311 participants; <a href="./references#CD013758-fig-0005" title="">Analysis 1.1</a>). Among the infants given formula in addition to complementary foods, there was a difference in weight‐for‐age z‐score between those fed high‐protein formula and those fed standard‐protein formula at one year of follow‐up (MD 0.20 SDs, 95% CI 0.11 to 0.30; P &lt; 0.001, I<sup>2</sup> = 0%; 3 studies, 1318 participants; <a href="./references#CD013758-fig-0005" title="">Analysis 1.1</a>). The P value of the test for subgroup differences was less than 0.001. </p> <p>Three of the seven studies were at high risk of attrition bias (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). When we removed these studies in an overall sensitivity analysis, the effect estimate did not change (MD 0.0 SDs, 95% CI −0.27 to 0.26; P = 0.98, I<sup>2</sup> = 72%; 4 studies, 361 participants). In a detailed sensitivity analysis by type of formula feeding, we found a slight change in the effect estimate between the high‐protein and standard‐protein groups among exclusively formula‐fed infants (MD −0.28 SDs, 95% CI −0.53 to −0.03; P = 0.03, I<sup>2</sup> = 0%; 2 studies, 133 participants) and among infants fed formula with complementary foods (MD 0.21 SDs, 95% CI 0.05 to 0.37; P = 0.009, I<sup>2</sup> = 0%; 2 studies, 228 participants). </p> <p>In a subgroup analysis according to different follow‐up time points, we identified that the weight‐for‐age z‐score of participants in the high‐protein group relative to the standard‐protein group gradually increased from an MD of −0.01 SDs (95% CI −0.13 to 0.10; P = 0.80, I<sup>2</sup> = 43%; 4 studies, 1458 participants; <a href="./references#CD013758-fig-0006" title="">Analysis 1.2</a>) at two months to an MD of 0.15 SDs (95% CI 0.01 to 0.29; P = 0.03; 1 study, 1090 participants; <a href="./references#CD013758-fig-0006" title="">Analysis 1.2</a>) at six years of follow‐up. The P value of the test for subgroup differences was 0.01. </p> <p>To determine whether the change in weight‐for‐age over time was affected by the high‐protein formula, we performed meta‐regression and linear regression with panel‐corrected standard error analyses adjusted for study weight in STATA v15.1 software (<a href="./references#CD013758-bbs2-0126" title="Stata. Version 15.1. Collegue Station, TX: StataCorp, 2017. Available at www.stata.com.">Stata 2017</a>). The results suggested no effect (P = 0.16 for meta‐regression, and P = 0.38 for linear regression). </p> </section> <section id="CD013758-sec-0070"> <p><b>b) Stunting (height‐for‐age z‐score)</b></p> <p>Two studies provided height‐for‐age z‐scores (<a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>), and five studies provided data that we could use to calculate height‐for‐age z‐scores (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). We are unsure if feeding healthy term infants high‐protein formula compared to standard‐protein formula has any effect on height‐for‐age z‐score in the first year of life (MD 0.15 SDs, 95% CI −0.05 to 0.35; P = 0.14, I<sup>2</sup> = 73%; 7 studies, 1629 participants; very low‐certainty evidence; <a href="./references#CD013758-fig-0007" title="">Analysis 1.3</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in height‐for‐age z‐score between those fed high‐protein formula and those fed standard‐protein formula at four months of follow‐up (MD 0.01 SDs, 95% CI −0.32 to 0.34; P = 0.97, I<sup>2</sup> = 73%; 4 studies, 311 participants; <a href="./references#CD013758-fig-0007" title="">Analysis 1.3</a>). Among the infants given formula in addition to complementary foods, those fed high‐protein formula had a higher height‐for‐age z‐score compared with those fed standard‐protein formula at one year of follow‐up (MD 0.29 SDs, 95% CI 0.02 to 0.57; P = 0.04, I<sup>2</sup> = 78%; 3 studies, 1318 participants; <a href="./references#CD013758-fig-0007" title="">Analysis 1.3</a>). The P value of the test for subgroup differences was 0.19. </p> <p>Three of the seven studies were at high risk of attrition bias (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). When we removed these studies in an overall sensitivity analysis, the effect estimate did not change (MD 0.18 SDs, 95% CI −0.19 to 0.55; P = 0.35, I<sup>2</sup> = 81%; 4 studies, 361 participants). In a detailed sensitivity analysis by type of formula feeding, we found a slight change in the effect estimate between the high‐protein and standard‐protein groups among exclusively formula‐fed infants (MD −0.11 SDs, 95% CI −0.67 to 0.45; P = 0.69, I<sup>2</sup> = 76%; 2 studies, 133 participants) and among infants fed formula with complementary foods (MD 0.43 SDs, 95% CI 0.25 to 0.62; P &lt; 0.001, I<sup>2</sup> = 0%; 2 studies, 228 participants). </p> <p>In a subgroup analysis according to different follow‐up time points, we identified that the height‐for‐age z‐score of participants in the high‐protein group relative to the standard‐protein group gradually increased, from an MD of −0.00 SDs (95% CI −0.17 to 0.17; P = 1.0, I<sup>2</sup> = 49%; 4 studies, 1458 participants; <a href="./references#CD013758-fig-0008" title="">Analysis 1.4</a>) at two months to an MD of 0.29 SDs (95% CI 0.02 to 0.57; P = 0.04, I<sup>2</sup> = 78%; 3 studies, 1318 participants; <a href="./references#CD013758-fig-0008" title="">Analysis 1.4</a>) at one year of follow‐up; but this increase in height‐for‐age z‐score was no longer observed at two years (MD −0.07 SDs, 95% CI −0.17 to 0.03; P = 0.17; 1 study, 1090 participants; <a href="./references#CD013758-fig-0008" title="">Analysis 1.4</a>), or six years (MD −0.04 SDs, 95% CI −0.17 to 0.09; P = 0.54; 1 study, 1090 participants; <a href="./references#CD013758-fig-0008" title="">Analysis 1.4</a>). The P value of the test for subgroup differences was 0.13. </p> <p>Meta‐regression analysis and linear regression with panel‐corrected standard error analyses showed that the change in height‐for‐age over time was not influenced by the type of infant formula (P = 0.94 for meta‐regression and P = 0.86 for linear regression). </p> </section> <section id="CD013758-sec-0071"> <p><b>c) Wasting (weight‐for‐height z‐score)</b></p> <p>Two studies provided weight‐for‐height z‐scores (<a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>), and five studies provided data that we could use to calculate weight‐for‐height z‐scores (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). We are unsure if feeding healthy term infants high‐protein formula compared to standard‐protein formula has any effect on weight‐for‐height z‐score in the first year of life (MD −0.12 SDs, 95% CI −0.31 to 0.07; P = 0.20, I<sup>2</sup> = 94%; 7 studies, 1629 participants; very low‐certainty evidence; <a href="./references#CD013758-fig-0009" title="">Analysis 1.5</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in weight‐for‐height z‐score between those fed high‐protein formula and those fed standard‐protein formula at four months of follow‐up (MD −0.20 SDs, 95% CI −0.41 to 0.01; P = 0.07, I<sup>2</sup> = 93%; 4 studies, 311 participants; <a href="./references#CD013758-fig-0009" title="">Analysis 1.5</a>). Among the infants given formula in addition to complementary foods, there was also no difference in weight‐for‐height z‐score between those fed high‐protein formula and those fed standard‐protein formula at one year of follow‐up (MD −0.02 SDs, 95% CI −0.37 to 0.32; P = 0.90, I<sup>2</sup> = 93%; 3 studies, 1318 participants; <a href="./references#CD013758-fig-0009" title="">Analysis 1.5</a>). The P value of the test for subgroup differences was 0.40. </p> <p>Three of the seven studies were at high risk of attrition bias (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). When we removed these studies in an overall sensitivity analysis, the effect estimate did not change (MD −0.22 SDs, 95% CI −0.48 to 0.04; P = 0.10, I<sup>2</sup> = 92%; 4 studies, 361 participants). In a detailed sensitivity analysis by type of formula feeding, we found a slight change in the effect estimate between the high‐protein and standard‐protein groups among exclusively formula‐fed infants (MD −0.29 SDs, 95% CI −0.71 to 0.13; P = 0.18, I<sup>2</sup> = 94%; 2 studies, 133 participants) and among infants fed formula with complementary foods (MD −0.16 SDs, 95% CI −0.66 to 0.35; P = 0.55, I<sup>2</sup> = 94%; 2 studies, 228 participants). </p> <p>In a subgroup analysis according to different follow‐up time points, we found that the weight‐for‐height z‐score of participants in the high‐protein group relative to the standard‐protein group gradually increased, from an MD of −0.06 SDs (95% CI −0.41 to 0.29; P = 0.74, I<sup>2</sup> = 99%; 4 studies, 1458 participants; <a href="./references#CD013758-fig-0010" title="">Analysis 1.6</a>) at two months to an MD of 0.27 SDs (95% CI −0.00 to 0.54; P = 0.05, I<sup>2</sup> = 98%; 2 studies, 1244 participants; <a href="./references#CD013758-fig-0010" title="">Analysis 1.6</a>) at five years of follow‐up. The P value of the test for subgroup differences was 0.10. </p> </section> </section> <section id="CD013758-sec-0072"> <h6 class="title">2. Overweight or obesity</h6> <p>One study reported the risk of developing overweight or obesity in infants fed formula in addition to complementary foods (<a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>). </p> <section id="CD013758-sec-0073"> <p><b>a. Overweight</b></p> <p>We are unsure if feeding healthy term infants high‐protein formula compared to standard‐protein formula has any effect on the risk of overweight in the first five years of life (RR 1.26, 95% CI 0.63 to 2.51; P = 0.51; 1 study, 1090 participants; very low‐certainty evidence; <a href="./references#CD013758-fig-0011" title="">Analysis 1.7</a>). </p> <p>In an analysis of different time points of follow‐up, we found that the risk of developing overweight in participants in the high‐protein group relative to the standard‐protein group ranged from an RR of 1.26 (95% CI 0.63 to 2.51; P = 0.51; 1 study, 1090 participants; <a href="./references#CD013758-fig-0012" title="">Analysis 1.8</a>) at five years to an RR of 1.16 (95% CI 0.83 to 1.64; P = 0.39; 1 study, 1090 participants; <a href="./references#CD013758-fig-0012" title="">Analysis 1.8</a>) at 11 years of follow‐up. The P value of the test for subgroup differences was 0.90. </p> <p>We could not perform sensitivity analysis because only one study reported this outcome.</p> </section> <section id="CD013758-sec-0074"> <p><b>b. Obesity</b></p> <p>We are unsure if feeding healthy term infants high‐protein formula compared to standard‐protein formula has any effect on the risk of obesity in the first five years of life (RR 1.96, 95% CI 0.59 to 6.48; P = 0.27; 1 study, 1090 participants; very low‐certainty evidence; <a href="./references#CD013758-fig-0013" title="">Analysis 1.9</a>). </p> <p>In a subgroup analysis according to different follow‐up time points, we observed that the risk of developing obesity in participants in the high‐protein group relative to the standard‐protein group ranged from an RR of 1.96 (95% CI 0.59 to 6.48; P = 0.27; 1 study, 1090 participants; <a href="./references#CD013758-fig-0014" title="">Analysis 1.10</a>) at five years to an RR of 1.28 (95% CI 0.63 to 2.62; P = 0.49; 1 study, 1090 participants; <a href="./references#CD013758-fig-0014" title="">Analysis 1.10</a>) at 11 years of follow‐up. The P value of the test for subgroup differences was 0.65. </p> <p>We could not perform sensitivity analysis because only one study reported this outcome.</p> </section> </section> </section> <section id="CD013758-sec-0075"> <h5 class="title">Secondary outcomes</h5> <section id="CD013758-sec-0076"> <h6 class="title">1. Neurodevelopmental outcomes</h6> <p>One observational study of the participants in <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a> reported neurodevelopment outcomes up to eight years of age, using the following instruments (<a href="./references#CD013758-bbs2-0078" title="EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2016;122(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]">Escribano 2016</a>). </p> <p> <ol id="CD013758-list-0028"> <li> <p>Memory using the recall objects test and the Rey auditory verbal learning test (<a href="./references#CD013758-bbs2-0119" title="ReyA . The psychological examination of cases of traumatic encephalopathy [L’examen psychologique dans les cas d’encephopathie traumatique]. Archives de Psychologie1941;28(21):286-340.">Rey 1941</a>; <a href="./references#CD013758-bbs2-0124" title="SnodgrassJG , VanderwartM . A standardized set of 260 pictures: norms for name agreement, image agreement, familiarity, and visual complexity. Journal of Experimental Psychology. Human Learning and Memory1980;6(2):174-215. [DOI: 10.1037//0278-7393.6.2.174] [PMID: 7373248]">Snodgrass 1980</a>) </p> </li> <li> <p>Attention using the continuous performance test and the cancelation test (Tachar) of Woodcook‐Muñoz (<a href="./references#CD013758-bbs2-0069" title="ConnersCK , EpsteinJN , AngoldA , Klaric. Continuous performance test performance in a normative epidemiological sample. Journal of Abnormal Child Psychology2003;31(5):555-62. [DOI: 10.1023/a:1025457300409] [PMID: 14561062]">Conners 2003</a>; <a href="./references#CD013758-bbs2-0125" title="De Sousa-MagalhãesS , Fernandes-Malloy-DinizL , Cavalheiro-HamdanA . Validity convergent and reliability test-retest of the rey auditory verbal learning test. Clinical Neuropsychiatry2012;9(3):129-37. [DOI: 10.1037/t27193-000]">Sousa‐Magalhães 2012</a>) </p> </li> <li> <p>Perception using the Hooper visual organization test (<a href="./references#CD013758-bbs2-0106" title="MariaM , PonchelA . Hooper visual organization test. Les Cahiers de Neuropsychologie2012;1:3-8.">Maria 2012</a>) </p> </li> <li> <p>Language with Animals – FAS (measure of phonemic word fluency that asks the individual to orally produce as many words as possible that begin with the letters F, A, and S within 1 minute; <a href="./references#CD013758-bbs2-0117" title="PattersonJ . F-A-S test. In: KreutzerJS , DeLucaJ , CaplanB , editors(s). Encyclopedia of Clinical Neuropsychology. New York: Springer, 2011:1024-26. [DOI: 10.1007/978-0-387-79948-3_886]">Patterson 2011</a>) and Nepsy's token test (NEPSY‐II; <a href="./references#CD013758-bbs2-0136" title="VoughtJR , DeanRS . Woodcock-Johnson III tests of cognitive abilities. In: GoldsteinS , NaglieriJA , editors(s). Encyclopedia of Child Behavior and Development. Boston, MA: Springer, 2011:1577-8. [DOI: 10.1007/978-0-387-79061-9_3096]">Vought 2011</a>) </p> </li> <li> <p>Processing speed using the symbol digit modalities test (<a href="./references#CD013758-bbs2-0091" title="Western Psychological Services (Firm). Hooper visual organization test (vot) : manual. Western Psychological Services, 1983.">Hooper 1983</a>) </p> </li> <li> <p>Motor by grooved pegboard test (<a href="./references#CD013758-bbs2-0103" title="LopezMN , LazarMD , OhS . Psychometric properties of the Hooper visual organization test. Assessment2003;10(1):66-71. [DOI: 10.1177/1073191102250183] [PMID: 12675385]">Lopez 2003</a>) </p> </li> <li> <p>Executive functions using the Stroop (first to fourth condition), reversal digits (of Woodcook–Muñoz battery of tests), Kaufman‐ABC II pattern reasoning, children's color trail test, and hungry donkey task (<a href="./references#CD013758-bbs2-0123" title="SmithA . Symbol digit modalities test. 10th edition. Torrance, CA: WPS Western Psychological Services, 2007.">Smith 2007</a>; <a href="./references#CD013758-bbs2-0136" title="VoughtJR , DeanRS . Woodcock-Johnson III tests of cognitive abilities. In: GoldsteinS , NaglieriJA , editors(s). Encyclopedia of Child Behavior and Development. Boston, MA: Springer, 2011:1577-8. [DOI: 10.1007/978-0-387-79061-9_3096]">Vought 2011</a>) </p> </li> <li> <p>Behavior using the child behavior checklist 4 to 18 (CBCL; <a href="./references#CD013758-bbs2-0056" title="AchenbachTM . Manual for the child behavior checklist / 4 - 18 and profiles. Burlington: University of Vermont. Department of Psychiatry, 1991.">Achenbach 1991</a>) </p> </li> </ol> </p> <p>Overall, <a href="./references#CD013758-bbs2-0078" title="EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2016;122(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]">Escribano 2016</a> reported no differences in any of the behavioral or performance domains between participants in the two feeding groups. </p> </section> <section id="CD013758-sec-0077"> <h6 class="title">2. All‐cause mortality</h6> <p>No studies reported all‐cause mortality.</p> </section> <section id="CD013758-sec-0078"> <h6 class="title">3. Adverse events</h6> <p>Four studies (involving 445 participants) reported adverse events (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). Of these studies, only <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a> administered infant formula in addition to complementary foods. The most common adverse events were diarrhea, vomiting, and milk hypersensitivity. In total, 70 of the 226 infants (31%) who received high‐protein formula experienced at least one adverse event, compared with 75 of the 219 infants (34%) who received standard‐protein formula. The evidence suggests there may be little or no difference in the occurrence of adverse events between infants fed high‐protein formula and infants fed standard‐protein formula in the first year of life (RR 0.93, 95% CI 0.76 to 1.13; P = 0.44, I<sup>2</sup> = 0%; 4 studies, 445 participants; low‐certainty evidence; <a href="./references#CD013758-fig-0015" title="">Analysis 1.11</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in risk of adverse event between those fed high‐protein formula and those fed standard‐protein formula at four months of follow‐up (RR 0.95, 95% CI 0.78 to 1.16; P = 0.63, I<sup>2</sup> = 0%; 3 studies, 291 participants; <a href="./references#CD013758-fig-0015" title="">Analysis 1.11</a>). Among the infants given formula in addition to complementary foods, there was also no difference in risk of adverse events between those fed high‐protein formula and those fed standard‐protein formula at one year of follow‐up (RR 0.19, 95% CI 0.01 to 3.79; P = 0.27; 1 study, 154 participants; <a href="./references#CD013758-fig-0015" title="">Analysis 1.11</a>). The P value of the test for subgroup differences was 0.29. </p> <p>Two of the four studies were at high risk of attrition bias (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). When we removed these studies in an overall sensitivity analysis, the effect estimate did not change (RR 0.82, 95% CI 0.55 to 1.22; P = 0.32, I<sup>2</sup> = 5%; 2 studies, 267 participants). In a detailed sensitivity analysis by type of formula feeding, we found that the effect estimate did not change among the infants who were exclusively formula‐fed (RR 0.88, 95% CI 0.59 to 1.31; P = 0.52; 1 study, 113 participants) or among infants fed formula with complementary foods (RR 0.19, 95% CI 0.01 to 3.79; P = 0.27; 1 study, 154 participants). </p> <p>We performed a detailed analysis by type of adverse event. In the infants fed only formula, we found no difference between the high‐protein group and the standard‐protein group in the risk of vomiting (Peto OR 3.29, 95% CI 0.55 to 19.61; P = 0.19; 1 study, 113 participants; <a href="./references#CD013758-fig-0016" title="">Analysis 1.12</a>) or milk hypersensitivity (Peto OR 2.91, 95% CI 0.39 to 21.51; P = 0.30; 1 study, 77 participants; <a href="./references#CD013758-fig-0016" title="">Analysis 1.12</a>). In the infants given formula in addition to complementary foods, we found no difference between the high‐protein group and the standard‐protein group in the risk of diarrhea (Peto OR 0.12, 95% CI 0.01 to 1.99; P = 0.14; 1 study, 154 participants; <a href="./references#CD013758-fig-0017" title="">Analysis 1.13</a>) or vomiting (Peto OR 0.12, 95% CI 0.0 to 6.31; P = 0.30; 1 study, 154 participants; <a href="./references#CD013758-fig-0017" title="">Analysis 1.13</a>). </p> <p>No studies reported the risk of developing renal insufficiency.</p> </section> <section id="CD013758-sec-0079"> <h6 class="title">4. Anthropometric measurements</h6> <p>Seven studies reported anthropometric measurements (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). </p> <section id="CD013758-sec-0080"> <p><b>a) Weight</b></p> <p>Seven studies reported weight (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). There was no difference in weight between infants fed high‐protein formula and those fed standard‐protein formula in the first year of life (MD −0.01 kg, 95% CI −0.12 to 0.09; P = 0.83, I<sup>2</sup> = 55%; 7 studies, 1629 participants; <a href="./references#CD013758-fig-0018" title="">Analysis 1.14</a>) in the first year of life. </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in weight between those fed high‐protein formula and those fed standard‐protein formula at four months of follow‐up (MD −0.07 kg, 95% CI −0.18 to 0.04; P = 0.24, I<sup>2</sup> = 35%; 4 studies, 311 participants; <a href="./references#CD013758-fig-0018" title="">Analysis 1.14</a>). Among the infants given formula in addition to complementary foods, there was also no difference in weight between those fed high‐protein formula and those fed standard‐protein formula at one year of follow‐up (MD 0.09 kg, 95% CI −0.12 to 0.29; P = 0.42, I<sup>2</sup> = 64%; 3 studies, 1318 participants; <a href="./references#CD013758-fig-0018" title="">Analysis 1.14</a>). The P value of the test for subgroup differences was 0.21. </p> <p>Three of the seven studies were at high risk of attrition bias (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). When we removed these studies in an overall sensitivity analysis, the effect estimate did not change (MD −0.10 kg, 95% CI −0.24 to 0.05; P = 0.21, I<sup>2</sup> = 38%; 4 studies, 361 participants). In a detailed sensitivity analysis by type of formula feeding, we found a slight change in the effect estimate between the high‐protein and standard‐protein groups among exclusively formula‐fed infants (MD −0.19 kg, 95% CI −0.33 to −0.04; P = 0.01, I<sup>2</sup> = 0%; 2 studies, 133 participants) and among infants fed formula with complementary foods (MD 0.03 kg, 95% CI −0.28 to 0.34; P = 0.85, I<sup>2</sup> = 63%; 2 studies, 228 participants). </p> <p>In a subgroup analysis according to different follow‐up time points, we observed a gradual increase in weight in infants fed the high‐protein formula compared with the standard‐protein group, from an MD of −0.03 kg (95% CI −0.09 to 0.04; P = 0.40, I<sup>2</sup> = 11%; 4 studies, 1458 participants; <a href="./references#CD013758-fig-0019" title="">Analysis 1.15</a>) at two months to an MD of 0.61 kg (95% CI 0.12 to 1.10; P = 0.01; 1 study, 1090 participants; <a href="./references#CD013758-fig-0019" title="">Analysis 1.15</a>) at six years of follow‐up. The P value of the test for subgroup differences was 0.001. </p> </section> <section id="CD013758-sec-0081"> <p><b>b) Height</b></p> <p>Seven studies reported height (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). There was no difference in height between infants fed high‐protein formula and those fed standard‐protein formula in the first year of life (MD 0.27 cm, 95% CI −0.19 to 0.74; P = 0.25, I<sup>2</sup> = 77%; 7 studies, 1629 participants; <a href="./references#CD013758-fig-0020" title="">Analysis 1.16</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in height between those fed high‐protein formula and those fed standard‐protein formula among the exclusively formula‐fed infants (MD 0.16 cm, 95% CI −0.39 to 0.72; P = 0.56, I<sup>2</sup> = 71%; 4 studies, 311 participants; <a href="./references#CD013758-fig-0020" title="">Analysis 1.16</a>). Among the infants given formula in addition to complementary foods, there was no difference in height between those fed high‐protein formula and those fed standard‐protein formula at one year of follow‐up (MD 0.49 cm, 95% CI −0.52 to 1.50; P = 0.34, I<sup>2</sup> = 87%; 3 studies, 1318 participants; <a href="./references#CD013758-fig-0020" title="">Analysis 1.16</a>). The P value of the test for subgroup differences was 0.58. </p> <p>Three of the seven studies were at high risk of attrition bias (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). When we removed these studies in an overall sensitivity analysis, the effect estimate did not change (MD 0.44 cm, 95% CI −0.21 to 1.10; P = 0.19, I<sup>2</sup> = 68%; 4 studies, 361 participants). In a detailed sensitivity analysis by subgroups, we found that the effect estimate changed among the infants who received formula in addition to complementary foods (MD 1.00 cm, 95% CI 0.45 to 1.54; P = 0.004, I<sup>2</sup> = 0%; 2 studies, 228 participants), but not among the infants who were fed only formula (MD −0.04 cm, 95% CI −1.00 to 0.91; P = 0.93, I<sup>2</sup> = 71%; 2 studies, 133 participants). </p> <p>In a subgroup analysis according to different follow‐up time points, we observed a gradual increase in height in infants fed the high‐protein formula compared with those in the standard‐protein group, from an MD of 0.04 cm (95% CI −0.33 to 0.42; P = 0.82, I<sup>2</sup> = 44%; 4 studies, 1458 participants; <a href="./references#CD013758-fig-0021" title="">Analysis 1.17</a>) at two months to an MD of 1.00 cm (95% CI 0.45 to 1.54; P &lt; 0.01, I<sup>2</sup> = 0%; 2 studies, 228 participants; <a href="./references#CD013758-fig-0021" title="">Analysis 1.17</a>) at one year of follow‐up. However, the MD at two years was −0.30 cm (95% CI −0.67 to 0.07; P = 0.12; 1 study, 1090 participants; <a href="./references#CD013758-fig-0021" title="">Analysis 1.17</a>), and the MD at six years was −0.10 cm (95% CI −0.76 to 0.56; P = 0.77; 1 study, 1090 participants; <a href="./references#CD013758-fig-0021" title="">Analysis 1.17</a>). The P value of the test for subgroup differences was 0.01. </p> </section> <section id="CD013758-sec-0082"> <p><b>C) Body mass index</b></p> <p>Seven studies reported BMI z‐score or provided data that we could use to calculate BMI z‐score (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). There was no difference in BMI z‐score between the high‐protein group and the standard‐protein group in the first year of life (MD −0.14 SDs, 95% CI −0.32 to 0.04; P = 0.13, I<sup>2</sup> = 92%; 7 studies, 1629 participants; <a href="./references#CD013758-fig-0022" title="">Analysis 1.18</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, BMI z‐score was lower in those fed high‐protein formula compared to those fed standard‐protein formula at four months of follow‐up (MD −0.21 SDs, 95% CI −0.39 to −0.03; P = 0.02, I<sup>2</sup> = 82%; 4 studies, 311 participants; <a href="./references#CD013758-fig-0022" title="">Analysis 1.18</a>). Among the infants given formula in addition to complementary foods, there was no difference in BMI z‐score between those fed high‐protein formula and those fed standard‐protein formula at one year of follow‐up (MD −0.06 SDs, 95% CI −0.39 to 0.26; P = 0.71, I<sup>2</sup> = 94%; 3 studies, 1318 participants; <a href="./references#CD013758-fig-0022" title="">Analysis 1.18</a>). The P value of the test for subgroup differences was 0.43. </p> <p>Three of the seven studies were at high risk of attrition bias (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). When we removed these studies in an overall sensitivity analysis, the effect estimate changed slightly (MD −0.25 SDs, 95% CI −0.50 to 0.01; P = 0.06, I<sup>2</sup> = 91%; 4 studies, 361 participants). In a detailed sensitivity analysis by subgroups, we found that the effect estimate changed among the infants who were fed only formula (MD −0.29 SDs, 95% CI −0.65 to 0.07; P = 0.12, I<sup>2</sup> = 89%; 2 studies, 133 participants), but not among the infants given formula in addition to complementary foods (MD −0.21 SDs, 95% CI −0.70 to 0.28; P = 0.40, I<sup>2</sup> = 95%; 2 studies, 228 participants). </p> <p>In a subgroup analysis according to different follow‐up time points, we observed a gradual increase in BMI z‐score in infants fed the high‐protein formula compared with the standard‐protein group, from an MD of −0.07 SDs (95% CI −0.30 to 0.17; P = 0.57, I<sup>2</sup> = 95%; 4 studies, 1458 participants; <a href="./references#CD013758-fig-0023" title="">Analysis 1.19</a>) at two months to an MD of 0.27 SDs (95% CI 0.11 to 0.43; P &lt; 0.01; 1 study, 1090 participants; <a href="./references#CD013758-fig-0023" title="">Analysis 1.19</a>) at six years of follow‐up. The P value of the test for subgroup differences was 0.02. </p> <p>Seven studies reported BMI in kg/m<sup>2</sup> (<a href="./references#CD013758-bbs2-0001" title="AkesonP , AxelssonI , RaihaN . Growth and nutrient intake in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(1):1-8. [DOI: 10.1097/00005176-199801000-00001] [PMID: 9443112]Karlsland AkesonPM , AxelssonIE , RäihäNC . Protein and amino acid metabolism in three- to twelve-month-old infants fed human milk or formulas with varying protein concentrations. Journal of Pediatric Gastroenterology and Nutrition1998;26(3):297-304. [DOI: 10.1097/00005176-199803000-00011] [PMID: 9523865.]">Åkeson 1998</a>; <a href="./references#CD013758-bbs2-0002" title="AxelssonIE , IvarssonSA , RäihäNC . Protein intake in early infancy: effects on plasma amino acid concentrations, insulin metabolism, and growth. Pediatric Research1989;26(6):614-7. [DOI: 10.1203/00006450-198912000-00020] [PMID: 2689986]AxelssonIE , JakobssonI , RäihäNC . Formula with reduced protein content: effects on growth and protein metabolism during weaning. Pediatric Research1988;24(3):297-301. [DOI: 10.1203/00006450-198809000-00004] [PMID: 3062558]">Axelsson 1988</a>; <a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). The meta‐analysis showed no difference in BMI between infants fed high‐protein formula compared with the standard‐protein group in the first year of life (MD −0.22 kg/m<sup>2</sup>, 95% CI −0.53 to 0.09; P = 0.17, I<sup>2</sup> = 95%, 7 studies, 1629 participants; <a href="./references#CD013758-fig-0024" title="">Analysis 1.20</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, BMI was lower in those fed high‐protein formula compared with those fed standard‐protein formula at four months of follow‐up (MD −0.32 kg/m<sup>2</sup>, 95% CI −0.59 to −0.04; P = 0.03, I<sup>2</sup> = 91%; 4 studies, 311 participants; <a href="./references#CD013758-fig-0024" title="">Analysis 1.20</a>). Among the infants given formula in addition to complementary foods, there was no difference in BMI between those fed high‐protein formula and those fed standard‐protein formula at the end of follow‐up (MD −0.12 kg/m<sup>2</sup>, 95% CI −0.73 to 0.49; P = 0.70, I<sup>2</sup> = 92%; 3 studies, 1318 participants; <a href="./references#CD013758-fig-0024" title="">Analysis 1.20</a>). The P value of the test for subgroup differences was 0.57. </p> <p>Three of the seven studies were at high risk of attrition bias (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>; <a href="./references#CD013758-bbs2-0011" title="TurckD , GrillonC , LachambreE , RobiliardP , BeckL , Maurin J-L, et al. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life. Journal of Pediatric Gastroenterology and Nutrition2006;43(3):364-71. [DOI: 10.1097/01.mpg.0000228113.29359.b1] [PMID: 16954961]">Turck 2006</a>). When we removed these studies in an overall sensitivity analysis, the effect estimate changed slightly (MD −0.39 kg/m<sup>2</sup>, 95% CI −0.77 to 0.00; P = 0.05, I<sup>2</sup> = 90%; 4 studies, 361 participants). In a detailed sensitivity analysis by subgroups, we found that the effect estimate changed among the infants who were fed only formula (MD −0.41 kg/m<sup>2</sup>, 95% CI −0.99 to 0.18; P = 0.17, I<sup>2</sup> = 95%; 2 studies, 133 participants), but not among the infants given formula in addition to complementary foods (MD −0.35 kg/m<sup>2</sup>, 95% CI −1.04 to 0.33; P = 0.31, I<sup>2</sup> = 85%; 2 studies, 228 participants). </p> <p>In a subgroup analysis according to different follow‐up time points, we noted a gradual increase in BMI in infants fed the high‐protein formula compared with the standard‐protein group, from an MD of −0.18 kg/m<sup>2</sup> (95% CI −0.38 to 0.02; P = 0.07, I<sup>2</sup> = 83%; 4 studies, 1458 participants; <a href="./references#CD013758-fig-0025" title="">Analysis 1.21</a>) at two months, to an MD of 1.40 kg/m<sup>2</sup> (95% CI 1.13 to 1.67; P &lt; 0.01 ; 1 study, 1090 participants; <a href="./references#CD013758-fig-0025" title="">Analysis 1.21</a>) at six years of follow‐up. The P value of the test for subgroup differences was less than 0.001. </p> </section> <section id="CD013758-sec-0083"> <p><b>D) Head circumference</b></p> <p>Three studies reported head circumference z‐score or provided data that we could use to calculate head circumference z‐score (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>). The meta‐analysis showed no difference in head circumference z‐score between infants fed high‐protein formula compared with the standard‐protein group in the first year of life (MD 0.13 SDs, 95% CI −0.21 to 0.47; P = 0.46, I<sup>2</sup> = 58%; 3 studies, 344 participants; <a href="./references#CD013758-fig-0026" title="">Analysis 1.22</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in head circumference z‐score between those fed high‐protein formula and those fed standard‐protein formula (MD −0.07 SDs, 95% CI −0.39 to 0.24; P = 0.65, I<sup>2</sup> = 0%; 2 studies, 190 participants; <a href="./references#CD013758-fig-0026" title="">Analysis 1.22</a>) at four months of follow‐up. Among the infants given formula in addition to complementary foods, head circumference z‐score was higher among those fed high‐protein formula compared with those fed standard‐protein formula at one year of follow‐up (MD 0.37 SDs, 95% CI 0.13 to 0.61; P = 0.003; 1 study, 154 participants; <a href="./references#CD013758-fig-0026" title="">Analysis 1.22</a>). The P value of the test for subgroup differences was 0.03. </p> <p>One of the three studies was at high risk of attrition bias (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>). When we removed it in an overall sensitivity analysis, the effect estimate did not change (MD 0.15 SDs, 95% CI −0.31 to 0.62; P = 0.52, I<sup>2</sup> = 76%; 2 studies, 267 participants). In a detailed sensitivity analysis by subgroups, we noted that the effect estimate did not change among infants who were fed only formula (MD −0.11 SDs, 95% CI −0.50 to 0.28; P = 0.58; 1 study, 113 participants). We were unable to calculate the effect estimate for infants given formula in addition to complementary foods. </p> <p>In a subgroup analysis according to different follow‐up time points, we observed a gradual increase in head circumference z‐score in infants fed high‐protein formula compared with the standard‐protein group, from an MD of 0.25 SDs (95% CI −0.18 to 0.68; P = 0.25, I<sup>2</sup> = 70%; 2 studies, 267 participants; <a href="./references#CD013758-fig-0027" title="">Analysis 1.23</a>) at two months to an MD of 0.56 SDs (95% CI 0.34 to 0.78; P &lt; 0.01 ; 1 study, 154 participants; <a href="./references#CD013758-fig-0027" title="">Analysis 1.23</a>) at five years of follow‐up. The P value of the test for subgroup differences was 0.49. </p> <p>Three studies reported head circumference in cm (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>; <a href="./references#CD013758-bbs2-0007" title="LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CondelloCC , et al. Clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):59. [DOI: 10.1186/s12887-018-1046-6] [PMID: 29439736]LiottoN , OrsiA , MenisC , PiemonteseP , MorlacchiL , CristianaCC , et al. Correction to: clinical evaluation of two different protein content formulas fed to full-term healthy infants: a randomized controlled trial. BMC Pediatrics2018;18(1):135. [DOI: 10.1186/s12887-018-1109-8] [PMID: 29649986]NCT03035721. Clinical evaluation of a low protein content formula in the first months of life: a RCT. clinicaltrials.gov/ct2/show/NCT03035721 (first received 30 January 2017). [CENTRAL: CN-01561617] ">Liotto 2018</a>; <a href="./references#CD013758-bbs2-0009" title="PutetG , Labaune J-M, MaceK , SteenhoutP , GrathwohlD , RaverotV , et al. Effect of dietary protein on plasma insulin-like growth factor-1, growth, and body composition in healthy term infants: a randomised, double-blind, controlled trial (Early Protein and Obesity in Childhood (EPOCH) study). British Journal of Nutrition2016;115(2):271-84. [DOI: 10.1017/S0007114515004456] [PMID: 26586096]">Putet 2016</a>). The meta‐analysis showed no difference in head circumference between infants fed high‐protein formula and infants fed standard‐protein formula in the first year of life (MD 0.32 cm, 95% CI 0.0 to 0.63; P = 0.05, I<sup>2</sup> = 0%; 3 studies, 344 participants; <a href="./references#CD013758-fig-0028" title="">Analysis 1.24</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in head circumference between those fed high‐protein formula and those fed standard‐protein formula at four months of follow‐up (MD 0.16 cm, 95% CI −0.28 to 0.59; P = 0.48, I<sup>2</sup> = 0%; 2 studies, 190 participants; <a href="./references#CD013758-fig-0028" title="">Analysis 1.24</a>). Among the infants given formula in addition to complementary foods, those fed high‐protein formula had a larger head circumference than those fed standard‐protein formula at one year of follow‐up (MD 0.50 cm, 95% CI 0.04 to 0.96; P = 0.03; 1 study, 154 participants; <a href="./references#CD013758-fig-0028" title="">Analysis 1.24</a>). The P value of the test for subgroup differences was 0.29. </p> <p>One of the three studies was at high risk of attrition bias (<a href="./references#CD013758-bbs2-0004" title="HascoetJM , HubertC , RochatF , LegagneurH , GagaS , Emady-AzarS , et al. Effect of formula composition on the development of infant gut microbiota. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):756-62. [DOI: 10.1097/MPG.0b013e3182105850] [PMID: 21593648]">Hascoet 2011</a>). When we removed it in an overall sensitivity analysis, the effect estimate did not change (MD 0.38 cm, 95% CI 0.03 to 0.74; P = 0.04, I<sup>2</sup> = 0%; 2 studies, 267 participants). In a detailed sensitivity analysis by subgroups, we found an MD of 0.20 cm (95% CI −0.37 to 0.77; P = 0.49; 1 study, 113 participants) among the infants who were fed only formula. We were unable to calculate the effect estimate for infants given formula in addition to complementary foods. </p> <p>In a subgroup analysis according to different follow‐up time points, we observed a gradual increase in head circumference in infants fed the high‐protein formula compared with the standard‐protein group, from an MD of 0.24 cm (95% CI −0.35 to 0.82; P = 0.43, I<sup>2</sup> = 67%; 2 studies, 267 participants; <a href="./references#CD013758-fig-0029" title="">Analysis 1.25</a>) at two months to an MD of 0.80 cm (95% CI 0.37 to 1.23; P &lt; 0.01; 1 study, 154 participants; <a href="./references#CD013758-fig-0029" title="">Analysis 1.25</a>) at five years of follow‐up. The P value of the test for subgroup differences was 0.56. </p> </section> <section id="CD013758-sec-0084"> <p><b>e) Arm circumference</b></p> <p>No studies reported arm circumference.</p> </section> </section> </section> </section> <section id="CD013758-sec-0085"> <h4 class="title">Standard‐protein formula versus low‐protein formula</h4> <p>See <a href="./full#CD013758-tbl-0002">summary of findings Table 2</a>. </p> <p>Four studies (involving 256 participants) evaluated infants who were fed standard‐protein formula versus infants fed low‐protein formula (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>). In all studies, infants received formula as the sole feeding method for four months. The participants of <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a> also received infant formula with complementary foods up to two years of age (reported in <a href="./references#CD013758-bbs2-0100" title="KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]">Kouwenhoven 2021b</a>, an observational study). </p> <section id="CD013758-sec-0086"> <h5 class="title">Primary outcomes</h5> <section id="CD013758-sec-0087"> <h6 class="title">1. Undernutrition</h6> <section id="CD013758-sec-0088"> <p><b>a) Underweight (weight‐for‐age z‐score)</b></p> <p>Four studies provided data that we could use to calculate weight‐for‐age z‐scores (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>). We are unsure if feeding healthy term infants standard‐protein formula compared to low‐protein formula has any effect on weight‐for‐age z‐score in the first year of life (MD 0.0 SDs, 95% CI −0.43 to 0.43; P = 0.99, I<sup>2</sup> = 81%; 4 studies, 256 participants; very low‐certainty evidence; <a href="./references#CD013758-fig-0030" title="">Analysis 2.1</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in weight‐for‐age z‐score between those fed standard‐protein formula and those fed low‐protein formula at four months of follow‐up (MD −0.04 SDs, 95% CI −0.66 to 0.58; P = 0.90, I<sup>2</sup> = 84%; 3 studies, 78 participants; <a href="./references#CD013758-fig-0030" title="">Analysis 2.1</a>). Among the infants given formula in addition to complementary foods, there was no difference in weight‐for‐age z‐score between those fed standard‐protein formula and those fed low‐protein formula at one year of follow‐up (MD 0.15 SDs, 95% CI −0.10 to 0.40; P = 0.24; 1 study, 178 participants; <a href="./references#CD013758-fig-0030" title="">Analysis 2.1</a>). The P value of the test for subgroup differences was 0.58<b>.</b> </p> <p>One of the four studies was at high risk of selection bias (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>). When we removed it in an overall sensitivity analysis, the effect estimate did not change (MD −0.13 SDs, 95% CI −0.59 to 0.33; P = 0.57, I<sup>2</sup> = 83%; 3 studies, 228 participants). In a detailed sensitivity analysis by subgroups, we found that the effect estimate did not change among the infants who were fed only formula (MD −0.29 SDs, 95% CI −0.89 to 0.30; P = 0.34, I<sup>2</sup> = 80%; 2 studies, 50 participants). We were unable to calculate the effect estimate for infants given formula in addition to complementary foods. </p> <p>In a subgroup analysis according to different follow‐up time points, we found no change in the weight‐for‐age z‐score over time: the MD for standard‐protein formula versus low‐protein formula was 0.03 SDs (95% CI −0.37 to 0.42; P = 0.90, I<sup>2</sup> = 87%; 4 studies, 256 participants; <a href="./references#CD013758-fig-0031" title="">Analysis 2.2</a>) at two months and −0.01 SDs (95% CI −0.26 to 0.24; P = 0.94; 1 study, 178 participants; <a href="./references#CD013758-fig-0031" title="">Analysis 2.2</a>) at two years of follow‐up. The P value of the test for subgroup differences was 0.72. </p> </section> <section id="CD013758-sec-0089"> <p><b>b) Stunting (height‐for‐age z‐score)</b></p> <p>Four studies provided data that we could use to calculate height‐for‐age z‐scores (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>). We are unsure if feeding healthy term infants standard‐protein formula compared to low‐protein formula has any effect on weight‐for‐age z‐score in the first year of life (MD −0.01 SDs, 95% CI −0.36 to 0.35; P = 0.96, I<sup>2</sup> = 73%; 4 studies, 256 participants; very low‐certainty evidence; <a href="./references#CD013758-fig-0032" title="">Analysis 2.3</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in height‐for‐age z‐score between those fed standard‐protein formula and those fed low‐protein formula at four months of follow‐up (MD −0.11 SDs, 95% CI −0.55 to 0.34; P = 0.64, I<sup>2</sup> = 72%; 3 studies, 78 participants; <a href="./references#CD013758-fig-0032" title="">Analysis 2.3</a>). Among the infants given formula in addition to complementary foods, there was no difference in height‐for‐age z‐score between those fed standard‐protein formula and those fed low‐protein formula at one year of follow‐up (MD 0.24 SDs, 95% CI −0.04 to 0.52; P = 0.09; 1 study, 178 participants; <a href="./references#CD013758-fig-0032" title="">Analysis 2.3</a>). The P value of the test for subgroup differences was 0.20. </p> <p>One of the four studies was at high risk of selection bias (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>). When we removed it in an overall sensitivity analysis, the effect estimate did not change (MD −0.10 SDs, 95% CI −0.55 to 0.34; P = 0.65, I<sup>2</sup> = 78%; 3 studies, 228 participants). In a detailed sensitivity analysis by subgroups, we found that the effect estimate did not change among the infants who were fed only formula (MD −0.31 SDs, 95% CI −0.69 to 0.07; P = 0.11, I<sup>2</sup> = 43%; 2 studies, 50 participants). We were unable to calculate the effect estimate for infants given formula in addition to complementary foods. </p> <p>In a subgroup analysis according to different follow‐up time points, we found no change in height‐for‐age z‐score over time: the MD for standard‐protein formula versus low‐protein formula was −0.07 SDs (95% CI −0.30 to 0.16; P = 0.54, I<sup>2</sup> = 51%; 4 studies, 256 participants; <a href="./references#CD013758-fig-0033" title="">Analysis 2.4</a>) at two months, and −0.01 SDs (95% CI −0.29 to 0.2; P = 0.94; 1 study, 178 participants <a href="./references#CD013758-fig-0033" title="">Analysis 2.4</a>) at two years of follow‐up. The P value of the test for subgroup differences was 0.16. </p> </section> <section id="CD013758-sec-0090"> <p><b>c) Wasting (weight‐for‐height z‐score)</b></p> <p>Four studies provided data that we could use to calculate weight‐for‐height z‐scores (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>). We are unsure if feeding healthy term infants standard‐protein formula compared to low‐protein formula has any effect on weight‐for‐height z‐score in the first year of life (MD 0.13 SDs, 95% CI −0.29 to 0.56; P = 0.54, I<sup>2</sup> = 95%; 4 studies, 256 participants; very low‐certainty evidence; <a href="./references#CD013758-fig-0034" title="">Analysis 2.5</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in weight‐for‐height z‐score between those fed standard‐protein formula and those fed low‐protein formula at four months of follow‐up (MD 0.16 SDs, 95% CI −0.39 to 0.70; P = 0.57, I<sup>2</sup> = 96%; 3 studies, 78 participants; <a href="./references#CD013758-fig-0034" title="">Analysis 2.5</a>). Among the infants given formula in addition to complementary foods, there was no difference in weight‐for‐height z‐score between those fed standard‐protein formula and those fed low‐protein formula at one year of follow‐up (MD 0.07 SDs, 95% CI −0.21 to 0.35; P = 0.63; 1 study, 178 participants; <a href="./references#CD013758-fig-0034" title="">Analysis 2.5</a>). The P value of the test for subgroup differences was 0.78. </p> <p>One of the four studies was at high risk of selection bias (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>). When we removed it in an overall sensitivity analysis, the effect estimate did not change (MD 0.03 SDs, 95% CI −0.45 to 0.51; P = 0.91, I<sup>2</sup> = 96%; 3 studies, 228 participants). In a detailed sensitivity analysis by subgroups, we found that the effect estimate did not change among the infants who were fed only formula (MD 0.01 SDs, 95% CI −0.66 to 0.68; P =0.98, I<sup>2</sup> = 98%; 2 studies, 50 participants). We were unable to calculate the effect estimate for infants given formula in addition to complementary foods. </p> <p>In a subgroup analysis according to different follow‐up time points, we found no change in weight‐for‐height z‐score over time: the MD for standard‐protein formula versus low‐protein formula was 0.04 SDs (95% CI −0.13 to 0.22; P = 0.62, I<sup>2</sup> = 97%; 4 studies, 256 participants; <a href="./references#CD013758-fig-0035" title="">Analysis 2.6</a>) at two months, and 0.0 SDs (95% CI −0.28 to 0.28; P = 1.0; 1 study, 178 participants; <a href="./references#CD013758-fig-0035" title="">Analysis 2.6</a>) at two years of follow‐up. The P value of the test for subgroup differences was 0.93. </p> </section> </section> <section id="CD013758-sec-0091"> <h6 class="title">2. Overweight or obesity</h6> <p>No studies reported overweight or obesity.</p> </section> </section> <section id="CD013758-sec-0092"> <h5 class="title">Secondary outcomes</h5> <section id="CD013758-sec-0093"> <h6 class="title">1. Neurodevelopmental outcomes</h6> <p>No studies neurodevelopmental outcomes.</p> </section> <section id="CD013758-sec-0094"> <h6 class="title">2. All‐cause mortality</h6> <p>No studies reported all‐cause mortality.</p> </section> <section id="CD013758-sec-0095"> <h6 class="title">3. Adverse events</h6> <p>Two studies (involving 206 participants) reported adverse events (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>). The most common events were diarrhea, vomiting, and milk hypersensitivity. In both studies, the children were exclusively formula‐fed for the first four months of life. </p> <p>In total, 17 of the 101 participants (17%) who received standard‐protein formula experienced at least one adverse event, compared with 12 of the 105 infants (11%) who received low‐protein formula. There may be little or no difference in adverse events between healthy term infants fed standard‐protein formula and those fed low‐protein formula in the first four months of life (Peto OR 1.55, 95% CI 0.70 to 3.40; P = 0.28, I<sup>2</sup> = 0%; 2 studies, 206 participants; low‐certainty evidence; <a href="./references#CD013758-fig-0036" title="">Analysis 2.7</a>). </p> <p>One of the four studies was at high risk of selection bias (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>). When we removed it in an overall sensitivity analysis, the effect estimate did not change (Peto OR 1.44, 95% CI 0.64 to 3.22; P = 0.38; 1 study, 178 participants). </p> <p>We performed a detailed analysis by type of adverse event. We found no difference between the standard‐protein group and the low‐protein group in the risk of diarrhea (Peto OR 1.44, 95% CI 0.64 to 3.22; P = 0.38; 1 study, 178 participants; <a href="./references#CD013758-fig-0037" title="">Analysis 2.8</a>), vomiting (Peto OR 0.44, 95% CI 0.12 to 1.57; P = 0.21; 1 study, 178 participants; <a href="./references#CD013758-fig-0037" title="">Analysis 2.8</a>), or milk hypersensitivity (Peto OR 0.63, 95% CI 0.24 to 1.67; P = 0.36, I<sup>2</sup> = 0.44%; 2 studies, 206 participants; <a href="./references#CD013758-fig-0037" title="">Analysis 2.8</a>) during the first four months of life. </p> <p>No studies reported the risk of developing renal insufficiency.</p> </section> <section id="CD013758-sec-0096"> <h6 class="title">4. Anthropometric measurements</h6> <section id="CD013758-sec-0097"> <p><b>a) Weight</b></p> <p>Four studies reported weight (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>). The meta‐analysis showed no difference in weight between the standard‐protein group and the low‐protein group in the first year of life (MD 0.03 kg, 95% CI −0.32 to 0.38; P = 0.87, I<sup>2</sup> = 89%; 4 studies, 256 participants; <a href="./references#CD013758-fig-0038" title="">Analysis 2.9</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in weight between those fed standard‐protein formula and those fed low‐protein formula at four months of follow‐up (MD −0.03 kg, 95% CI −0.44 to 0.38; P = 0.89, I<sup>2</sup> = 91%; 3 studies, 78 participants; <a href="./references#CD013758-fig-0038" title="">Analysis 2.9</a>). Among the infants given formula in addition to complementary foods, there was no difference in weight between those fed standard‐protein formula and those fed low‐protein formula at one year of follow‐up (MD 0.22 kg, 95% CI −0.09 to 0.53; P = 0.16; 1 study, 178 participants; <a href="./references#CD013758-fig-0038" title="">Analysis 2.9</a>). The P value of the test for subgroup differences was 0.34. </p> <p>One of the four studies was at high risk of selection bias (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>). When we removed it in an overall sensitivity analysis, the effect estimate did not change (MD −0.08 kg, 95% CI −0.44 to 0.28; P = 0.67, I<sup>2</sup> = 90%; 3 studies, 228 participants). In a detailed sensitivity analysis by subgroups, we found that the effect estimate did not change among the infants who were fed only formula (MD −0.21 kg, 95% CI −0.63 to 0.22; P = 0.34, I<sup>2</sup> = 93%; 2 studies, 50 participants). We were unable to calculate the effect estimate for infants given formula in addition to complementary foods. </p> <p>In a subgroup analysis according to different follow‐up time points, we observed a gradual increase in weight in infants fed the standard‐protein formula compared with the low‐protein group, from an MD of −0.04 kg (95% CI −0.12 to 0.04; P = 0.34, I<sup>2</sup> = 95%; 3 studies, 78 participants; <a href="./references#CD013758-fig-0039" title="">Analysis 2.10</a>) at two months to an MD of −0.01 kg (95% CI −0.41 to 0.39; P = 0.96; 1 study, 178 participants; <a href="./references#CD013758-fig-0039" title="">Analysis 2.10</a>) at two years of follow‐up. The P value of the test for subgroup differences was 0.19. </p> </section> <section id="CD013758-sec-0098"> <p><b>B) Height</b></p> <p>Four studies reported height (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>). The meta‐analysis showed no difference in height between the standard‐protein group and the low‐protein group in the first year of life (MD 0.0 cm, 95% CI −0.81 to 0.82; P = 0.99, I<sup>2</sup> = 85%; 4 studies, 256 participants; <a href="./references#CD013758-fig-0040" title="">Analysis 2.11</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in height between those fed standard‐protein formula and those fed low‐protein formula at four months of follow‐up (MD −0.26 cm, 95% CI −1.08 to 0.57; P = 0.54, I<sup>2</sup> = 83%; 3 studies, 78 participants; <a href="./references#CD013758-fig-0040" title="">Analysis 2.11</a>). Among the infants given formula in addition to complementary foods, those fed standard‐protein formula were taller than those fed low‐protein formula at one year of follow‐up (MD 0.80 cm, 95% CI 0.06 to 1.54; P = 0.03; 1 study, 178 participants; <a href="./references#CD013758-fig-0040" title="">Analysis 2.11</a>). The P value of the test for subgroup differences was 0.06. </p> <p>One of the four studies was at high risk of selection bias (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>). When we removed it in an overall sensitivity analysis, the effect estimate did not change (MD −0.17 cm, 95% CI −1.10 to 0.77; P = 0.73, I<sup>2</sup> = 88%; 3 studies, 228 participants). In a detailed sensitivity analysis by subgroups, we found that the effect estimate did not change among the infants who were fed only formula (MD −0.60 cm, 95% CI −1.39 to 0.18; P = 0.13, I<sup>2</sup> = 80%; 2 studies, 50 participants). We were unable to calculate the effect estimate for infants given formula in addition to complementary foods. </p> <p>In a subgroup analysis according to different follow‐up time points, we found no change in height in infants fed the standard‐protein formula compared with the low‐protein group, from an MD of −0.28 cm (95% CI −0.91 to 0.35; P = 0.38, I<sup>2</sup> = 78%; 3 studies, 78 participants; <a href="./references#CD013758-fig-0041" title="">Analysis 2.12</a>) at two months to an MD of −0.10 cm (95% CI −0.97 to 0.77; P = 0.82; 1 study, 178 participants; <a href="./references#CD013758-fig-0041" title="">Analysis 2.12</a>) at two years of follow‐up. The P value of the test for subgroup differences was 0.17. </p> </section> <section id="CD013758-sec-0099"> <p><b>c) Body mass index</b></p> <p>Four studies provided data we could use to calculate BMI z‐score (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>). The meta‐analysis showed no difference in BMI z‐score between the standard‐protein group and the low‐protein group in the first year of life (MD 0.03 SDs, 95% CI −0.34 to 0.39; P = 0.89, I<sup>2</sup> = 87%; 4 studies, 256 participants; <a href="./references#CD013758-fig-0042" title="">Analysis 2.13</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in BMI z‐score between those fed standard‐protein formula and those fed low‐protein formula at four months of follow‐up (MD 0.03 SDs, 95% CI −0.46 to 0.53; P = 0.90, I<sup>2</sup> = 91%; 3 studies, 78 participants; <a href="./references#CD013758-fig-0042" title="">Analysis 2.13</a>). Among the infants given formula in addition to complementary foods, there was no difference in BMI z‐score between those fed standard‐protein formula and those fed low‐protein formula at one year of follow‐up (MD 0.04 SDs, 95% CI −0.25 to 0.33; P = 0.79; 1 study, 178 participants; <a href="./references#CD013758-fig-0042" title="">Analysis 2.13</a>). The P value of the test for subgroup differences was 0.98. </p> <p>One of the four studies was at high risk of selection bias (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>). When we removed it in an overall sensitivity analysis, the effect estimate did not change (MD −0.11 SDs, 95% CI −0.47 to 0.25; P = 0.56, I<sup>2</sup> = 86%; 3 studies, 228 participants). In a detailed sensitivity analysis by subgroups, we found that the effect estimate did not change among the infants who were fed only formula (MD −0.17 SDs, 95% CI −0.68 to 0.34; P = 0.51, I<sup>2</sup> = 92%; 2 studies, 50 participants). We were unable to calculate the effect estimate for infants given formula in addition to complementary foods. </p> <p>In a subgroup analysis according to different follow‐up time points, we found no change in BMI z‐score in infants fed the standard‐protein formula compared with the low‐protein group, from an MD of 0.09 SDs (95% CI −0.29 to 0.48; P = 0.64, I<sup>2</sup> = 96%; 4 studies, 256 participants; <a href="./references#CD013758-fig-0043" title="">Analysis 2.14</a>) at two months to an MD of 0.01 SDs (95% CI −0.28 to 0.30; P = 0.95; 1 study, 178 participants; <a href="./references#CD013758-fig-0043" title="">Analysis 2.14</a>) at two years of follow‐up. The P value of the test for subgroup differences was 0.99. </p> <p>Four studies reported BMI (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>; <a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>). The meta‐analysis showed no difference in BMI between the standard‐protein group and the low‐protein group in the first year of life (MD 0.05 kg/m<sup>2</sup>, 95% CI −0.53 to 0.64; P = 0.85, I<sup>2</sup> = 96%; 4 studies, 256 participants; <a href="./references#CD013758-fig-0044" title="">Analysis 2.15</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in BMI between those fed standard‐protein formula and those fed low‐protein formula at four months of follow‐up (MD 0.08 kg/m<sup>2</sup>, 95% CI −0.63 to 0.79; P = 0.83, I<sup>2</sup> = 97%; 3 studies, 78 participants; <a href="./references#CD013758-fig-0044" title="">Analysis 2.15</a>). Among the infants given formula in addition to complementary foods, there was no difference in BMI between those fed standard‐protein formula and those fed low‐protein formula at one year of follow‐up (MD 0.0 kg/m<sup>2</sup>, 95% CI −0.41 to 0.41; P = 1.0; 1 study, 178 participants; <a href="./references#CD013758-fig-0044" title="">Analysis 2.15</a>). The P value of the test for subgroup differences was 0.85. </p> <p>One of the four studies was at high risk of selection bias (<a href="./references#CD013758-bbs2-0003" title="FomonSJ , ZieglerEE , NelsonSE , FrantzJA . What is the safe protein-energy ratio for infant formulas?American Journal of Clinical Nutrition1995;62(2):358-63. [DOI: 10.1093/ajcn/62.2.358] [PMID: 7625343]">Fomon 1995</a>). When we removed it in an overall sensitivity analysis, the effect estimate did not change (MD −0.14 kg/m<sup>2</sup>, 95% CI −0.76 to 0.47; P = 0.65, I<sup>2</sup> = 97%; 3 studies, 228 participants). In a detailed sensitivity analysis by subgroups, we found that the effect estimate did not change among the infants who were fed only formula (MD −0.21 kg/m<sup>2</sup>, 95% CI −0.99 to 0.58; P = 0.61, I<sup>2</sup> = 98%; 2 studies, 50 participants). We were unable to calculate the effect estimate for infants given formula in addition to complementary foods. </p> <p>In a subgroup analysis according to different follow‐up time points, we found no change in BMI in infants fed the standard‐protein formula compared with the low‐protein group, from an MD of −0.50 kg/m<sup>2</sup> (95% CI −1.17 to 0.17; P = 0.14, I<sup>2</sup> = 98%; 3 studies, 78 participants; <a href="./references#CD013758-fig-0045" title="">Analysis 2.16</a>) at two months to an MD of 0.0 kg/m<sup>2</sup> (95% CI −0.40 to 0.40; P = 1.0; 1 study, 178 participants; <a href="./references#CD013758-fig-0045" title="">Analysis 2.16</a>) at two years of follow‐up. The P value of the test for subgroup differences was less than 0.001. </p> </section> <section id="CD013758-sec-0100"> <p><b>d) Head circumference</b></p> <p>Three studies provided data we could use to calculate head circumference z‐score (<a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>). The meta‐analysis showed no difference in head circumference z‐score between the standard‐protein group and the low‐protein group in the first year of life (MD 0.10 SDs, 95% CI −0.55 to 0.74; P = 0.77, I<sup>2</sup> = 90%; 3 studies, 228 participants ; <a href="./references#CD013758-fig-0046" title="">Analysis 2.17</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in head circumference z‐score between those fed standard‐protein formula and those fed low‐protein formula at four months of follow‐up (MD 0.09 SDs, 95% CI −1.20 to 1.37; P = 0.89, I<sup>2</sup> = 95%; 2 studies, 50 participants; <a href="./references#CD013758-fig-0046" title="">Analysis 2.17</a>). Among the infants given formula in addition to complementary foods, there was no difference in head circumference z‐score between those fed standard‐protein formula and those fed low‐protein formula at one year of follow‐up (MD 0.10 SDs, 95% CI −0.17 to 0.37; P = 0.46; 1 study, 178 participants; <a href="./references#CD013758-fig-0046" title="">Analysis 2.17</a>). The P value of the test for subgroup differences was 0.99. </p> <p>We did not perform a sensitivity analysis based on risk of bias because no studies had high risk of bias judgments. </p> <p>In a subgroup analysis according to different follow‐up time points, we found no change over time in head circumference z‐score in infants fed the standard‐protein formula compared with the low‐protein group, from an MD of 0.09 SDs (95% CI −0.49 to 0.66; P = 0.77, I<sup>2</sup> = 87%; 3 studies, 228 participants; <a href="./references#CD013758-fig-0047" title="">Analysis 2.18</a>) at two months to an MD of −0.01 SDs (95% CI −0.29 to 0.27; P = 0.94; 1 study, 178 participants; <a href="./references#CD013758-fig-0047" title="">Analysis 2.18</a>) at two years of follow‐up. The P value of the test for subgroup differences was 0.88. </p> <p>Three studies reported head circumference (<a href="./references#CD013758-bbs2-0006" title="KouwenhovenS , AntlN , FinkenM , TwiskJ , Van Der BeekE , Abrahamse-BerkeveldM , et al. Growth and body composition in children fed a modified, low-protein infant formula: follow-up of a randomized controlled trial. Journal of Pediatric Gastroenterology and Nutrition2021;72(1):1049-50. [DOI: 10.1097/MPG.0000000000003177]KouwenhovenS , AntlN , FinkenM , Van Der BeekE , KoletzkoB , Van GoudoeverJ . Safety of a modified, low protein infant formula in term infants; an RCT with a reference breastfed group. Journal of Pediatric Gastroenterology and Nutrition2018;66(Suppl 2):915-6. KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , Van der BeekEM , Abrahamse-BerkeveldM , et al. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial. American Journal of Clinical Nutrition2019;111(5):962-74. [DOI: 10.1093/ajcn/nqz308] [PMID: 31868201]KouwenhovenSM , AntlN , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Long-term effects of a modified, low-protein infant formula on growth and body composition: follow-up of a randomized, double-blind, equivalence trial. Clinical Nutrition (Edinburgh, Scotland)2021;40(6):3914-21. [DOI: 10.1016/j.clnu.2021.04.034] [PMID: 34139464]KouwenhovenSM , FleddermannM , FinkenMJ , TwiskJW , van derBeekEM , Abrahamse-BerkeveldM , et al. Early-life metabolic and hormonal markers in blood and growth until age 2 years: results from a randomized controlled trial in healthy infants fed a modified low-protein infant formula. Nutrients2021;13(4):1159. [DOI: 10.3390/nu13041159] [PMID: 33915788]NTR4829. ProtEUs [ProtEUs: effects of an infant formula with an optimized amino acid composition on growth and body composition in infants]. trialsearch.who.int/Trial2.aspx?TrialID=NTR4829 (first received 10 March 2014). [CENTRAL: CN-01873920] ">Kouwenhoven 2020</a>; <a href="./references#CD013758-bbs2-0008" title="Hahn-ZoricM , FulconisF , MinoliI , MoroG , CarlssonB , BottigerM , et al. Antibody responses to parenteral and oral vaccines are impaired by conventional and low protein formulas as compared to breast-feeding. Acta Paediatrica Scandinavica1990;79(12):1137-42. [DOI: 10.1111/j.1651-2227.1990.tb11401.x] [PMID: 2085099]PiconeT , BensonJ , MoroG , MinoliI , FulconisF , RassinD , et al. Growth, serum biochemistries, and amino acids of term infants fed formulas with amino acid and protein concentrations similar to human milk. Journal of Pediatric Gastroenterology and Nutrition1989;9(3):351-60. [DOI: 10.1097/00005176-198910000-00015] [PMID: 2614623]">Picone 1989</a>; <a href="./references#CD013758-bbs2-0010" title="RäihäN , MinoliI , MoroG , BremerHJ . Milk protein intake in the term infant. II. Effects on plasma amino acid concentrations. Acta Paediatrica Scandinavica1986;75(6):887-92. [DOI: 10.1111/j.1651-2227.1986.tb10312.x] [PMID: 3564970]RäihäN , MinoliI , MoroG . Milk protein intake in the term infant. I. Metabolic responses and effects on growth. Acta Paediatrica Scandinavica1986;75(6):881-6. [DOI: 10.1111/j.1651-2227.1986.tb10311.x] [PMID: 3564969]">Räihä 1986a</a>). The meta‐analysis showed no difference in head circumference between the standard‐protein group and the low‐protein group in the first year of life (MD 0.11 cm, 95% CI −0.92 to 1.13; P = 0.84, I<sup>2</sup> = 96%; 3 studies, 228 participants; <a href="./references#CD013758-fig-0048" title="">Analysis 2.19</a>). </p> <p>We performed a subgroup analysis according to type of formula feeding (exclusive/with complementary foods). Among the exclusively formula‐fed infants, there was no difference in head circumference between those fed standard‐protein formula and those fed low‐protein formula at four months of follow‐up (MD 0.11 cm, 95% CI −1.46 to 1.68; P = 0.89, I<sup>2</sup> = 98%; 2 studies, 50 participants; <a href="./references#CD013758-fig-0048" title="">Analysis 2.19</a>). Among the infants given formula in addition to complementary foods, there was no difference in head circumference between those fed standard‐protein formula and those fed low‐protein formula at one year of follow‐up (MD 0.10 cm, 95% CI −0.35 to 0.55; P = 0.66; 1 study, 178 participants; <a href="./references#CD013758-fig-0048" title="">Analysis 2.19</a>). The P value of the test for subgroup differences was 0.99. </p> <p>We did not perform a sensitivity analysis based on risk of bias because no studies had high risk of bias judgments. </p> <p>In a detailed analysis at different follow‐up time points, we found no change in the head circumference in infants fed the standard‐protein formula compared with the low‐protein group, from an MD of 0.06 cm (95% CI −1.22 to 1.33; P = 0.93, I<sup>2</sup> = 97%; 2 studies, 50 participants; <a href="./references#CD013758-fig-0049" title="">Analysis 2.20</a>) at two months to an MD of −0.10 cm (95% CI −0.56 to 0.36; P = 0.67; 1 study,178 participants; <a href="./references#CD013758-fig-0049" title="">Analysis 2.20</a>) at two years of follow‐up. The P value of the test for subgroup differences was 0.78. </p> </section> <section id="CD013758-sec-0101"> <p><b>E) Arm circumference</b></p> <p>No studies reported arm circumference.</p> </section> </section> </section> <section id="CD013758-sec-0102"> <h5 class="title">Assessment of reporting bias</h5> <p>As no meta‐analysis included 10 studies or more, we did not create any funnel plots.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013758-sec-0103" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013758-sec-0103"></div> <section id="CD013758-sec-0104"> <h3 class="title" id="CD013758-sec-0104">Summary of main results</h3> <p>This review included 11 parallel‐group RCTs with individual randomization; 10 studies included an observational group of exclusively breastfed infants. For six of the 11 trials, we found secondary observational studies with follow‐up information. We extracted data from these observational studies to complete the analyses. </p> <p>The studies analyzed 1885 healthy term infants with weight and height within 2 SDs of the WHO Child Growth Standards' median (<a href="./references#CD013758-bbs2-0144" title="World Health Organization. Child growth standards. who.int/tools/child-growth-standards/standards (accessed 13 April 2023).">WHO standards 2023</a>). All the studies were set in high‐income countries. The infants were fed from day two of life to two years of age with formulas of varying amounts of protein, ranging from 1.2 g to 2.9 g/100 kcal. In some studies, participants were followed‐up beyond two years (up to 11 years of age in one study). </p> <p>Of all the participants in the completed studies, 809 were assigned to high‐protein formula (≥ 2.5 g protein/100 kcal), 951 infants were assigned to standard‐protein formula (1.8 g to &lt; 2.5 g protein/100 kcal), and 125 were assigned to low‐protein formula (&lt; 1.8 g protein/100 kcal); 954 control infants were exclusively breastfed. The trials assessed anthropometric parameters (weight, height, BMI, head circumference), protein metabolism (albumin, urea serum levels), gut microbiota, and adverse events. </p> <p>In view of the considerable variation among the interventions, in terms of the protein content of the formulas, the type of formula feeding (exclusive or with complementary foods), and the follow‐up time, we divided the comparisons into two groups to analyze the efficacy and safety of infant formula feeding with the least possible heterogeneity. </p> <p>Overall, in this review's main comparison, the findings suggest that high‐protein formula compared with standard‐protein formula may have no little or no effect on undernutrition, overweight, or obesity; however, the certainty of the evidence is very low. Although we observed that high‐protein formula compared to standard‐protein formula led to an increase in weight‐for‐age z‐score (0.20 SDs) and height‐for age z‐score (0.29 SDs) when given with complementary foods in infants from four months of age, this appears to reflect overall growth. </p> <p>The meta‐analysis suggested that there may be no increased risk of adverse events (e.g. diarrhea, vomiting, milk hypersensitivity) with high‐protein formula compared to standard‐protein formula among infants who were fed only formula and among infants who were fed formula in addition to complementary foods. </p> <p>The findings for our second comparison suggest that standard‐protein formula compared to low‐protein formula may have little or no effect on undernutrition, overweight, or obesity; however, the certainty of the evidence is very low. Among infants who were fed formula in addition to complementary foods, we found an increase in height‐for age (0.8 cm), but this also appears to reflect overall growth. </p> <p>The meta‐analysis suggested that there may be no increased risk of adverse events with standard‐protein formula compared to low‐protein formula among infants who are exclusively formula‐fed fed during the first four months of life. </p> <p>There was insufficient data to analyze all‐cause mortality, renal insufficiency, or neurological development in infants. The results of this review may change if and when we incorporate data from the six ongoing trials and the two trials pending classification in future updates. </p> </section> <section id="CD013758-sec-0105"> <h3 class="title" id="CD013758-sec-0105">Overall completeness and applicability of evidence</h3> <p>Although this review included seven trials (1629 infants) with the main comparison of high‐protein formula versus standard‐protein formula, their effects on infant nutrition remain uncertain. This is because the available data on weight and height were limited and heterogeneous, both in infants fed only formula and in infants fed formula with complementary foods, impacting the certainty of the evidence. </p> <p>Although all the studies evaluated the growth of formula‐fed infants, only two trials reported z‐scores. Consequently, for the remaining trials, we had to use the reported data and calculate weighted mean z‐score values using the WHO Child Growth Standards software (<a href="https://www.who.int/tools/child-growth-standards/software" target="_blank">WHO Anthro v3.2.2</a>), adjusting for age, sex, and number of participants in each study, to obtain a standard measure and perform the analyses of the different outcomes. Therefore, it is important that future studies standardize the reporting of participants' growth measures, and include data on all‐cause mortality, renal insufficiency, and neurodevelopment. The addition of these data could improve the certainty of the results. </p> </section> <section id="CD013758-sec-0106"> <h3 class="title" id="CD013758-sec-0106">Quality of the evidence</h3> <p>The formulas comprised a variety of whey/casein ratios in the intervention and comparison groups. In addition, the timing of participant initiation and follow‐up varied among the groups, and there were differences in whether infants were exclusively formula‐fed or given formula with complementary foods. Furthermore, although all trials analyzed participants' growth, the results were reported in different ways, increasing heterogeneity between the trials. </p> <p>Although allocation concealment was unclear in most trials, and we considered three trials at high risk of attrition bias (because attrition rates exceeded 20%), we observed no reporting bias. The certainty of the evidence was generally low or very low, mainly owing to risk of bias and imprecision (low number of trials, and wide CIs consistent with benefit and harm). </p> </section> <section id="CD013758-sec-0107"> <h3 class="title" id="CD013758-sec-0107">Potential biases in the review process</h3> <p>We followed standard Cochrane methodology and applied no restrictions on language or date of publication when searching for studies. We added information from observational studies to complete the follow‐up of participants. Two of four review authors independently selected studies, extracted data, and assessed risk of bias and certainty of the evidence; a fifth review author resolved discrepancies to minimize review bias. When we identified substantial heterogeneity in the analyses, we explored possible causes by stratifying the data. </p> <p>Because almost half of the trials were conducted before the 2000s and the reporting of the information varied widely, we had to standardize data using the WHO Child Growth Standards (<a href="./references#CD013758-bbs2-0144" title="World Health Organization. Child growth standards. who.int/tools/child-growth-standards/standards (accessed 13 April 2023).">WHO standards 2023</a>). </p> </section> <section id="CD013758-sec-0108"> <h3 class="title" id="CD013758-sec-0108">Agreements and disagreements with other studies or reviews</h3> <p>The results of this review are consistent with those reported in one of the included trials (<a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>), and in one systematic review published in 2020 (<a href="./references#CD013758-bbs2-0079" title="FentonTR , Al-WassiaH , PremjiSS , Sauve Rs. Higher versus lower protein intake in formula-fed low birth weight infants. Cochrane Database of Systematic Reviews2020, Issue 6. Art. No: CD003959. [DOI: 10.1002/14651858.CD003959.pub4]">Fenton 2020</a>), though there are key differences. </p> <p> <ul id="CD013758-list-0029"> <li> <p><a href="./references#CD013758-bbs2-0005" title="Closa-ManesteroloR , FerreN , LuqueV , Zaragoza-JordanaM , GroteV , WeberM , et al, Childhood Obesity Project Study Group. Sex differences in the endocrine system in response to protein intake early in life. American Journal of Clinical Nutrition2011;94(6 Suppl):1920s-27s. [DOI: 10.3945/ajcn.110.001123] [PMID: 22089446]CollellR , Closa-MonasteroloR , FerreN , LuqueV , KoletzkoB , GroteV , et al. Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatric Research2016;79(6):880-8. [DOI: 10.1038/pr.2016.30] [PMID: 26882370]CollellR , FerreN , EscribanoJ , Closa-MonasteroloR , LuqueV , Zaragoza-JordanaM , et al. Effect of early protein intake on later cardiac function: the EU chop project. Annals of Nutrition &amp; Metabolism2001;58:191. [DOI: 10.1159/000334393]DamianidiL , GruszfeldD , VerduciE , VecchiF , XhonneuxA , Langhendries J-P, et al. Protein intakes and their nutritional sources during the first 2 years of life: secondary data evaluation from the European Childhood Obesity Project. European Journal of Clinical Nutrition2016;70(11):1291-97. [DOI: 10.1038/ejcn.2016.108] [PMID: 27329609]EscribanoJ , ClosaR , LuqueV , ZaragozaM , FerreN , GroteV . The effects of increased protein intake on kidney size and function in healthy infants: a randomized clinical trial. Pediatric Nephrology2010;25(3):576. [DOI: 10.1007/s00467-009-1423-3]EscribanoJ , LuqueV , Canals-SansJ , FerreN , KoletzkoB , GroteV , et al, EU Childhood Obesity Project Group. Mental performance in 8-year-old children fed reduced protein content formula during the 1st year of life: safety analysis of a randomised clinical trial. British Journal of Nutrition2019;122(s1)(Suppl 1):S22-30. [DOI: 10.1017/S0007114515000768] [PMID: 31638498]EscribanoJ , LuqueV , ClosaR , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Critical postnatal window for programming kidney by protein intake: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58:189. [DOI: 10.1159/000334393]EscribanoJ , LuqueV , FerreN , Mendez-RieraG , KoletzkoB , GroteV , et al, European Childhood Obesity Trial Study Group. Effect of protein intake and weight gain velocity on body fat mass at 6 months of age: the EU Childhood Obesity Programme. International Journal of Obesity2012;36(4):548-53. [DOI: 10.1038/ijo.2011.276] [PMID: 22310472]EscribanoJ , LuqueV , FerreN , Zaragoza-JordanaM , GroteV , KoletzkoB , et al. Increased protein intake augments kidney volume and function in healthy infants. Kidney International2011;79(7):783-90. [DOI: 10.1038/ki.2010.499] [PMID: 21191362]FerreN , Rubio-TorrentsC , LuqueV , Closa-MonasteroloR , GroteV , KoletzkoB , et al, European Childhood Obesity Project Group. Influence of feeding types during the first months of life on calciuria levels in healthy infants: a secondary analysis from a randomized clinical trial. Annals of Nutrition &amp; Metabolism2017;70(2):132-39. [DOI: 10.1159/000468156] [PMID: 28351028]GruszfeldD , WeberM , GradowskaK , SochaP , GroteV , XhonneuxA , et al, European Childhood Obesity Study Group. Association of early protein intake and pre-peritoneal fat at five years of age: follow-up of a randomized clinical trial. Nutrition, Metabolism, and Cardiovascular Diseases : NMCD2016;26(9):824-32. [DOI: 10.1016/j.numecd.2016.04.005] [PMID: 27212617]GruszfeldD , WeberM , Nowakowska-RyszM , JanasR , Kozlik-FeldmannR , XhonneuxA , et al, European Childhood Obesity Study Group. Protein intake in infancy and carotid intima media thickness at 5 years - a secondary analysis from a randomized trial. Annals of Nutrition &amp; Metabolism2015;66(1):51-9. [DOI: 10.1159/000369980] [PMID: 25572773]KirchbergF , HarderU , WeberM , GroteV , DemmelmairH , PeissnerW , et al, European Childhood Obesity Trial Study Group. Dietary protein intake affects amino acid and acyl carnitine metabolism in infants aged 6 months. Journal of Clinical Endocrinology and Metabolism2015;100(1):149-58. [DOI: 10.1210/jc.2014-3157] [PMID: 25368978]Kirchberg FrancaF , HellmuthC , TotzauerM , UhlO , Closa-MonasteroloR , EscribanoJ , et al, European Childhood Obesity Trial Study Group. Impact of infant protein supply and other early life factors on plasma metabolome at 5.5 and 8 years of age: a randomized trial. International Journal of Obesity2020;44(1):69-81. [DOI: 10.1038/s41366-019-0398-9] [PMID: 31300705]KoletzkoB , BrandsB , DemmelmairH , GroteV , RzehakP , WeberM . Early nutrition - impact on later health. Acta Paediatrica2011;100(Suppl 463):5-6. KoletzkoB , DemmelmairH , GroteV , TotzauerM . Optimized protein intakes in term infants support physiological growth and promote long-term health. Seminars in Perinatology2019;43(7):1-8. [DOI: 10.1053/j.semperi.2019.06.001] [PMID: 31466703]KoletzkoB , Von KriesR , ClosaR , EscribanoJ , ScaglioniS , GiovanniniM , et al, European Childhood Obesity Trial Study Group. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. American Journal of Clinical Nutrition2009;89(6):1836-45. [DOI: 10.3945/ajcn.2008.27091] [PMID: 19386747]LuqueV , Closa-MonasteroloR , EscribanoJ , FerreN , Zaragoza-JordanaM , KoletzkoB , et al. Effect of protein intake on BMI and adiposity early in life: the EU CHOP project. Annals of Nutrition &amp; Metabolism2011;58(Suppl 1):325. [DOI: 10.1159/000334393]LuqueV , EscribanoJ , GroteV , FerreN , KoletzkoB , GruszfeldD , et al, European Childhood Obesity Project. Does insulin-like growth factor-1 mediate protein-induced kidney growth in infants? A secondary analysis from a randomized controlled trial. Pediatric Research2013;74(2):223-9. [DOI: 10.1038/pr.2013.87] [PMID: 23708690]LuqueV , Zaragoza-JordanaM , Closa-MonasteroloR , FerreN , KoletzkoB , GroteV , et al. Relation of early protein intake, overweight, waist circumference and cardiovascular risk factors in European children. Annals of Nutrition &amp; Metabolism2013;62(Suppl 2):59. [DOI: 10.1159/000351281]NCT00338689. European Childhood Obesity Project: early Programming by Infant Nutrition? (CHOP) [Childhood obesity ‐ programming by infant nutrition]. clinicaltrials.gov/ct2/show/NCT00338689 (first received 20 June 2006). [CENTRAL: CN-02029442] RzehakP , GroteV , LattkaE , WeberM , GruszfeldD , SochaP , et al, European Childhood Obesity Trial Study Group. Associations of IGF-1 gene variants and milk protein intake with IGF-I concentrations in infants at age 6 months - results from a randomized clinical trial. Growth Hormone &amp; IGF Research2013;23(5):149-58. [DOI: 10.1016/j.ghir.2013.05.002] [PMID: 23800627]RzehakP , HellmuthC , UhlO , KirchbergFF , PeissnerW , HarderU , et al, European Childhood Obesity Trial Study Group. Rapid growth and childhood obesity are strongly associated with lysoPC(14:0). Annals of Nutrition &amp; Metabolism2014;64(3-4):294-303. [DOI: 10.1159/000365037] [PMID: 25300273]SochaP , GroteV , GruszfeldD , JanasR , DemmelmairH , Closa-MonasteroloR , et al, European Childhood Obesity Trial Study Group. Milk protein intake, the metabolic-endocrine response, and growth in infancy: data from a randomized clinical trial. American Journal of Clinical Nutrition2011;94(Suppl 6):1776S-84S. [DOI: 10.3945/ajcn.110.000596] [PMID: 21849603]TotzauerM , EscribanoJ , Closa-MonasteroloR , LuqueV , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Different protein intake in the first year and its effects on adiposity rebound and obesity throughout childhood: 11 years follow-up of a randomized controlled trial. Pediatric Obesity2022;12:e.12961. [DOI: 10.1111/ijpo.12961] [PMID: 36355369]TotzauerM , LuqueV , EscribanoJ , Closa-MonasteroloR , VerduciE , ReDionigiA , et al, European Childhood Obesity Trial Study Group. Effect of lower versus higher protein content in infant formula through the first year on body composition from 1 to 6 years: follow-up of a randomized clinical trial. Obesity (Silver Spring, Md.)2018;26(7):1203-10. [DOI: 10.1002/oby.22203] [PMID: 29932518]WeberM , GroteV , Closa-MasteroloR , EscribanoJ , LanghendriesJP , DainE , et al, European Childhood Obesity Trial Study Group. Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. American Journal of Clinical Nutrition2014;99(5):1041-51. [DOI: 10.3945/ajcn.113.064071] [PMID: 24622805]WeberM , LuqueV , EscribanoJ , ClosaR , VerduciE , ReDionigiA , et al. Effect of early protein supply on body fat deposition during infancy and childhood: a randomized trial. Journal of Pediatric Gastroenterology and Nutrition2016;62(Suppl 1):668-9. [DOI: 10.1097/01.mpg.0000484500.48517.e7]">Koletzko 2009b</a>, a multicenter trial involving 1138 infants, reported that high‐protein formula was associated with increased weight, weight‐for‐length, and BMI from six months of age. Therefore, the study authors reasoned that feeding infants formula containing 1.8 g protein/100 kcal could reduce the later risk of overweight and obesity. However, the trial's high risk of attrition bias could have affected the findings in terms of height gain. </p> </li> <li> <p><a href="./references#CD013758-bbs2-0079" title="FentonTR , Al-WassiaH , PremjiSS , Sauve Rs. Higher versus lower protein intake in formula-fed low birth weight infants. Cochrane Database of Systematic Reviews2020, Issue 6. Art. No: CD003959. [DOI: 10.1002/14651858.CD003959.pub4]">Fenton 2020</a> found that in low birth weight infants who were exclusively formula‐fed, those fed 3.0 to 4.0 g of protein/kg/day compared with those fed low‐protein formula gained more weight (MD 2.36 g/kg/day, 95% CI 1.31 to 3.40; 5 studies, 114 participants) and height (MD 0.16 cm/week, 95% CI 0.02 to 0.34; 2 studies, 48 participants); however, the infants in <a href="./references#CD013758-bbs2-0079" title="FentonTR , Al-WassiaH , PremjiSS , Sauve Rs. Higher versus lower protein intake in formula-fed low birth weight infants. Cochrane Database of Systematic Reviews2020, Issue 6. Art. No: CD003959. [DOI: 10.1002/14651858.CD003959.pub4]">Fenton 2020</a> had different characteristics and different energy requirements compared to the infants in our review. </p> </li> </ul> </p> <p>Our findings are inconsistent with those reported in two other systematic reviews (<a href="./references#CD013758-bbs2-0072" title="DruetC , StettlerN , SharpS , SimmonsRK , CooperC , SmithGD , et al. Prediction of childhood obesity by infancy weight gain: an individual-level meta-analysis. Paediatric and Perinatal Epidemiology2012;26(1):19-26. [DOI: 10.1111/j.1365-3016.2011.01213.x] [PMID: 22150704]">Druet 2012</a>; <a href="./references#CD013758-bbs2-0116" title="Patro-GołąbB , ZalewskiBM , KowenhovenSM , KaraśJ , KoletzkoB , vanGoudoeverJB , et al. Protein concentration in milk formula, growth and later risk of obesity: a systematic review. Journal of Nutrition2016;146(3):1-14. [DOI: 10.3945/jn.115.223651] [PMID: 26865649]">Patro‐Gołąb 2016</a>). </p> <p> <ul id="CD013758-list-0030"> <li> <p><a href="./references#CD013758-bbs2-0116" title="Patro-GołąbB , ZalewskiBM , KowenhovenSM , KaraśJ , KoletzkoB , vanGoudoeverJB , et al. Protein concentration in milk formula, growth and later risk of obesity: a systematic review. Journal of Nutrition2016;146(3):1-14. [DOI: 10.3945/jn.115.223651] [PMID: 26865649]">Patro‐Gołąb 2016</a> observed that healthy infants younger than three years who were fed high‐protein formula grew more in length than those fed low‐protein formula in the first three months of life (MD 0.27 cm, 95% CI 0.02 to 0.52; P = 0.03; I<sup>2</sup> = 42%; 4 RCTs, 998 participants). However, this difference disappeared when the participants reached one year of age, possibly because <a href="./references#CD013758-bbs2-0116" title="Patro-GołąbB , ZalewskiBM , KowenhovenSM , KaraśJ , KoletzkoB , vanGoudoeverJB , et al. Protein concentration in milk formula, growth and later risk of obesity: a systematic review. Journal of Nutrition2016;146(3):1-14. [DOI: 10.3945/jn.115.223651] [PMID: 26865649]">Patro‐Gołąb 2016</a> did not analyze the growth of the participants in terms of z‐score values (the usual method of assessment; <a href="./references#CD013758-bbs2-0065" title="Center for Disease Control and Prevention. CDC growth charts: United States. cdc.gov/growthcharts/background.htm (accessed 24 April 2023).">CDC 2009</a>). </p> </li> <li> <p><a href="./references#CD013758-bbs2-0072" title="DruetC , StettlerN , SharpS , SimmonsRK , CooperC , SmithGD , et al. Prediction of childhood obesity by infancy weight gain: an individual-level meta-analysis. Paediatric and Perinatal Epidemiology2012;26(1):19-26. [DOI: 10.1111/j.1365-3016.2011.01213.x] [PMID: 22150704]">Druet 2012</a> is a systematic review of observational studies with 4766 participants. It concluded that infants fed with high‐protein formulas during the first 12 years of life had an increased risk of developing obesity (OR 1.97, 95% CI 1.83 to 2.12; P = 0.21; I<sup>2</sup> = 30%; 10 cohorts, 47661 participants). However, the design of the studies included in the review limit the certainty of the evidence. </p> </li> </ul> </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013758-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Screen4Me summary diagram." data-id="CD013758-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Screen4Me summary diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/full#CD013758-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-FIG-02" target="_blank"><b></b></a></p> </div><img alt="PRISMA diagram illustrating the study selection process." data-id="CD013758-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>PRISMA diagram illustrating the study selection process.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/full#CD013758-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013758-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/full#CD013758-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD013758-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/full#CD013758-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 1: Underweight (weight‐for‐age z‐score)" data-id="CD013758-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 1: Underweight (weight‐for‐age z‐score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 2: Underweight (weight‐for‐age z‐score): subgroup analysis by duration of treatment" data-id="CD013758-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 2: Underweight (weight‐for‐age z‐score): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 3: Stunting (height‐for‐age z‐score)" data-id="CD013758-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 3: Stunting (height‐for‐age z‐score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 4: Stunting (height‐for‐age z‐score): subgroup analysis by duration of treatment" data-id="CD013758-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 4: Stunting (height‐for‐age z‐score): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 5: Wasting (weight‐for‐height z‐score)" data-id="CD013758-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 5: Wasting (weight‐for‐height z‐score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 6: Wasting (weight‐for‐height z‐score): subgroup analysis by duration of treatment" data-id="CD013758-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 6: Wasting (weight‐for‐height z‐score): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 7: Overweight" data-id="CD013758-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 7: Overweight</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 8: Overweight (formula with complementary foods): subgroup analysis by duration of treatment" data-id="CD013758-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 8: Overweight (formula with complementary foods): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 9: Obesity" data-id="CD013758-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 9: Obesity</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 10: Obesity (formula with complementary foods): subgroup analysis by duration of treatment" data-id="CD013758-fig-0014" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 10: Obesity (formula with complementary foods): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 11: Any adverse event" data-id="CD013758-fig-0015" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 11: Any adverse event </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 12: Adverse events (sole feeding method)" data-id="CD013758-fig-0016" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 12: Adverse events (sole feeding method) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 13: Adverse events (formula with complementary foods)" data-id="CD013758-fig-0017" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 13: Adverse events (formula with complementary foods) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 14: Weight (kg)" data-id="CD013758-fig-0018" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 14: Weight (kg) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 15: Weight (kg): subgroup analysis by duration of treatment" data-id="CD013758-fig-0019" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 15: Weight (kg): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 16: Height (cm)" data-id="CD013758-fig-0020" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 16: Height (cm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 17: Height (cm): subgroup analysis by duration of treatment" data-id="CD013758-fig-0021" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 17: Height (cm): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 18: BMI (z‐score)" data-id="CD013758-fig-0022" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 18: BMI (z‐score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 19: BMI (z‐score): subgroup analysis by duration of treatment" data-id="CD013758-fig-0023" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 19: BMI (z‐score): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.20" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 20: BMI (kg/m2)" data-id="CD013758-fig-0024" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.20.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.20.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 20: BMI (kg/m<sup>2</sup>) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.20.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.21" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 21: BMI (kg/m2): subgroup analysis by duration of treatment" data-id="CD013758-fig-0025" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.21.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.21.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 21: BMI (kg/m<sup>2</sup>): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.21.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.22" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 22: Head circumference (z‐score)" data-id="CD013758-fig-0026" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.22.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.22.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 22: Head circumference (z‐score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.22.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.23" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 23: Head circumference (z‐score): subgroup analysis by duration of treatment" data-id="CD013758-fig-0027" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.23.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.23.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 23: Head circumference (z‐score): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.23.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.24" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 24: Head circumference (cm)" data-id="CD013758-fig-0028" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.24.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.24.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 24: Head circumference (cm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.24.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-001.25" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 25: Head circumference (cm): subgroup analysis by duration of treatment" data-id="CD013758-fig-0029" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.25.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-001.25.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1: High‐protein formula versus standard‐protein formula, Outcome 25: Head circumference (cm): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-001.25.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 1: Underweight (weight‐for‐age z‐score)" data-id="CD013758-fig-0030" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 1: Underweight (weight‐for‐age z‐score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 2: Underweight (weight‐for‐age z‐score): subgroup analysis by duration of treatment" data-id="CD013758-fig-0031" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 2: Underweight (weight‐for‐age z‐score): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 3: Stunting (height‐for‐age z‐score)" data-id="CD013758-fig-0032" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 3: Stunting (height‐for‐age z‐score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 4: Stunting (height‐for‐age z‐score): subgroup analysis by duration of treatment" data-id="CD013758-fig-0033" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 4: Stunting (height‐for‐age z‐score): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 5: Wasting (weight‐for‐height z‐score)" data-id="CD013758-fig-0034" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 5: Wasting (weight‐for‐height z‐score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 6: Wasting (weight‐for‐height z‐score): subgroup analysis by duration of treatment" data-id="CD013758-fig-0035" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 6: Wasting (weight‐for‐height z‐score): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 7: Any adverse event" data-id="CD013758-fig-0036" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 7: Any adverse event </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 8: Adverse events: subgroup analysis by type" data-id="CD013758-fig-0037" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 8: Adverse events: subgroup analysis by type </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 9: Weight (kg)" data-id="CD013758-fig-0038" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 9: Weight (kg) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 10: Weight (kg): subgroup analysis by duration of treatment" data-id="CD013758-fig-0039" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 10: Weight (kg): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 11: Height (cm)" data-id="CD013758-fig-0040" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 11: Height (cm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 12: Height (cm): subgroup analysis by duration of treatment" data-id="CD013758-fig-0041" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 12: Height (cm): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 13: BMI (z‐score)" data-id="CD013758-fig-0042" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 13: BMI (z‐score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 14: BMI (z‐score): subgroup analysis by duration of treatment" data-id="CD013758-fig-0043" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.14</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 14: BMI (z‐score): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 15: BMI (kg/m2)" data-id="CD013758-fig-0044" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.15</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 15: BMI (kg/m<sup>2</sup>) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 16: BMI (kg/m2): subgroup analysis by duration of treatment" data-id="CD013758-fig-0045" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.16</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 16: BMI (kg/m<sup>2</sup>): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 17: Head circumference (z‐score)" data-id="CD013758-fig-0046" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.17</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 17: Head circumference (z‐score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 18: Head circumference (z‐score): subgroup analysis by duration of treatment" data-id="CD013758-fig-0047" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.18</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 18: Head circumference (z‐score): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 19: Head circumference (cm)" data-id="CD013758-fig-0048" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.19</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 19: Head circumference (cm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013758-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/urn:x-wiley:14651858:media:CD013758:CD013758-CMP-002.20" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 20: Head circumference (cm): subgroup analysis by duration of treatment" data-id="CD013758-fig-0049" src="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.20.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_t/tCD013758-CMP-002.20.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.20</div> <div class="figure-caption"> <p>Comparison 2: Standard‐protein formula versus low‐protein formula, Outcome 20: Head circumference (cm): subgroup analysis by duration of treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/media/CDSR/CD013758/image_n/nCD013758-CMP-002.20.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013758-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">High‐protein formula versus standard‐protein formula in healthy term infants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>High‐protein formula versus standard‐protein formula in healthy term infants</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Population:</b> healthy, full‐term, formula‐fed infants<br/><b>Setting:</b> outpatient<br/><b>Intervention:</b> high‐protein formula (≥ 2.5 g per 100 kcal)<br/><b>Comparison:</b> standard‐protein formula (1.8 g to &lt; 2.5 g per 100 kcal) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with standard‐protein formula</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with high‐protein formula</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Underweight (weight‐for‐age z‐score)</b> </p> <p>Follow‐up: median 4 months, maximum 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean weight‐for‐age z‐score was 0.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD0.05 higher</b> (0.09 lower to 0.19 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1629<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are unsure if feeding healthy term infants high‐protein formula compared to standard‐protein formula has an effect on weight‐for‐age z‐score in the first year of life. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Stunting (height‐for‐age z‐score)</b> </p> <p>Follow‐up: median 4 months, maximum 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean height‐for‐age z‐score was 0.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD0.15 higher</b> (0.05 lower to 0.35 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1629<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are unsure if feeding healthy term infants high‐protein formula compared to standard‐protein formula has an effect on height‐for‐age z‐score in the first year of life. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Wasting (weight‐for‐height z‐score)</b> </p> <p>Follow‐up: median 4 months, maximum 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean weight‐for‐height z‐score was 0.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.12 lower</b> (0.31 lower to 0.07 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1629<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are unsure if feeding healthy term infants high‐protein formula compared to standard‐protein formula has an effect on weight‐for‐height z‐score in the first year of life. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Overweight</b> </p> <p>Follow up: 5 years</p> </td> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.26</b> (0.63 to 2.51) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1090</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We are unsure if feeding healthy term infants high‐protein formula compared to standard‐protein formula has an effect on risk of overweight in the first five years of life. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>26 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b> </p> <p>(16 to 65)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Obesity</b> </p> <p>Follow up: 5 years</p> </td> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.96</b><br/>(0.59 to 6.48) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1090<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We are unsure if feeding healthy term infants high‐protein formula compared to standard‐protein formula has an effect on risk of obesity in the first five years of life. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>7 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b><br/>(4 to 48) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No studies reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> </p> <p>Follow‐up: median 4 months, maximum 1 year</p> </td> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Study population</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.93</b><br/>(0.76 to 1.13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>445<br/>(4 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There may be little or no difference between the risk of adverse events with high‐protein formula versus standard‐protein formula in healthy term infants in the first year of life. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>342 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>318 per 1000</b><br/>(260 to 387) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>RR:</b> risk ratio; <b>RCT:</b> randomized controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level for attrition bias (data available in up to 55% of the random sample), one level for inconsistency (I<sup>2</sup> &gt; 30%), and one level for imprecision (wide 95% CI encompassing both potential benefit and potential harm).<br/><sup>b</sup> Downgraded one level for attrition bias (data available in up to 55% of the random sample), two levels for inconsistency (I<sup>2</sup> &gt; 80%), and one level for imprecision (wide 95% CI encompassing both potential benefit and potential harm).<br/><sup>c</sup> Downgraded one level for attrition bias (data available in up to 55% of the random sample) and two levels for imprecision (wide 95% CI encompassing both potential benefit and potential harm).<br/><sup>d</sup> Downgraded one level for attrition bias (data available in up to 55% of the random sample) and one level for imprecision (wide 95% CI encompasses both potential benefit and potential harm). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">High‐protein formula versus standard‐protein formula in healthy term infants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/full#CD013758-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013758-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Standard‐protein formula versus low‐protein formula in healthy term infants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Standard‐protein formula versus low‐protein formula in healthy term infants</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Population:</b> healthy, full‐term (37 to 42 weeks), formula‐fed infants<br/><b>Setting:</b> outpatient<br/><b>Intervention:</b> standard‐protein formula (1.8 g to &lt; 2.5 g per 100 kcal)<br/><b>Comparison:</b> low‐protein formula (&lt; 1.8 g per 100 kcal) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with low‐protein formula</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with standard‐protein formula</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Underweight (weight‐for‐age z‐score)</b> </p> <p>Follow‐up: median 4 months, maximum 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean weight‐for‐age z‐score was 0</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0</b> (0.43 lower to 0.43 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>256</p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are unsure if feeding healthy term infants standard‐protein formula compared to low‐protein formula has an effect on weight‐for‐age z‐score in the first year of life. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Stunting (height‐for‐age z‐score)</b> </p> <p>Follow‐up: median 4 months, maximum 1 yea</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean height‐for‐age z‐score was 0.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.01 lower</b> (0.36 lower to 0.35 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>256</p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are unsure if feeding healthy term infants standard‐protein formula compared to low‐protein formula has an effect on height‐for‐age z‐score in the first year of life. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Wasting (weight‐for‐height z‐score)</b> </p> <p>Follow‐up: median 4 months, maximum 1 year</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean weight‐for‐height z‐score was 0.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.13 higher</b> (0.29 lower to 0.56 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>256</p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We are unsure if feeding healthy term infants standard‐protein formula compared to low‐protein formula has an effect on weight‐for‐height z‐score in the first year of life. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Overweight</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No studies reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Obesity</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No studies reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No studies reported this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Adverse events</b> </p> <p>Follow‐up: maximum 4 months</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Peto OR 1.55</b> (0.70 to 3.40) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>206</p> <p>(2 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There may be little or no difference between the risk of adverse events with standard‐protein formula versus low‐protein formula in healthy term infants in the first year of life. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>114 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>167 per 1000</b><br/>(83 to 305) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>OR:</b> odds ratio; <b>RCT:</b> randomized controlled trial. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level for selection bias, two levels for inconsistency (I<sup>2</sup> &gt; 80%), and one level for imprecision (wide 95% CI encompassing both potential benefit and potential harm).<br/><sup>b</sup> Downgraded one level for selection bias, one level for inconsistency (I<sup>2</sup> &gt; 30%), and one level for imprecision (wide 95% CI encompassing both potential benefit and potential harm).<br/><sup>c</sup> Downgraded one level for selection bias and one level for imprecision (wide 95% CI encompassing both potential benefit and potential harm). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Standard‐protein formula versus low‐protein formula in healthy term infants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/full#CD013758-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013758-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">High‐protein formula versus standard‐protein formula</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Underweight (weight‐for‐age z‐score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1629</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.09, 0.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.24, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.11, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Underweight (weight‐for‐age z‐score): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.13, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1555</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.13, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.08, 0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.11, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.5 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.01, 0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.6 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.12, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.7 &gt; 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.01, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Stunting (height‐for‐age z‐score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1629</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [‐0.05, 0.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.32, 0.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.02, 0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Stunting (height‐for‐age z‐score): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.17, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1555</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.10, 0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [‐0.05, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.02, 0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.5 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.17, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.6 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.22, 0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.7 &gt; 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.17, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Wasting (weight‐for‐height z‐score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1629</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.31, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐0.41, 0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.37, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Wasting (weight‐for‐height z‐score): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.41, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1555</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.30, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.18, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.37, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.5 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.08, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.6 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [‐0.00, 0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Overweight <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.63, 2.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.63, 2.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Overweight (formula with complementary foods): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.63, 2.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 8 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.73, 1.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.3 11 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.83, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Obesity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.96 [0.59, 6.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.96 [0.59, 6.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Obesity (formula with complementary foods): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.1 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.96 [0.59, 6.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.2 8 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.09 [0.91, 4.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.3 11 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.63, 2.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>445</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.76, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>291</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.78, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.01, 3.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Adverse events (sole feeding method) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.1 Vomiting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.29 [0.55, 19.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.2 Milk hypersensitivity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.91 [0.39, 21.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Adverse events (formula with complementary foods) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.1 Diarrhea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.01, 1.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.2 Vomiting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.00, 6.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Weight (kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1629</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.12, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.18, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.12, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 Weight (kg): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.09, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>465</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.15, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.09, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.28, 0.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.5 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.01, 0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.6 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.25, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.7 &gt; 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.12, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 Height (cm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1629</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [‐0.19, 0.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐0.39, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [‐0.52, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.17 Height (cm): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.33, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>465</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [‐0.23, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [‐0.21, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.45, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.5 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐0.67, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.6 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐1.06, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.7 &gt; 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.76, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.18 BMI (z‐score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1629</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.32, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.18.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.39, ‐0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.18.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.39, 0.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.19 BMI (z‐score): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.19.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.30, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.19.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1555</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.29, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.19.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.20, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.19.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.39, 0.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.19.5 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.10, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.19.6 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.03, 0.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.19.7 &gt; 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.11, 0.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.20 BMI (kg/m<sup>2</sup>) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1629</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.22 [‐0.53, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.20.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐0.59, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.20.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.73, 0.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.21 BMI (kg/m<sup>2</sup>): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.21.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.38, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.21.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>465</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.50, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.21.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1264</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.37, 0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.21.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.35 [‐1.04, 0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.21.5 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.15, 0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.21.6 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1244</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [‐0.07, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.21.7 &gt; 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [1.13, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.22 Head circumference (z‐score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.21, 0.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.22.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.39, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.22.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.13, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.23 Head circumference (z‐score): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.23.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐0.18, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.23.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [‐0.25, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.23.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.17, 0.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.23.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.21, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.23.5 3 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.13, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.23.6 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.34, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.24 Head circumference (cm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.00, 0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.24.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐0.28, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.24.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.04, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.25 Head circumference (cm): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.25.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [‐0.35, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.25.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>344</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.05, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.25.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.07, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.25.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.16, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.25.5 3years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.04, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.25.6 5 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.37, 1.23]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">High‐protein formula versus standard‐protein formula</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013758-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Standard‐protein formula versus low‐protein formula</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Underweight (weight‐for‐age z‐score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.43, 0.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.66, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [‐0.10, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Underweight (weight‐for‐age z‐score): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.37, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.43, 0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.04, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [‐0.10, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.5 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.26, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Stunting (height‐for‐age z‐score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.36, 0.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.55, 0.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [‐0.04, 0.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Stunting (height‐for‐age z‐score): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.30, 0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.37, 0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.01, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [‐0.04, 0.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.5 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.29, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Wasting (weight‐for‐height z‐score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.29, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐0.39, 0.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.21, 0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Wasting (weight‐for‐height z‐score): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.13, 0.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [‐0.18, 0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.05, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.21, 0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.5 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.28, 0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [0.70, 3.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [0.70, 3.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Adverse events: subgroup analysis by type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.1 Diarrhea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.64, 3.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.2 Vomiting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.12, 1.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.3 Milk hypersensitivity</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.24, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.9 Weight (kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.32, 0.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.44, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [‐0.09, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.10 Weight (kg): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.12, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.06, 0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐0.07, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.22 [‐0.09, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.5 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.41, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.11 Height (cm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.81, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.11.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐1.08, 0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.11.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.06, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.12 Height (cm): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.28 [‐0.91, 0.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐1.65, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [‐0.13, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.06, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.5 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.97, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.13 BMI (z‐score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.34, 0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.13.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.46, 0.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.13.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.25, 0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.14 BMI (z‐score): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.14.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.29, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.14.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.31, 0.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.14.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.03, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.14.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.25, 0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.14.5 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.28, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.15 BMI (kg/m<sup>2</sup>) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.53, 0.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.15.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.63, 0.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.15.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.41, 0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.16 BMI (kg/m<sup>2</sup>): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.16.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.50 [‐1.17, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.16.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.47, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.16.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.12, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.16.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.41, 0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.16.5 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.40, 0.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.17 Head circumference (z‐score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.55, 0.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.17.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐1.20, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.17.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.17, 0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.18 Head circumference (z‐score): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.18.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.49, 0.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.18.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.53, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.18.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐0.05, 0.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.18.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.17, 0.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.18.5 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.29, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.19 Head circumference (cm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.92, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.19.1 Sole feeding method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐1.46, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.19.2 With complementary foods</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.35, 0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.20 Head circumference (cm): subgroup analysis by duration of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.20.1 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐1.22, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.20.2 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.22, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.20.3 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.08, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.20.4 1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.35, 0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.20.5 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.56, 0.36]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Standard‐protein formula versus low‐protein formula</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013758.pub2/references#CD013758-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013758.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013758-note-0015">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013758-note-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013758-note-0014">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD013758-note-0011">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ko#CD013758-note-0009">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD013758-note-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD013758-note-0013">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD013758-note-0007">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013758-note-0008">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013758\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013758\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013758\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013758\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013758\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013758\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013758\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013758\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013758\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013758\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013758\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013758\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013758\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013758\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013758\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013758\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013758\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013758\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=na56WA6j&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013758.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013758.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013758.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013758.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013758.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740724295722"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013758.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740724295727"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013758.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e5f565bfff409',t:'MTc0MDcyNDI5Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 